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ABSTRACT 
 
Living or working within an unhealthy environment is attributed to 12.6 million deaths 
worldwide and 2.2 million deaths in Africa. Ambient air pollution (AAP) exposure is amongst 
the major contributors of environmental and air quality decay. Durban South Africa (SA) is a 
rapidly developing city that requires increased infrastructure, transportation, and energy 
production to support the growing urban population. This leads to air quality degradation, in 
addition to the heavy burden of human immunodeficiency virus (HIV) and obesity SA faces 
increase the susceptibility of pathological conditions including respiratory diseases and adverse 
birth outcomes. Infants in utero are particularly vulnerable to adverse AAP effects, attributed to 
oxidative stress (OS), inflammation and genetic susceptibility, due to their biological 
vulnerability, sensitivity to their environment and rapid differentiation and growth.  
 
South Durban (SD) comprises a complex mix of dense residential settlements and heavily 
industrialised areas with high levels of air pollution (AP). This makes SD an ideal location to 
investigate the effects of AAP, in particular, traffic-related AP (atmospheric oxides of nitrogen 
(NOx)), on OS and endoplasmic reticulum (ER) stress responses within third trimester pregnant 
women. A comparison sample of pregnant women, located within north Durban (ND) of similar 
socio-economic status were used for this study. The susceptibility of OS markers, including 8-
oxo-7,8-dihydro-2’-deoxyguanosine (8-OHdG) DNA adducts, lipid peroxidation (LP) and nitric 
oxide (NO) levels, on adverse birth outcomes, including low birthweight (LBW) and pre-term 
birth (PTB), were also determined. Additional risk factors such as HIV, obesity and single 
nucleotide polymorphisms (SNP) within genes of the antioxidant response pathway were 
investigated for OS and adverse birth outcome susceptibility. Atmospheric NOx pollution data 
were obtained from land use regression modelling that was previously reported. 
 
Atmospheric NOx and maternal serum 8-OHdG adducts were significantly elevated within SD 
living pregnant women. This induction of DNA damage was found to be the direct consequence 
of NOx exposure. Pregnant women carrying the variant and wild-type (wt) genotypes of 
glutathione S transferase (GST) P1 and M1 SNPs, respectively, increased the susceptibility of 
NOx induced OS. Exposure to increased NOx levels significantly reduced the gestational age 
(GA) of these pregnant women, with increased susceptibility for mothers carrying male 
neonates. 
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The wt 8-oxoguanine glycosylase 1 (OGG1) Ser326Cys genotype was found to be associated 
with both HIV and obesity. Therefore pregnant women infected with HIV (HIV+) and carrying 
the wt genotype significantly increased the risk for HIV associated LBW and PTB. In addition, 
living within SD and being exposed to higher levels of AAP significantly increased the 
susceptibility for PTB. Comorbid HIV and obesity were identified as additional risk factors for 
birthweight (BW) reduction. 
 
Increased maternal serum NO levels were observed within HIV+ women, with reciprocal 
activity on malondialdehyde (MDA) levels. Increased levels of NO directly reduced BW, 
especially for HIV+ and SD living women. This suggests NO may play a key role in LBW 
aetiology as a consequence of HIV infection and traffic-related AP.  HIV was shown to 
differentially modulate MDA’s effect on neonatal BW. Exposure to increased levels of NOx and 
HIV infection induced the expression of microRNA (miR)-144, which was shown to negatively 
regulate nuclear factor (erythroid-derived 2)-like 2 (Nrf2). This transcription factor, Nrf2, was 
shown to significantly increase antioxidant gene expressions. Therefore the induction of miR-
144 was implicated as a mechanism for increased OS due to HIV and NOx exposure. In 
addition, elevated ER stress genes were observed within HIV negative SD living patients.  
Hence, exposure to higher levels of AAP within SD led to increased ER stress, which may act 
reciprocally on the induction of ROS leading to increased OS. 
 
These findings indicate that exposure to atmospheric NOx, elevated AAP levels within SD and 
exposure to HIV infection resulted in increased OS with increased susceptibility towards 
adverse birth outcomes within pregnant women. Further studies into the mechanisms proposed 
within a larger population including multiple pollutants and gene interactions may give 
additional insight into the aetiology of adverse birth outcomes as a consequence of AAP 
exposure. 
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INTRODUCTION 
 
The atmosphere is an essential shared source that protects and supports life. However, the 
atmosphere is threatened by anthropogenic activities where large amounts of pollutants are 
released into the ambient air daily. This threatens the air quality, where pollution load has 
become greater than pollutant dispersion, leading to ambient air pollution (AAP). 
 
 Ambient air pollution has been implicated in a wide range of pathological conditions that have 
contributed to 5.4% of deaths worldwide [1]. These conditions include cardiovascular disease, 
asthma, acute respiratory infections and lung cancer [2, 3]. Adverse effects of AAP on human 
health have gained global interest. The most vulnerable population are infants in utero. 
Exposure to AAP has been linked to adverse birth outcomes such as low birth weight (LBW) 
and pre-term birth (PTB) and is associated with infant morbidity, mortality and risk of 
development of respiratory and neurocognitive disorders later in life [4]. The exact mechanism 
by which AAP exposure leads to adverse birth outcomes has yet to be determined, however 
oxidative stress (OS) and inflammation have been implicated including genetic susceptibility. 
 
South Africa (SA) is a developing country with a growing urban population which requires 
increased infrastructure, energy and natural resources for human consumption [5]. This has led 
to the deterioration of the environment and air quality. A major consequence of urbanisation is 
increased road traffic due to the lack of functional public transport, increased vehicle fleets with 
increased emissions from traffic congestion, poor vehicle maintenance, and aged vehicles. 
Additionally, due to poor land use planning, dense human settlements are in close proximity to 
heavily industrialised areas [5]. This is most noticeably observed within the Durban south 
industrial basin (DSIB) or south Durban (SD) in SA, where a large portion of the population 
resides in low-income households or informal settlements.  They form dense communities in 
close proximity to busy roads, for easy access to transport for daily activities, and amidst 
industrialised areas. These communities also rely heavily on domestic fuels, such as coal, 
paraffin, and wood, for cooking and heating. Upon burning of these fuels, pollutants such as 
oxides of nitrogen (NOx) are released [5]. As a result, large communities are exposed daily to 
large amounts of AAP and this in combination with the heavy burden of human 
immunodeficiency virus (HIV) and obesity that SA is facing, drastically impacts human health. 
 
Oxides of nitrogen comprise 60-70% of pollution associated with vehicle emissions [5]. These 
nitrogen (N) centred free radicals, upon inhalation, are absorbed into the lung tissue and produce 
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free radicals which enter the blood stream. Subsequently, they react with macromolecules 
(proteins, lipids and deoxyribonucleic acids (DNA)) present causing damage including lipid 
peroxidation (LP) and the production of 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-OHdG) 
mutagenic lesions [6–8]. Cytoprotection against these insults are provided by antioxidant 
enzymes including glutathione S-transferases (GSTs) that scavenge and eliminate reactive 
oxygen species (ROS) to prevent oxidant-related damage [9, 10].  Repair mechanisms including 
the DNA repair pathway and its key enzyme human 8-oxoguanine glycosylase 1 (OGG1), help 
mitigate stress through the repair of damaged macromolecules [11, 12].  
 
The antioxidant response is regulated via the antioxidant response element (ARE) and its key 
transcription factor, nuclear factor (erythroid-derived 2)-like 2 (Nrf2) [13–15]. Upon increased 
oxidative damage, Nrf2 dissociates from kelch-like ECH-associated protein 1 (Keap1) and 
translocates to the nucleus. It then binds to the ARE resulting in transcriptional activation of 
specific target genes including antioxidants e.g., superoxide dismutase 2 (SOD2) and catalase 
(CAT) [9, 16]. However, if the production of ROS exceeds the scavenging capacity of 
antioxidants, OS results leading to extensive macromolecular and cellular damage. 
 
Excessive OS may lead to the disruption of cellular calcium homeostasis. The endoplasmic 
reticulum (ER) acts as a major reservoir of intracellular (IC) calcium and therefore plays a 
critical role in calcium homeostasis [17, 18]. This homeostasis is necessary for the proper 
function of the protein folding machinery; disruption results in the activation of the unfolded 
protein response (UPR) pathway that endeavours to restore balance within the ER [19]. 
 
Genetic susceptibility is an important determinate of an individual’s response to toxic insult, 
viz. AAP exposure, HIV infection or obesity [20]. Single nucleotide polymorphisms (SNP) 
within antioxidant genes including OGG1, GST Mu (M) 1 and GST Pi (P) 1 affect their 
enzymatic activity and scavenging potential which could lead to increased OS and subsequent 
damage [10, 21, 22]. Epigenetics influence and regulate gene expression [23]. Non-coding or 
micro- ribonucleic acids (RNA) (miR) are important for Nrf2 regulation. MiR-144 inhibits the 
expression of Nrf2 messenger RNA (mRNA) [24] whilst miR-28 regulates Nrf2 post-
transcriptionally by promoting Nrf2 degradation [25].  These genetic changes in human genes 
may lead to increased susceptibility to disease and neonatal conditions including LBW and 
PTB.  
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An unhealthy environment is linked to ~2.2 million deaths within Africa, of these, ~270,000 
deaths are due to neonatal conditions [26]. In addition, ~57% of the total SA population living 
with HIV are women [27] with 68% being obese [28], suggesting that women and infants in 
utero are greatly at risk for negative impacts of AAP exposure.  Pregnancy, a physiological state 
characterised by its high-energy and elevated basal oxygen demand, favours ROS production 
and increased susceptibility to OS [29]. In the presence of external or internal stressors viz. 
AAP and infection, the antioxidant stores would become saturated leading to increased OS [30, 
31]. Exposure to tobacco smoke and traffic-related air pollution (AP) have been associated with 
increased OS markers within pregnant women [32–34] and reduced foetal growth, LBW and 
PTB [35, 36]. Although OS has been implicated in adverse birth outcome aetiology [37], no 
mechanism linking AAP induced OS to adverse birth outcomes have been identified. In 
addition, HIV and obesity influences need to be considered, due to the heavy burden of these 
conditions in SA. 
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RESEARCH RATIONALE, AIM, HYPOTHESIS, OBJECTIVES AND STUDY 
DESIGN 
 
Research Rationale 
In order to reduce the incidence of adverse birth outcomes due to AAP exposure, improvements 
in diagnosis, interventions, and treatments are mandatory. For this to occur it is essential to 
understand how exposure to AAP induces adverse birth outcomes. This will ensure that novel 
biomarkers and targeted interventions can be developed. Oxidative stress has been implicated 
and exploring associated mechanisms may give insight into the aetiology of adverse birth 
outcomes which could help in its proper management. 
 
In SA, we have a unique population, heavily burdened with HIV and obesity. In addition to 
genetic susceptibility, these conditions may affect an individual’s response to environmental 
exposures. Investigating these interactions is therefore paramount for biomarker and 
intervention research. 
 
Aim 
The study aimed to investigate the effect of ambient air pollution exposure on oxidative and 
endoplasmic stress profiles within third trimester (T3) pregnant women, their subsequent effect 
on neonatal adverse birth outcomes and whether HIV and obesity influenced these effects. The 
study was conducted by comparing pregnant women living in the heavily polluted south 
Durban, with pregnant women living in the less-industrialised north Durban (ND), SA. 
 
Hypothesis 
Exposure to high pollution levels and HIV infection would induce oxidative stress profiles 
within pregnant women and lead to increased incidence of adverse birth outcomes including 
reduced foetal growth. 
 
Objectives 
The study was designed to determine: 
1. The effect NOx pollution had on oxidative stress markers within T3 and their subsequent 
effect on adverse birth outcomes  
2. Whether polymorphisms within genes of the antioxidant response pathways: GSTP1 and 
GSTM1, and DNA repair pathway: OGG1, affected the susceptibility of adverse birth 
outcomes within pregnant woman exposed to AAP, HIV, and obesity. 
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3. Whether epigenetic regulation of the Nrf2-Keap1 pathway by miR-144 and miR-28 within 
T3, was influenced by exposure to higher or lower pollution levels and HIV infection. 
4. The effect NOx pollution exposure in SD and ND had on the induction of the endoplasmic 
reticulum stress pathway within T3 and their subsequent effect on adverse birth outcomes. 
 
Study Design 
This study was conducted as a branch of the Mother and Child in the Environment (MACE) 
birth cohort study. Ethical clearance from the Biomedical Research Ethics Committee of the 
University of Kwa-Zulu Natal (BF263/12) (Appendix 1) and informed consent from study 
participants was obtained. 
 
Briefly, women were recruited from public antenatal clinics present within three hospitals 
(Wentworth, Prince Mshiyeni and King Edward VIII Hospitals) in the heavily polluted SD. 
Whilst, a comparison sample of women with similar socio-economic status were recruited from 
public antennal clinics present within three hospitals (Addington, Mahatma Gandhi and King 
George V Hospitals) in the less-industrialised ND, in SA. 
 
Upon enrolment, a questionnaire was completed which included the following relevant 
information: demographics, residential and antenatal history and potential confounding factors 
such as environmental and occupational exposures, maternal smoking, dietary history and pre-
existing medical conditions. Follow up interviews were conducted at each trimester subsequent 
to enrolment and prior to delivery, to evaluate any changes such as exposures, dietary changes 
and pregnancy complications. In addition, clinical parameters of the mother were assessed at 
trimester one (T1) and T3 visits including height, weight and the levels of haemoglobin (Hb), 
iron (Fe) and blood pressure (BP) that were used in subsequent analyse discussed in the 
following chapters. 
 
The basic clinical data of all neonates were obtained from birth records, including intra-labour 
history, birthweight (BW) and other anthropometric data. These were used in subsequent 
analyse discussed in the following chapters. 
 
Environmental exposure data and other biochemical data collection methods are discussed in 
detail within the relevant chapters. 
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CHAPTER 1 
LITERATURE REVIEW 
 
1.1.  Ambient air pollution 
The deterioration of air quality and general environmental degradation are frequently observed 
within developing countries. Rapid industrialisation, economic expansion, increased 
urbanisation due to the natural growth of the urban population and rural migration are 
implicated [5, 38]. This deterioration of air quality is of major public health concern, as 
exposure to AAP has been associated with adverse health consequences ranging from 
pulmonary to neurological conditions, including cardiovascular diseases, cancer and most 
notably adverse birth outcomes [2–4].  
 
Anthropogenic activities are the major cause of environmental AP; emitted from industrial 
facilities, motor vehicles, forest fires, tyre burning and burning of fossil fuels among others. 
Various pollutants have been identified; differing in their chemical composition and reactivity, 
whether they are transported via long or short ranges and their persistence within the 
environment. Their composition within ambient air ranges from gaseous pollutants, such as 
NOx and sulphur dioxide (SO2), to particulate matter (PM), such as dust, pollen and ultrafine 
particles (PM0.1). The main route of exposure is via inhalation, with ingestion and dermal 
contact minor routes of exposure. Upon inhalation, pollutants are absorbed and depending on 
their mode of action may enter general circulation and propagate their effects [3, 38].  The 
induction of OS within the lung, whether by inducing oxidants or impairing antioxidants; which 
initiates a cascade of responses, has been implicated in AAP mode of toxicity on human health. 
An influx and activation of inflammatory cells is one such response, where large quantities of 
free radicals are generated and released which may potentiate the pollutant effects [6]. 
 
1.1.1. Gaseous pollutants 
1.1.1.1. Nitrogen oxides 
Several forms of NOx exist within the ambient air, however, the two main forms are nitrogen 
dioxide (NO2) and nitric oxide (NO) [39]. Nitrogen oxides are generated by reactions between 
oxygen and N at high temperatures from combustion processes. Greater quantities of NO (90-
95%) compared to NO2 (5-10%) are released into the air. In ambient air, NO rapidly oxidises 
with oxidants present (oxygen, ozone, and volatile organic compounds) to form NO2 [6, 39, 40].  
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Major outdoor sources of NOx, are combustion processes from motor vehicles and stationary 
sources (i.e. power generation and heating). In urban areas, road traffic is the major contributor 
to atmospheric NOx. Principal indoor sources include tobacco smoke and burning of fossil 
fuels, wood, gas, oil, and kerosene for cooking or heating (Figure 1.1). Indoor levels are also 
determined by outdoor sources; poor ventilation and close proximity to heavily congested roads, 
would increase NOx levels indoors [39, 40]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Sources of Nitrogen oxides. The major outdoor sources are depicted in A) motor vehicle 
emissions, which produce 60-70% total NOx emissions in urban areas, and E) stationary combustion 
sources such as factories. The main indoor sources are depicted in image B) smoking and burning of C) 
wood and D) gas, common practices in the majority of households for cooking and heating (Images 
adapted from the internet [41]). 
 
Nitrogen dioxide has limited solubility in aqueous solutions and is an N-centred free radical 
with strong oxidising potential [6]. Inhalation of atmospheric NO2 and subsequent absorption 
and degradation in the lung fluids, forms metabolically activate and stable nitrites and nitrates. 
These metabolites are rapidly absorbed and translocated via the blood stream. Due to their 
strong oxidising potential, they are capable of interacting directly with lung-tissue components 
(protein and lipids) present resulting in a cascade of radical production, thereby exerting its 
A 
B 
D 
C 
E 
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effect [3, 34]. Studies have shown, in animal models and under environmentally relevant levels 
of NO2, atmospheric NO2 elevates LP (dose and time-dependent), reduces antioxidant enzyme 
activities including SOD, glutathione reductase and glutathione peroxidase (GPx) [42] and 
decreases reduced glutathione (GSH) [43–45]. Exposure in utero has been associated with 
placental LP, impaired neonatal development and PTB [34, 46, 47]. 
 
1.1.1.2. Ozone 
Ozone is highly reactive and formed through the interaction of sunlight with NOx and reactive 
hydrocarbons [48]. It is the main component within photochemical smog and the inhalation of 
slightly elevated concentrations (60–120 ppb) may cause several respiratory symptoms 
including decreased lung function, pulmonary inflammation, and increased airway hyper-
reactivity. Ozone is a relatively insoluble gas and powerful oxidant; it directly oxidises the 
substrate present (cells present at the air-tissue interface, including protein and lipids) resulting 
in a cascade of secondary ozonation products [6] and LP [48]. Studies have reported oxidative 
damage due to the activation of heat shock proteins, Nrf2, pro-inflammatory cytokines and c-
Jun onco genes [49, 50]. 
 
1.1.1.3. Carbon monoxide 
Carbon monoxide (CO) is formed through the incomplete combustion of carbonaceous fuels 
including wood, kerosene, petrol, coal and natural gas. The main outdoor sources of exposure 
are from road transportation and parking areas, whilst indoor sources include combustion of 
domestic fuels for cooking and heating [39, 40]. It is a reproductive toxicant that interferes with 
oxygen delivery to the foetus. Carbon monoxide displaces oxygen from Hb which shifts the 
oxyhaemoglobin dissociation equilibrium. It has been demonstrated that CO crosses the 
placental barrier which leads to its accumulation. This leads to low levels of oxygen within 
foetal blood as a result of CO-poisoning and causes oxidative injury [46, 51]. 
 
1.1.1.4. Sulphur dioxide 
Sulphur dioxide is generated through the combustion of sulphur-containing fossil fuels, such as 
coal and heavy oils. It is also produced through the smelting of sulphur containing ores [3].  The 
induction of OS, as a consequence of SO2 reactivity properties within an aqueous environment, 
has been implicated in the role of SO2 toxicity [52]. Studies in mice have reported reduced 
antioxidant activity (SOD and GPx) [53], elevated LP in mice testicles [54], brains, liver, lungs, 
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and heart [53]. Exposure in utero has been associated with functional and developmental 
toxicities [46, 55]. 
 
1.1.2. Particulate matter 
Particulate matter consists of a broad spectrum of particle types, of which a large portion 
induces OS via radical formation. The major sources of PM include power plants, factories, 
refuse incinerator fires, motor vehicles and windblown dust [40]. Particles are classified by their 
relative diameter (µm); coarse (PM10), fine (PM2.5), PM0.1 and nanoparticles. Inhaled PM10 
particles are mainly deposited on the upper airways and removed via mucociliary clearance; 
whilst PM2.5 and PM0.1 (about 50% of PM10 composition) are able to reach the lung parenchyma. 
Thus suggesting, PM2.5 and PM0.1 contribute more significantly to PM toxicity [3, 38, 56]. 
 
The relatively small size of PM allows it to escape phagocytosis, be absorbed into the blood 
stream and disperse into various organs, upon entry into the lung. This PM entry into the body 
could result in oxidative injury and pro-inflammatory processes within the lungs and other 
target organs, including the placenta [46, 57]. Ultrafine particles have been shown to cross the 
placental barrier and interact with membrane proteins, especially growth factor receptors and 
impair their function. This could lead to decreased placental size and impaired nutrient and 
oxygen exchange; which has been associated with increased blood coagulation and viscosity 
which alters blood perfusion [57]. 
 
Major constituents of PM are transition metals and polycyclic aromatic hydrocarbons (PAH). 
They have been associated with OS, cytokine induction, and inflammation [58, 59]. 
 
1.1.2.1. Transition metals 
Transition metals present on the particle surface have the ability to induce OS. These metals 
enter the environment through waste-water discharges, combustion, and manufacturing facilities 
[3]. Metals such as Fe, cobalt, and chromium undergo redox cycling, whilst lead, nickel, and 
mercury deplete GSH and protein-sulphydryl groups resulting in the production of ROS [56]. 
Metal catalysts are important in the Fenton oxidation reaction, where superoxide and hydrogen 
peroxide interact with transition metals, i.e. Fe and copper (Cu), via Fenton- Haber-Weiss 
reaction (Figure 1.2) to form hydroxyl radicals. Metal ions are also capable of direct interaction 
with cellular molecules and generate radicals such as thiol radicals. Thiol radicals may react 
with other thiol molecules to generate singlet oxygen which is converted to hydrogen peroxide 
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and induces additional ROS generation [60]. Metal ions also bind to proteins which disrupt 
antioxidant enzyme function and attack nucleic acids and proteins that result in the disruption of 
gene expression [3]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 The Fenton- Haber-Weiss reaction. The Haber-Weiss net reaction produces hydroxyl radicals 
from hydrogen dioxide and superoxide, which is catalysed by Fe [61]. 
 
1.1.2.2. Polycyclic aromatic hydrocarbons 
Polycyclic aromatic hydrocarbons are organic components carried on particulate surfaces. They 
indirectly induce OS, by cytochrome P450 biotransformation and generation of redox active 
quinones that act as free radical catalysts [6]. Polycyclic aromatic hydrocarbons have been 
associated with increased DNA-adduct formation [62–64], that is dose-dependent [65, 66]. 
Particulate matter has been implicated in the transfer of PAH from its surface across the 
placental barrier. The PAH within the placenta, interferes with placental development and the 
delivery of nutrients and oxygen to the foetus. This leads to reduced foetal nourishment in utero, 
as a consequence of increased blood viscosity and decreased placental blood flow [46, 58, 59]. 
 
Determining the exact mechanism by which pollutants exert their toxicity is challenging. This 
could be due to the differing concentrations of pollutants in the ambient air among locations, 
each possessing its own unique microenvironment. In addition, potential pollutant interactions, 
due to temperature differences and environmental pressures may affect their toxicity. 
Developing countries, such as SA, allow for the unique environment and ideal location for 
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investigating AAP effects on human health, especially those most vulnerable including woman, 
children, and infants in utero, due to the limited AAP monitoring sites and controls and a 
rapidly growing population in close proximity to pollution sources. 
 
1.2. Durban South Industrial Basin 
Durban, located within the province of KwaZulu-Natal, SA, is the second largest city by 
population in the country. It is home to the largest and busiest port including the primary route 
for exported petroleum and imported crude oil [67]. 
 
Apartheid-era policies that prioritised national strategic growth resulted in the heavy 
industrialisation of SD, with little regard for pollution load on the atmosphere and the effects of 
pollutant interactions. Thus it is considered one of the most heavily polluted and highly 
industrialised areas within SA. Today, SD comprises approximately 600 industries, including 
SA’s two largest oil refineries , pulp and paper mills, petroleum industries, a sugar refinery, 
waste-water treatment works, major chemical and petrochemical storage facilities, motor 
industries, breweries and other small industries [67, 68].  
 
Poor historic land use planning resulted in the juxtaposition of dense labour communities 
amongst industrial activity, with over 400,000 people living within this industrial hub today 
(Figure 1.3). In addition, to the continuous growth of vehicular traffic, aggravated by the 
dysfunctional rail service and public transport, shipping pollution and heavy truck traffic, 
creates a unique AP exposure setting [68, 69].  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 South Durban – Residential communities living within close proximity to industrial activity 
[70]. 
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The south Durban or often termed “South Durban Industrial Basin” is approximately 24km long 
and 4km wide, ranging from the central Durban business district southward to Umbogintwini 
(Figure 1.4).  The ‘basin’ like topography, due to the seaward ancient sand dunes at the coast 
(70-110m in height) and a ridge of hills landward (100-150m in height), in combination with the 
multiple pollutant sources in close proximity to dense residential areas in SD, create and possess 
adverse public health impacts. Dispersion of pollutants during the night and early morning is 
minimal, resulting in high levels of pollution; this deteriorates further in winter where surface 
temperature inversions prevent the upward migration of pollutants [67, 68]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Location of south Durban in South Africa, depicting the entanglement of residential and 
industrial areas [71]. 
 
Major pollutants of interest within this area include: SO2 emissions from stationary refineries 
and paper mills, NOx emitted from road traffic and industry and PM10 mainly emitted from 
traffic and industry with additional influences from biomass burning, dust, and salt. High levels 
13 
 
of these pollutants have been measured within SD [67, 72]. The communities living within SD 
are majority low-income households and informal settlements that rely heavily on domestic 
fuels such as coal, wood, and paraffin for cooking and heating. In addition to poor ventilation, 
the use of small-scale appliances that are poorly maintained, result in increased emissions of 
indoor AP including NOx, which puts them at risk for adverse health impacts of AAP [5]. 
 
Previous studies have shown that although the AAP levels fell below the national and 
international guidelines; SO2 and PM10 were significantly associated with adverse health 
outcomes; including moderate to severe asthma documented within children of school going 
age, within SD [69, 73]. In addition, higher levels of OS markers were observed in pregnant 
women exposed to AAP in SD compared to the less industrialised ND [74]. However, this study 
did not link these increased markers of OS to a particular pollutant, nor determined what impact 
these markers had on neither neonatal birth outcomes nor health later in life, if any. The adverse 
health outcomes associated with SD AAP emissions resulted in the monitoring of these toxic 
emission levels from industries within SD [67]. 
 
South Durban located within the city’s major transport routes including the national roads and 
highways, exposes residents to high levels of traffic-related AP, especially during morning and 
evening traffic (also times of low pollutant dispersion) [67]. Traffic-related AP, e.g. NOx, is 
rapidly worsening due to increased vehicle fleets, increased distance travelled, and high rates of 
emission from motor vehicles. High emission rates are due to road congestion which increases 
the rate of emission to km travelled, poor vehicle maintenance, and high age of vehicles [5]. The 
close proximity of these communities to heavily congested highways and roads, allows for the 
continuous exposure to traffic-related AP. Therefore, SD residents are highly vulnerable to 
traffic-related AP effects, especially those most susceptible to AAP adverse effects. 
 
1.3. Pregnancy, Adverse birth outcomes and Ambient air pollution exposure 
Infants in utero are among the most vulnerable to toxicant exposure, viz. AAP exposure. This 
susceptibility due to their biological vulnerability, sensitivity and rapid rates of replication and 
differentiation puts them at risk for impaired organ function and disease susceptibility later in 
life [38, 57]. 
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1.3.1. Pregnancy 
Pregnancy is a physiological state that is characterised by elevated basal oxygen demand and 
high-energy requirement for various organ functions including the foeto-placental unit [30, 31], 
which exhibits increased susceptibility to OS and OS-related injury. The human placenta is rich 
in mitochondria [29] and consumes about 1% of maternal basal energy production; it is highly 
vascular and exposed to high partial pressures of oxygen [31].  
 
During the first few months of development, the placental barrier is >20µm thick and under 
hypoxic conditions; as no perfusion can occur. Nutrient exchange occurs only through passive 
diffusion. Increased capillary production, occurs as pregnancy continues, which decreases the 
placental barrier thickness [57]. This results in a fully developed foeto-placental unit that 
favours the exchange of gas, nutrients and metabolic products from the foetal to the maternal 
blood circulation. 
 
Oxygen exchange across the placental barrier from maternal to foetal circulation is favoured by 
the low oxygen partial pressure, foetal Hb that has high affinity for oxygen and low pH of foetal 
blood [31]. The oxygen rich environment, increased energy consumption and abundant 
mitochondria mass within the placenta favours ROS production. The macrophage rich placenta 
also favours local production of free radicals, including NO metabolites and reactive nitrogen 
species (RNS) [31]. These increases in ROS and RNS can contribute to OS during in utero 
exposure to AAP. 
 
Exposure to PM and PAH in utero have been shown to affect placental development [57, 59]. 
Studies have shown that OS in pregnancy has been associated with placental ischemia, 
repetitive hypoxia-reperfusion injury that results from improper spiral arteriole development 
[75, 76]. The alteration in utero-placental and umbilical cord flow, glucose and oxygen transport 
across the placental barrier negatively influences foetal growth [77].   
 
1.3.2. Adverse birth outcomes and Ambient air exposure 
Ambient air pollution exposure has been implicated in adverse birth outcomes including LBW, 
intrauterine growth retardation (IUGR), preeclampsia and PTB. These adverse birth outcomes 
have been significantly associated with increased infant morbidity; that ranges from neural to 
pulmonary conditions as well as infant mortality.  They have also been shown to pre-dispose an 
individual to chronic diseases in adulthood [4].  
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Low birthweight affects 20 million people worldwide [78], whilst PTB has been implicated in 
75% of neonatal morbidities and 70% of neonatal deaths [38]. These adverse birth outcomes 
occur as a result of restricted foetal growth and/or reduced length of gestation; with neonates  
weighing <2500 g at birth and premature delivery of a foetus before 37weeks of gestation, 
respectively. Environmental factors have been associated with reduced BW and gestational age 
(GA) [79]. 
 
Many studies have been done to determine whether environmental tobacco smoke (ETS) 
elevates the risk for adverse birth outcomes, including LBW (reviewed elsewhere [32, 33]). 
Among these Ahluwalia et al. found that ETS exposure increased the risk for adverse birth 
outcomes and was modified by maternal age [80]. However, exposure to ETS can potentially be 
avoided, unlike ambient air exposure.   
 
The effects of AAP on foetal outcomes have become an important topic of study and are of 
great public health concern [51]. The first report of LBW babies were born to mothers living in 
highly polluted areas in Los Angeles (United States of America); in the early 1970s [81]. 
Following this initial report, publications sharply increased and extensive reviews were done 
which highlight all the current data about LBW  [2, 4, 46, 57, 82] and PTB [4, 46, 83], and their 
association with AAP. Studies have shown both an association and no association between 
LBW, PTB and AAP; however, there is extensive evidence that supports the idea that exposure 
to AAP whilst pregnant, increases the risk for LBW and PTB (Table 1.1). 
 
Table 1.1 Evidence of ambient air pollution and its association/non-association with low birthweight and 
pre-term birth 
Author AAP type LBW- Association Trimester of Exposure Country (Year) 
Wang et al. 1997 Total suspended 
particles (TSP), 
SO2, complex 
pollution mix 
Increased risk of LBW 3rd Trimester Beijing (1988-1991) 
Ritz & Yu 1999 CO Significant increased risk for LBW 3
rd Trimester Los Angelas, CA 
(1989-1993) 
Bobak & Leon 
1998 
SO2, NO2, TSP LBW associated with SO2 and TSP  Czech Republic 
(1986-1988) 
Bobak 2000 SO2, NO2, TSP LBW and PTB associated with SO2 and 
TSP 
1st Trimester Czech Republic 
(1991) 
Rogers et al. 2000 SO2, TSP VLBW associated with very high levels  George Health Care 
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of SO2, TSP District 9, USA 
(1986-1988) 
Maisonet et al. 
2001 
SO2, CO, PM10 SO2 and CO increase risk of LBW 
PM10 no association to LBW 
Increased ambient levels associated 
increased risk of LBW 
3
rd
 Trimester North-eastern USA 
(1994-1998) 
Vassilev et al. 2001 Polycyclic 
organic matter 
(POM) 
High POM concentrations associated 
with LBW and PTB 
 New Jersey (1990-
1991) 
Maroziene & 
Grazuleviciene 
2002 
NO2, Ambient 
formaldehyde 
Ambient formaldehyde associated with 
increased risk of LBW. 
10µg/m3 increase in NO2 concentrations 
increased risk of PTB by 25% 
1st Trimester City of Kaunas 
(1998) 
Liu et al. 2003 SO2, CO, Ozone, 
PM10, NO2 
Increased SO2 associated with LBW 
PTB associated with SO2 and CO 
exposure 
1st Trimester (LBW) 
3rd Trimester (PTB) 
Vancouver, Canada 
(1985-1998) 
Mishra et al. 2004 Biomass cooking 
fuels (wood, 
dung) 
Preliminary data -high pollution cooking 
fuels associated with LBW 
 Zimbabwe (1994-
1999) 
Seo et al. 2007 PM10, CO, SO2, 
NO2 
PM10, SO2 and NO2 increased risk of 
LBW 
CO increased personal risk of LBW 
3rd Trimester Seoul, South Korea 
(2002-2003) 
Nascimento & 
Moreira 2009 
SO2, ozone, PM10 SO2 and ozone associated with LBW – 
also risk factors for LBW 
PM10 not associated with LBW 
 São Paulo State, 
Brazil (2001) 
Ballester et al. 
2010 
NO2 Exposure to NO2 (>40µg/cm
3) associated 
with reduced birth length, BW and head 
circumference 
1st Trimester Valencia, Spain 
(2003-2005) 
Kloog et al. 2012 PM2.5 PM2.5 associated with increased risk of 
LBW and PTB 
3rd Trimester Massachusetts (2000-
2008) 
Clemente et al. 
2016 
NO2 10µg/m
3 increases in NO2 associated 
with 48g decrease in BW 
1st, 2nd and 3rd Trimester Spain and Belgium 
(2004-2008) 
Hao et al. 2016 NO2, CO, PM2.5 All pollutants investigated were 
associated with PTB 
1st, 2nd and 3rd Trimester Georgia, USA (2002-
2006) 
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1.3.2. Adverse birth outcomes and Oxidative stress 
The aetiology of adverse birth outcomes due to AAP exposure is not fully understood. 
However, factors that have been associated with AAP induced LBW and PTB pathology are 
OS, inflammation, endothelial dysfunction, reduced oxygen transport across the placenta and 
abnormalities of the placenta (Figure 1.5) [4].   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Ambient air pollution’s potential mechanism for foetal toxicity leading to adverse birth 
outcomes. Inhaled AP enters the alveolus resulting in free radical production, which targets 
macromolecules present within the alveolus tissue. This results in OS and inflammation which is able to 
cross into the maternal blood stream and subsequently affect foetal growth through increased OS and 
inflammation within the placenta [98]. 
 
Pregnancy favours ROS production and presents with increased susceptibility to OS, due to the 
limited levels of foetal antioxidants [99], therefore several studies have investigated OS as a 
potential risk factor for LBW and PTB (Table 1.2). These studies demonstrate that increased OS 
markers as well as decreased antioxidant defence result in OS observed in LBW and PTB 
neonates.  
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Table 1.2 Evidence for Oxidative stress as a mechanism for LBW and PTB 
 
Although studies have reported AAP exposure and OS, individually increase the risk of adverse 
birth outcomes, and OS is implicated in AAP toxicity. Investigating the biological mechanisms 
through which OS induced by AAP affects neonatal birth outcomes, could allow for their 
targeted interventions and treatments. In addition, identifying other factors such as genetic 
predisposition and periods of infant vulnerability would allow for the better understanding of 
AAP induced toxicities and disease susceptibility.  
 
Author Oxidative stress markers LBW- Association Country (Year) 
Matsubasa et al. 
2002 
Urinary 8-OHdG levels Increased 8-OHdG levels associated with LBW 
and PTB 
Japan 
Gupta et al. 2004 Cord blood – SOD, CAT, GSH and serum 
malondialdehyde (MDA) 
Increased MDA and decreased SOD, catalase, 
GSH (OS) associated with LBW 
New Delhi, India 
Kim et al. 2005 Maternal urinary 8-OHdG levels and 
MDA 
Increased 8-OHdG and MDA levels associated 
with PTB and reduced BW in full-term neonates 
Korea (2000-
2001) 
Kamath et al. 
2006 
Maternal and foetal MDA and proteolytic 
activity 
Increased LP and protein oxidant damage 
associated with IUGR (SGA) 
Manipal 
Chadha et al. 2007 Maternal blood and urine NO metabolites 
levels 
Increased levels of NO metabolites associated 
with PTB 
India 
Saker et al. 2008 Total antioxidant activity (ORAC), 
vitamin A, C and E, carbonyl proteins,   
hydro-peroxides, erythrocyte CAT, GPx, 
glutathione reductase, SOD, lipid and 
lipoprotein 
Decreased ORAC, vitamin C and E values, high 
plasma hydro-peroxide and carbonyl protein, 
decreased SOD and CAT – OS associated with 
LBW 
Algeria 
Gveric-
Ahmetasevic et al. 
2009 
MDA, serum peroxide and antioxidant 
capacity 
Mothers and babies exposed to OS associated 
with LBW 
Placental LP may be associated with LBW 
pathophysiology 
Croatia 
Rossner et al. 
2011 
Placental- 8-OHdG levels Increased 8-OHdG associated with LBW Czech Republic 
(1994-1998) 
Negi et al. 2012 Cord blood – MDA, carbonyl proteins, 
total antioxidant capacity, vitamin A, E 
and C 
Increased LP and protein oxidation with 
decreased vitamin A, E, C and antioxidant 
capacity (OS) associated with preterm-LBW 
India 
Kumarathasan et 
al. 2016 
Plasma 8-isoprostane (OS marker) The 8-isoprostane was negatively associated 
with BW and GA 
Canada 
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1.4. Oxidative Stress 
Interest in prenatal exposure to AAP and its subsequent effects on adverse birth outcomes is 
growing rapidly. As the pollutants discussed previously, act either as free radicals or have the 
potential to generate free radicals, and pregnancy favours ROS production due to its highly 
oxygen-rich and energy requiring state, OS has therefore been suggested as a mediator of AAP 
toxicity leading to adverse birth outcomes. 
 
Oxidative stress, within the human body, is the biochemical imbalance of oxidants and 
antioxidants that refers to a disturbance in the excessive production of oxidants over 
antioxidants [105]. Human redox biochemistry is predominantly made up of oxygen, as cells 
and cellular mechanisms require a reducing environment to function. Therefore, human cells are 
under constant threat by highly ROS as a natural consequence of aerobic respiration [106]. In 
analogy to OS, RNS function and are able to react with ROS to potentiate OS-damage [107]. 
Oxidative stress has been implicated in pathological conditions such as Parkinson’s disease, 
Rheumatoid arthritis and adverse birth outcomes [105, 108]. 
 
1.4.1. Reactive oxygen species 
Mitochondrial respiration is essential for energy production within human cells. A natural by-
product of this process is ROS, which includes both radicals and nonradicals. A radical is a 
chemical species that possesses one or more unpaired electrons and the ability for its 
independent existence. Radicals are less stable than non-radicals [108]. Radicals of importance 
in humans: include hydroxyl ions, superoxide, NO, and singlet oxygen. Non-radicals contain 
only paired electrons, with most biological molecules being nonradicals. Other non-radical 
compounds produced in high concentrations include hydrogen peroxide, ozone, and molecular 
oxygen (O2) [109]. This reactivity is necessary for normal molecular function through high-
energy transfers within the mitochondria to produce adenosine triphosphate (ATP), an essential 
energy source for cellular processes [105]. 
 
Oxidative phosphorylation, a process that involves the transfer of electrons through the 
mitochondrial electron transport chain (ETC), creates a proton gradient across the inner 
mitochondrial membrane that drives ATP synthesis.  This transfer of electrons results in the 
reduction of each protein complex until the electron is accepted by O2 to form water. However, 
about 1-3% of electrons entering the ETC are not accepted by O2 to form water but are instead 
catalysts for the reduction of oxygen into superoxide. These reduction reactions occur at 
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complexes I (nicotinamide adenine dinucleotide dehydrogenase) and III (ubiquinone-
cytochrome c reductase), where complex III is the main site of superoxide production 
(Figure1.6) [110]. The ROS produced via the ‘leaky’ ETC are highly reactive and their close 
proximity to their targets which include DNA, protein and lipids have great potential to cause 
deleterious effects [106].   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Mitochondrial reactive oxygen species production. During oxidative phosphorylation within 
the ETC, a leakage of electrons from complex I and III react with oxygen to form superoxide. This is a 
highly reactive molecule and undergoes the Fenton-Haber-Weiss reaction to produce hydroxyl radicals. 
The ROS are free to react and damage macromolecules within their proximity [111]. 
 
1.4.2. Antioxidants 
The human body has developed an antioxidant defence system that scavengers free radicals, as a 
result of continuous reactive metabolic insult. This defence system maintains the delicate 
balance between oxidants and antioxidants to prevent cellular damage [112]. There are two 
types of antioxidants: enzymatic and non-enzymatic. 
 
1.4.2.1. Enzymatic antioxidants 
Enzymatic antioxidants possess a transition metal core which allows them to move between 
valences and scavenge free electrons from ROS, during the detoxification process.  
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1.4.2.1.1. Superoxide dismutase 
The enzyme SOD exists as three isoforms: SOD1 which contains a metal co-factor comprising 
Cu-zinc (Zn) and is present within the cytosol, nucleus and plasma. Superoxide dismutase 2 has 
a manganese (Mn) core and is primarily located within the mitochondria. Lastly, the 
extracellular SOD3 comprises a Zn and Cu core similar to SOD1 [75, 109]. Superoxide 
dismutase catalyses the removal of superoxide and generates hydrogen peroxide as the reaction 
product (Figure 1.7). 
 
   2O2
-
 + 2H
+
               H2O2 + O2 
Figure 1.7 Dismutation of the superoxide radical into oxygen and hydrogen peroxide (Prepared by 
author). 
 
1.4.2.1.2. Catalase 
Catalase is an enzyme that removes hydrogen peroxide present in high concentrations, and is 
found in peroxisomes in most tissue. The enzyme consists of four protein subunits that contain 
ferric ions of the haem group. Two molecules of hydrogen peroxide are reduced to O2 by CAT. 
The ferric ions of CAT are oxidised after interaction with the first molecule of hydrogen 
peroxide to produce Fe
4+
 (compound 1). The second molecule of hydrogen peroxide acts as an 
electron donor resulting in the production of O2 (Figure 1.8) and the complete detoxification of 
two hydrogen peroxide molecules [109]. 
 
 
  H2O2         Compound 1 
 
  H2O2  + compound 1                   O2 + 2H2O 
 
  2H2O2         O2 + 2H2O 
Figure 1.8 Catalase detoxification of hydrogen peroxide (Prepared by author). 
 
1.4.2.1.3. Glutathione peroxidase 
Glutathione peroxidase exists in five isoforms and possesses high affinity for and removes 
hydrogen peroxide, generated by SOD in the cytosol and mitochondria. Its catalytic function is 
dependent on the presence of selenium within its active site and is important in protecting the 
lipid environment against oxidative damage [113].  
SOD 
CAT 
CAT 
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Glutathione is an essential thiol antioxidant that is formed within all human cells of the body. 
The formation of GSH occurs within the cytosol; it comprises of cysteine (Cys), glycine and 
glutamate, and is regulated by its de novo synthesis that is catalysed by ƴ-glutamylcysteine 
synthase and glutathione synthase [75]. Glutathione participates in various detoxifying reactions 
forming glutathione disulphide (GSSG). Glutathione is restored by glutathione reductase which 
requires reduced nicotinamide adenine dinucleotide phosphate (NADPH); generated in the 
pentose phosphate pathway [105]. The removal of hydrogen peroxide by GPx utilises GSH, as 
electron donors, where it is oxidised to form GSSG. The oxidation of two GSH molecules by 
hydrogen peroxide results in the formation of oxidised GSSG and two molecules of water 
(Figure 1.9) [105, 109]. 
 
 2GSH + H2O2    GSSG + 2H2O  
Figure 1.9 Glutathione peroxidase reduction of hydrogen peroxide to water (Prepared by author). 
 
1.4.2.1.4. Glutathione S transferase 
Glutathione S transferase inactivates secondary metabolites such as epoxides, unsaturated 
aldehydes and hydro-peroxides. There are three families of GSTs: cytosolic, mitochondrial and 
membrane-associated microsomal GSTs. The cytosolic GSTs are further divided into seven 
classes: Alpha, Mu, Pi, Sigma, Theta, Omega and Zeta. During non-stressed cells, Mu and Pi 
classes of GST interact with kinases apoptosis signal-regulating kinase 1 and c-Jun N-terminal 
kinases (JNK). It has been shown that GSTP1 dissociates from JNK in response to OS [60]. 
However, GST function has been shown to be influenced by genotypic differences from SNPs, 
common polymorphisms have been found in GSTP1 and GSTM1 genes [114]. These genetic 
polymorphisms may influence an individual’s susceptibility to OS and subsequent OS-related 
conditions, including adverse birth outcomes. 
 
The GSTM1 gene, a member of the Mu family, is located on chromosome 1p13.3 [115]. A 
homozygous deletion of this gene results in the complete loss of enzyme activity; and is known 
as the null genotype [116, 117]. This deletion has been associated with increased asthma and 
wheezing among children who were exposed to ETS in utero [10, 118, 119], cardiovascular 
disease [120, 121] and increased levels of 8-OHdG adduct in individuals exposed to organic 
carbon and SO2 [122]. This polymorphism was also suggested to increase the susceptibility of 
mothers to gestational diabetes mellitus [123]. 
 
GPx 
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The GSTP1 gene contains 7 exons and is located on chromosome 11q13 [115]. A functional 
polymorphism (Ile105Val; AA  AG/GG) in GSTP1 occurs due to the substitution of valine 
(Val) for isoleucine (Ile) at codon 105 within GSTP1. This affects the enzymes active site’s 
substrate specificity [124, 125]. Studies have shown that the wt (A105) has a threefold higher 
catalytic activity than the variant (G105) for 1-chloro-2,4-dinitrobenzene; however, the reverse is 
observed for PAH diol epoxides with a seven-fold difference [126]. This polymorphism’s 
variant genotype has been linked to an increased risk in cancer [127–129], increased 
susceptibility to NOx in individuals exposed to traffic-related AP [130] and increased levels of 
8-OHdG in oesophageal cancer patients [131]. 
 
1.4.2.2. Non-enzymatic antioxidants 
Non-enzymatic antioxidants are mainly comprised of synthetic antioxidants and dietary 
supplements such as GSH, selenium, vitamin C and E, and Zn that act as ROS scavengers 
resulting in their neutralisation. 
 
Ascorbic acid i.e., vitamin C is a water-soluble, redox catalyst that reduces and neutralises ROS. 
It is an essential cofactor for many enzymes, such as proline hydroxylase and dopamine-β-
hydroxylase. It is an efficient scavenger that acts as an electron donor and neutralises ROS. The 
relative stability of ascorbyl makes it a powerful antioxidant [109]. 
 
Glutathione is a thiol-containing tripeptide; the reduced form of glutathione is glutamic acid-
cysteine glycine. Glutathione is an important cofactor for enzyme peroxidase, therefore serves 
as an indirect antioxidant by donating electrons to detoxify hydrogen peroxide. It is important in 
many other biological functions including metabolism, Cu transport and preventing oxidation of 
sulphydryl protein groups. It also acts as a ROS scavenger where GSH interacts with hydroxyl, 
alkoxyl and peroxyl radicals as well as superoxide. Glutathione is also able to bind transition 
metals and prevent their participation in the Fenton- Haber-Weiss reaction, which requires 
transitional metals, to act as electron donors. In the absence of free transition metals the reaction 
does not occur which inhibits the production of hydroxyl radicals, as described in figure 1.2 
[109].  
 
1.4.3. Imbalance 
Reactive oxygen species are of biological importance as they act as important signalling 
molecules and transcription factors in a diverse range of cell functions, this is comprehensively 
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reviewed elsewhere [105]. However, if ROS production exceeds the capacity of antioxidant 
scavenging, OS results leading to extensive damage of macromolecules such as lipids, proteins, 
and DNA.  
 
Lipid peroxidation occurs as a result of the oxidation of polyunsaturated fatty acid side chains 
(PUFA) by hydroxyl radicals. Protein carbonyl groups are formed from the direct oxidation of 
protein side chains. Abstraction of hydrogen ions (H
+
) within thiol groups of cysteine leads to 
disulfide bond generation which results in misfolded proteins. Hydroxyl radicals also attack 
DNA which generates DNA-adducts such as 8-OHdG. 
 
Mitochondrial DNA is highly susceptible to oxidative attack. It is located close to the site of 
ROS production, has minimal repair mechanisms present, lacks protective histones and has a 
high mutation rate [105, 132, 133].  Mitochondrial DNA encodes proteins that are essential 
within the ETC, therefore mutations within the mitochondria due to ROS attack may lead to 
impaired ATP production which could further increase ROS production, potentiating the 
original OS (Figure 1.10) [105, 109]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10 Oxidative damage induced by reactive oxygen species [109]. 
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Pregnancy is a condition exhibiting increased susceptibility to OS, evidence from studies has 
associated increased OS markers [29] and raised lipid hydro-peroxides and MDA [134, 135] 
within normal pregnancies. It has been suggested that due to the high energy requirement 
necessary for placental and foetal development and increased inflammation, ROS production is 
favoured [136]. It should be noted that Fe supplementation during pregnancy, may also be a 
source for free radical production, as Fe is used within the Fenton- Haber-Weiss reaction to 
produce hydroxyl radicals [135]. Therefore any exogenous or endogenous toxicant is able to tip 
the balance between oxidant and antioxidant causing OS and OS-related damage. It has been 
reported that the DNA adduct, 8-OHdG, can be used as a biomarker of OS within clinical 
studies [7]. 
 
1.4.3.1. DNA damage- 7,8-dihydro-8-oxoguanine adduct  
ROS generates a variety of mutagenic DNA lesions, including abasic or apurinic/apyrimidinic 
(AP) sites, DNA single (ss) or double strand (ds) breaks and base oxidation. Due to guanine’s 
low redox potential, it is highly susceptible to oxidation. This results in the abundant production 
of 8-OHdG mutagenic lesions, with approximately 10
3
 lesions generated per cell per day [137, 
138]. 
 
The hydroxyl radical, when produced adjacent to nuclear and mitochondrial DNA, attacks DNA 
strands leading to the incorporation of radical adducts opposite 8-OHdG which induces the G:C 
 T:A transversion, where it aberrantly pairs with cytosine in an anti-conformation [139, 140]. 
This may lead to the accumulation of GC to TA mutations, if left unrepaired [22]. In addition, 
ROS are able to oxidise nucleotide pools [139]. 
 
Although an increase in modified DNA frequently occurs, the excessive accumulation of 8-
OHdG in DNA has been linked to various inflammatory diseases and adverse birth outcomes 
[138]. The level of genomic 8-OHdG has been shown to correlate well with the dose and length 
of exposure to environmental agents, as well as inhaled environmental pollutant chemical 
composition and physical nature [138, 141, 142]. However, repair mechanisms are present 
within human cells in order to reduce or remove DNA modified bases. 
 
1.5. Base excision repair pathway 
Several repair DNA damage pathways exist, each targeting specific types of damage, to 
counteract the effects of ROS [139]. The base excision repair (BER) pathway preferentially 
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repairs oxidised bases within nuclear and mitochondrial DNA [131]. It comprises short- and 
long- patch pathways, which repair single and two or more nucleotides, respectively [106]. The 
BER preserves genome integrity by utilising glycosylases that excise the mutagenic adduct, 
which subsequently allows endonucleolytic cleavage and gap filling [138]. 
 
In eukaryotes, the 8-oxoguanine DNA glycosylase (OGG1) plays a pivotal role in the BER. It 
recognises 8-OHdG G:C base pairs, catalyses the expulsion of 8-OHdG and the cleavage of the 
DNA backbone which forms an AP site [11, 143]. The cleaved DNA is subsequently completed 
by AP endonuclease, DNA polymerase β and DNA ligase III to repair the oxidative damage 
(Figure 1.11) [144].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11 DNA damage repair initiated by 8-oxoguanine DNA glycosylase. The OGG1 recognises 8-
OHdG and subsequently cleaves the DNA backbone which generates an AP site within the 3’-blocking 
end of the DNA. The cleaved DNA is subsequently cleaved by AP endonuclease 1 to remove the 
aldehyde residue to for a 3’ hydroxyl end, followed by the addition of a guanine base by DNA 
polymerase β which is ligated by DNA ligase III to form a complete DNA strand [145]. 
 
1.5.1. Human 8-oxoguanine glycosylase 1 
The OGG1 gene, mapped on chromosome 3p26.2 encodes the human OGG1 protein. This 
region consists of 7 exons and encodes 345 amino acids (AA) and a bifunctional glycosylase. 
The OGG1 carboxyl (C) –terminus undergoes alternative splicing and generates α-OGG1or β-
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OGG1. The N-terminus, comprising a mitochondrial target sequence, is similar between α-
OGG1 and β-OGG1 proteins, whilst the C-terminus is extensively different. Therefore, the 
production of either α- or β- OGG1 is dependent on the presence of a C-terminal nuclear 
localisation sequence. This sequence, present within α-OGG1 but absent from β-OGG1, 
suppresses the mitochondrial target sequence and is localised in the nucleus. The β-OGG1 
which only consists of the mitochondrial target sequence is localised within the mitochondria 
[137, 139]. Although the α-isoform is located within the nucleus, it is thought to be responsible 
for nuclear and mitochondrial 8-OHdG repair [137]. 
 
The bifunctional glycosylase, OGG1, specifically recognises 8-OHdG paired with cytosine. 
This allows it to cleave oxidative base pairs and degrades adducts within the nucleoside pool 
[139].  The recognition of 8-OHdG by OGG1 occurs through the enzyme’s ability to interact 
directly with a proton present on N7 instead of identifying its 8-oxo-carbonyl feature [106]. 
 
The human OGG1 protein comprising 8 cysteine residues, two of which (Cys253 and Cys255) 
are present within the active site, may be susceptible to regulation through oxidative 
modifications [11]. Cysteines are surrounded by a positive AA sequence which makes it 
susceptible to form reactive thiolate anions; which are particularly predisposed to oxidative 
modifications [22]. Reversible modifications of cysteine residues affect OGG1’s enzyme 
activity [11, 22, 144]. 
  
The activity and expression of OGG1 has been found to be modulated post-transcriptional by 
OS [137] with the OGG1 promoter having binding sites for the specific protein 1 (Sp1) 
transcription factor and Nrf2 antioxidant response element. Its expression was also found to be 
inhibited by NO [11, 144, 146]. 
 
1.5.2. 8-oxoguanine glycosylase 1 serine-326-cysteine polymorphism 
Several DNA repair genes have been shown to be highly polymorphic which alters protein 
structure and function. These changes could influence the genetic susceptibility individuals have 
towards certain diseases, such as carcinogenesis, cardiovascular and inflammatory diseases 
[147, 148]. 
 
Structural analysis of the OGG1 gene demonstrated the presence of several SNPs, the most 
common of these is the serine-326-cysteine (Ser326Cys) rs1052133 OGG1 SNP [143]. Within 
the OGG1 gene, a CG transversion occurs at position 1245 in exon 7, which results in a 
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serine to cysteine AA substitution at codon 326 of the OGG1 protein. Ethnicity determines 
allelic frequency, where Caucasians have a 23-41% frequency for the G allele, the Asian 
population has a frequency of 40-60% [22, 139] and Sub-Saharan African populations were 
found to have 14.4% G allele frequencies [149]. However, limited data is available in African 
populations for the OGG1 Ser326Cys SNP and disease risk [149–152]. 
 
Functional studies have been broadly investigated, in vitro, with purified proteins and in 
cells/cells extracts, to determine the phenotypic impact the OGG1 Ser326Cys SNP has on 
enzyme repair activity [148].  Several studies revealed the Cys326 (G) allele was associated 
with reduced DNA adduct repair activity and posed an increased risk for 8-OHdG formation 
[22]. However, Janssen and colleagues reported no difference in repair activity amongst the wt 
and variant alleles [153]. 
 
Kohno and colleagues’ study revealed the Ser326 wt allele had a repair capacity 7 fold greater 
than the Cys326 variant in Escheria Coli [154]. The greater repair rate of Ser326 compared to 
the C326 variant was also observed by Aka et al. [155]. A similar result was obtained in a 
lymphocyte study where the Cys326 variant protein had 40% reduced repair activity [156]. 
Bravard and colleagues’ demonstrated the Cys326 variant cells presented with a greater genetic 
instability and decreased DNA repair rate [22]. They also showed Cys326 variant protein’s 
repair capacity was sensitive to the cell redox status. Their analyses indicated the reduced 
enzymatic activity within the variant protein was due to the oxidation of its extra cysteine 
residue, which was also suggested by Lee et al. [157].  Bagryantseva and colleagues 
demonstrated a higher level of 8-OHdG in Cys326 variant patients compared to Ser326 wt 
patients exposed to traffic PAH [158]. A Japanese study reported reduced BW and birth length 
in neonates whose mother’s carried the variant genotype, exposed to cigarette smoke; however, 
this association was removed when the study area was controlled [159].  
 
Hill and Evans demonstrated, the Cys326 variant excised 8-OHdG from the dsDNA and cleaved 
AP sites at a rate 2-6 fold lower than Ser326 wt, depending on the base opposite to lesion [160]. 
This was further investigated by Simonelli and colleagues, who demonstrated that homozygous 
Cys326 variant carriers present with decreased cleavage activity, whilst the OGG1 mRNA 
expression remained unaffected [148]. The extra cysteine residue also promoted dimerization of 
Cys326 variant, and the formation of disulfide bond which suggested several factors occur in 
order to impair repair activity. The variant was shown to affect the efficiency of the BER, and 
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this affect in protein conformation and stability was amplified under mild oxidative conditions 
[148].  
 
Although the variant protein is prone to oxidation and undergoes conformational modifications, 
which modulates its cell localisation and catalytic activity, the precise nature of the functional 
defect remains unclear. In addition, no studies have reported the effect of AAP such as NOx and 
PM, has on the susceptibility of adverse birth outcomes in pregnant women carrying the 
Ser326Cys OGG1 SNP. 
 
1.6. Nuclear factor (erythroid-derived 2)-like 2 and Kelch-like ECH-associated protein 1 
signalling 
Cytoprotection against toxic insult within the human body is provided through the expression of 
antioxidant proteins and phase 2 detoxifying enzymes. Under normal conditions, these 
protective proteins are expressed minimally but are highly inducible by transcriptional 
activation, in the presence of low levels of ROS. This co-ordinated response is regulated 
through a cis-acting element known as the ARE which is located on the upstream regulatory 
sequence present on each gene in either single or multiple copies [9, 16].  
 
The laboratories of Kan [13] and Yamamoto [14], simultaneously discovered that Nrf2 is the 
key transcription factor that regulates xenobiotic metabolism via ARE regulated genes. 
Jaiswal’s group subsequently provided evidence for NADPH quinone oxidoreductase positive 
regulation by Nrf2 via its ARE [15]. Nrf2 belongs to a subset of basic leucine-zipper (bZip) 
genes that share a conserved structural domain known as a cap ‘n’ collar (CNC)-domain, 
therefore, the C-terminus of Nrf2 comprises a characteristic bZip CNC domain (Figure 1.12b) 
[13, 161].  DNA binding occurs at the basic region, whilst the leucine-zipper heterodimerises 
with small musculoaponeurotic fibrosarcoma (Maf) proteins. These Maf proteins act as essential 
heterodimeric partners for the binding of large CNC bZip proteins to the GC dinucleotide of 
ARE [16, 162, 163]. Transcriptional activation of Nrf2 is conferred within its N-terminus and at 
the end of its C-terminus. A Nrf2-ECH homology (Neh) 2 domain is present within the N-
terminus, which has been shown to negatively regulate Nrf2 activation via Keap1 [164]. 
 
The suppressor of Nrf2, Keap1 was initially discovered by Yamamoto and colleagues, who 
demonstrated a negative regulatory control of Keap1 over Nrf2 by sequestering it within the 
cytoplasm [164]. Keap1 is a member of the Kelch family that contains two known protein-
interaction domains: the broad complex/tramtrack/bric-a-brac (BTB) and the double glycine 
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receptor (DGR) domain. They are located within the N- and C-terminal region, respectively 
(Figure 1.12a) [9, 16, 165]. The BTB domain mediates homodimerisation and binding of Keap1 
to Cullin 3 (Cul3), a Nrf2 ubiquitin ligase (E3) scaffolding protein. Whereas, binding of Keap1 
to the Neh2 domain of Nrf2, is mediated by the DGR domain. Between the two domains, a 
region abundant in cysteine residues, known as the intervening region (IVR) or linker region 
exists [161, 166, 167]. These three components are important for the regulation of the protective 
response against environmental stresses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12 Domain structures present on a) Keap1 and b) Nrf2 genes. a) The DC domain present on the 
C-terminal of Keap1 binds Nrf2 whilst the N-terminal domain BTB homodimerises and binds Keap1 to 
Cul3. b) The Neh1 domain, present on the C-terminal region of Nrf2, mediates the heterodimerisation of 
small Maf proteins and the ARE on target genes, whilst the Neh2 domain present on the N-terminal binds 
to Keap1[168]. 
 
1.6.1. Under basal conditions, Nrf2 is suppressed by Keap1 
Keap1 interacts directly with the actin cytoskeleton and is co-localised within the cytoplasm 
[169]. Under normal physiological conditions, Nrf2 is sequestered by Keap1 (Figure1.13a). The 
β-propeller within Keap1’s DGR domain initially binds the conserved motif (ETGE) within the 
C-terminus of Nrf2’s Neh2 domain, followed by the Nrf2’s DLG motif. The stability of this 
complex is maintained through extensive inter- and intra-blade hydrogen bonds [9, 161, 167]. 
This Keap1-Nrf2 complex promotes the rapid degradation of Nrf2 by the ubiquitin-proteasome 
pathway, which accounts for the low levels of Nrf2 observed in many cell types due to its short 
a) 
b) 
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half-life of approximately 20 minutes. Keap1-Nrf2 interaction promotes the basal expression of 
cytoprotective genes and proteins within senescent cells [170, 171].   
 
1.6.2. Activation of Nrf2 by ARE inducers 
Upon oxidative insult, as a result of exogenous or endogenous stimuli viz. environmental 
pollution or infection, Nrf2 dissociates from Keap1 and translocates to the nucleus. Nrf2 and 
small Maf proteins form a heterodimer; which then binds to the ARE in the promoter region 
resulting in the transcriptional activation of specific target genes (Figure 1.13b) [9, 161]. Studies 
have shown that c-Jun and activating transcription factor (ATF) 4 can heterodimerise with Nrf2 
and enhance the activation of ARE-driven reporter genes [172, 173]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13 Transcriptional activation of Nrf2. a) Under Basal conditions, Nrf2 is bound to Keap1 within 
the cytoplasm and undergoes proteasomal degradation. b) Upon endogenous or exogenous toxic insult, 
Keap1’s conformation is altered resulting in the release of Nrf2 into the cytoplasm where it translocates to 
the nucleus, heterodimers with small Maf proteins and binds to the ARE of its target gene resulting in its 
transcriptional activation (Prepared by author). 
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A variety of chemicals including environmental agents induce ARE genes through Nrf2 
transcriptional activation [9, 161]. These inducers are all structurally diverse, however, share a 
common property; the ability to modify sulphydryl groups by alkylation, oxidation or reduction 
[174]. This ability of cells to recognise these inducer properties, suggest that they contain 
sensors rich in highly reactive cysteine residues. Therefore, as Keap1 contains 27 cysteine 
residues within its IVR, with Cys257, Cys273, Cys288 and Cys297 being the most reactive, it 
was proposed as a sensor for Nrf2 inducers [16, 174]. This was confirmed within mutational 
studies where Cys151, Cys273 and Cys288 were found to be essential for Keap1 regulation of 
Nrf2 [175, 176].  
 
Several mechanisms result in the dissociation of Nrf2 from Keap1. Inducers are able to change 
the conformational structure of Nrf2-Keap1 complex, by modifying Keap1’s cysteine thiols, 
resulting in the inhibition of Nrf2 ubiquitination. Whilst, other inducers bind directly to Keap1’s 
IVR cysteines thereby preventing the formation of the stability complex, mentioned above, 
which prevents the ubiquitination of the Neh2 domain. Therefore, Nrf2 is able to bypass Keap1, 
enter the nucleus and facilitate transcriptional activation. However, other inducers such as toxic 
metals, are able to directly dissociate Nrf2 from Keap1, allowing Nrf2 stabilisation. In addition, 
Nrf2 transcriptional activation, nuclear translocation and degradation is regulated by covalent 
acetylation/deacetylation or phosphorylation/de-phosphorylation modifications within the Nrf2 
gene [161]. 
 
Protein kinases (PK) have also be identified as possible sensors, where studies have 
demonstrated PKC and protein kinase RNA-like endoplasmic reticulum kinase (PERK) directly 
phosphorylate Nrf2 which results in the dissociation of Nrf2 from Keap1-Nrf2 complex [177–
179]. Therefore suggesting, ER stress may play a role in Nrf2 activation and subsequent 
antioxidant transcription. 
 
1.6.3. Target genes for Nrf2 regulation 
Nrf2 regulates a substantial number of genes. The induction of the Nrf2 transcription factor, 
targets two main groups of regulation which include drug metabolism and disposition and 
antioxidant defence. In addition, Nrf2 regulates cell proliferation, proteasomal protein 
degradation, metabolic reprogramming and oxidative signalling [161, 168, 180, 181].  
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In response to environmental toxins, Nrf2’s induction of drug metabolism enzymes and 
transporters such as cytochrome P450 [182] and GSTs [183, 184], control the metabolic fate of 
numerous pro-oxidants within the body.  
 
An essential regulatory feature of Nrf2 transcriptional activation is the control of ROS 
homeostasis within the cell by its induction of antioxidant enzymes. This control occurs via 
several mechanisms: the induction of stress response proteins such as HO-1, regeneration of 
oxidised cofactors and proteins such as GSSG reduced to GSH, the synthesis of reducing factors 
such as NADPH and GSH and the induction of antioxidant enzymes such as SOD, CAT and 
GPx. Without Nrf2, the induction of cytoprotective proteins are insufficient resulting in 
increased susceptibility of tissues to toxic insult [161, 185, 186].  
 
1.6.4. Epigenetic regulation of Nrf2 
Human genetic susceptibility towards diseases has been an important feature in discovering how 
alterations in the genome predispose an individual to certain adverse conditions. The study of 
epigenetics has been highlighted most notably as a potential mechanism for the regulation of the 
Nrf2-Keap1 pathway. It is defined as the study of heritable changes in gene expression that does 
not alter the DNA sequence [187]. Several epigenetic mechanisms exist that regulate gene 
expression including non-coding RNAs, chromatin remodelling, histone modification and DNA 
methylation [188]. 
 
The non-coding RNAs or miRs are of particular interest in Nrf2 regulation. They are a class of 
small non-coding ssRNAs that are approximately 21-23 nucleotides in length. They exert their 
control over cellular functions including cell proliferation, differentiation and apoptosis through 
post-transcriptional regulation of gene expression. RNA polymerase II transcribes miRs from 
genomic loci, which is then processed by Drosha and transported to the nucleus as short hairpin 
precursors. Dicer then cleaves the miR precursors to generate mature miRs. The mature miRs 
are then loaded onto Argonaut proteins to form the RNA-induced silencing complex (RISC). 
This complex, together with base pairing of the miR onto the 3’- untranslated region (UTR) of 
target mRNAs, results in the inhibition of targeted gene expression. This occurs through either 
mRNA degradation or inhibition of protein translation (Figure 1.14) [24, 25, 189]. 
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Figure 1.14 microRNA Biogenesis. The transcription of miRs from genomic DNA by RNA polymerase 
II, its subsequent cropping by Drosha and exportation out of the nucleus via Exportin-5, is followed by 
cleavage of the precursor miR by DICER. This results in the formation of mature miRs that binds to 
Argonaut proteins to form the RISC complex which leads to the transcriptional inhibition of target genes 
(Prepared by author). 
 
Several studies have identified miRs that regulate Nrf2 and Keap1 signalling. Sangokoya and 
colleagues demonstrated that the miR-144 inhibited the expression of Nrf2 mRNA within a 
myelogenous leukaemia cell line [190]. This was later verified by Yamamoto et al., who 
showed a negative association of miR-144 with Nrf2 and downstream enzymes in response to 
diesel exhaust exposure [24]. The miR-28 was found to post-transcriptionally regulate Nrf2 
expression by binding directly to Nrf2’s mRNA 3’UTR which resulted in Nrf2 mRNA 
degradation. In addition, miR-28 also directly promoted Nrf2 protein degradation. This was not 
as a result of Keap1 protein expression or the Keap1-Nrf2 interaction but rather supressed 
mRNA expression through translational inhibition [25].  
 
The controlled regulation and induction of Nrf2 is important to combat oxidative damage due to 
toxic insult from endogenous and exogenous sources to maintain homeostasis within the body. 
This prevents and helps fight against oxidative injury which may lead to inflammatory diseases, 
cardiovascular disorders, adverse birth outcomes and carcinogenesis. Investigating this pathway 
in response to AAP, and understanding how AAP affects this pathway may identify specific 
targets for potential therapeutic interventions for diseases associated with OS-damage such as 
adverse birth outcomes. 
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1.7. Reactive nitrogen species 
Nitric oxide plays a major role in a variety of physiological processes including: the regulation 
of vasodilation, modification of neurotransmission, memory formation and has anti-microbial 
activity [191–193]. However, its elevated production has also been implicated in several 
inflammatory diseases, neurotoxicity, ischaemia and adverse birth outcomes [34, 107]. The term 
‘nitrosative stress’ was coined by Stamler and colleagues [194], to describe the excessive 
production and dysregulated formation of NO and NO-metabolites.  
 
1.7.1. Chemistry of NO 
NO is a simple heterodimeric molecule that is highly reactive and unstable. It has a half-life of 
about 6-10 seconds [47] and degrades rapidly to form nitrites and nitrates. NO is produced 
endogenously and has exogenous sources. Within the body, NO is synthesised by a family of 
enzymes known as nitric oxide synthases (NOS). There are three isoforms that produce NO: 
neural (nNOS), endothelial (eNOS) and inducible (iNOS); each dependent on structural and 
functional properties including its tissue of origin [195, 196].  
 
The constitutive NOS (cNOS) comprise eNOS and nNOS, which are found within vascular 
endothelial cells, neurons, smooth muscles and platelets. They have been shown to be positively 
modulated by IC levels of calcium and calmodulin binding [197]. NO produced via cNOS act as 
important signalling molecules within the cardiovascular and neural system. 
 
The iNOS are found within immune cells such as macrophages, lymphocytes and neutrophils. It 
does not require activation by calcium and calmodulin, but is rather positively or negatively 
regulated by cell-cell contact in lymphocytes, inflammatory cytokines, bacterial and viral 
endotoxins. The production of NO via iNOS occurs over long periods of time and has been 
shown to be cytostatic or cytotoxic to tumour cells and microbial organisms [197]. 
Inflammatory cytokines that induce iNOS include interleukin (IL)- 1β, IL-6, IL-17, tumour 
necrosis factor (TNF)-α and interferon (IFN)- ƴ,  whilst TNF-β, IL-4, 10, 11 and IL-13 suppress 
iNOS [198]. 
 
All NOS are haemoproteins that produce NO as a reaction by-product, during the catalytic 
conversion of L-arginine to L-citrulline. This reaction requires NADPH and O2 with flavin 
mononucleotide (FMN), flavin adenine dinucleotide (FAD), heme and tetrahydrobiopterin 
(BH4) acting as cofactors (Figure 1.15) [195, 199]. 
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Figure 1.15 Synthesis of nitric oxide as a reaction by-product from the conversion of L-arginine to L-
citrulline [200]. 
 
NO is able to diffuse across the cell membrane and has high affinity for Hb. At low levels of 
NO, it is rapidly inactivated by binding to Hb to form methaemoglobin (methHb) followed by 
degradation to inorganic nitrites and nitrates [201]. However, at higher levels of NO, it rapidly 
reacts with superoxide and O2 to form peroxynitrite and dinitrogen trioxide, respectively. These 
NO intermediates and NO are highly reactive and result in macromolecular damage. The 
modification of peptides and proteins occurs as a result of S-nitrosylation, where NO directly 
modifies cysteine AA of target proteins to form S-nitrothiol adducts, as well as nitration of 
tyrosine in proteins. NO has been shown to directly oxidise to nitrite, which induces DNA 
damage, along with highly reactive peroxynitrite [107, 195, 196, 199]. 
 
Peroxynitrite is the most reactive intermediate of NO oxidation. It exists in two forms: 
nucleophilic or protonated peroxynitrite, it is highly reactive with a half-life <1second. 
Depending on its cellular environment and availability of reactive targets, it undergoes a variety 
of chemical reactions that not only cause nitration of tyrosine but also triggers LP, inactivate 
aconitases, inhibit the ETC and oxidise biological thiol-containing compounds. Peroxynitrite 
decays to form nitrates and undergoes homolytic decomposition to form highly reactive and 
toxic hydroxyl
 
and nitrite radicals [196, 199]. 
 
1.7.2. Lipid peroxidation 
Lipid peroxidation is the oxidative degradation of PUFA to products known as lipid peroxides 
or MDA. It consists of three stages: initiation, propagation and termination. Initiation strictly 
refers to the initial H
+
 abstraction. Termination or LP decomposition is catalysed by transition 
metals and metal complexes [8]. 
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The accumulation of NO within lipid bilayers and lipoproteins (hydrophobic cell regions) 
occurs due to its partition coefficient in octanol/water being 5.5 [199]. In addition, hydroperoxyl 
radicals, formed through the protonation of superoxide, a ROS produced via the ETC, are able 
to accumulate within this hydrophobic environment. This confers increased susceptibility of 
these areas to peroxynitrite attack and subsequent damage [199].  
 
Peroxynitrite then undergoes decomposition to form hydroxyl and nitrite radicals that initiate 
LP chain reactions. These radicals abstract H
+
 from the methylene group within the PUFA 
which leaves being an unpaired electron on the carbon. This C-centred radical undergoes 
molecular rearrangement to form conjugated dienes that react with O2 to form peroxyl radicals, 
which is able to abstract H
+
 itself, which subsequently sets up a chain reaction [199]. The 
peroxyl radical will continue to react with substrates present unless the chain reaction is 
terminated (Figure 1.16). Antioxidants such as vitamin E and other enzymes are able to end the 
reaction [8]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.16 The lipid peroxidation chain reaction. Polyunsaturated fatty acids are oxidised to form fatty 
acid radicals that propagate the chain reaction until final termination into detectable products of LP 
including MDA, 4-hydroxyalkenals and 2-alkenals [202]. 
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Lipid peroxidation has been associated with various inflammatory conditions [8, 203], 
cardiovascular disorders [204, 205] and adverse birth outcomes [103, 206, 207]. 
 
1.7.3. NO inhibition of OGG1 and other zinc-finger motifs 
NO and its intermediates, not only directly target tissue components (lipids, DNA and proteins) 
but are able to inhibit or suppress antioxidant protective systems [208, 209]. The BER is an 
important pathway responsible for the repair of damaged DNA; with OGG1 function of utmost 
importance, as mentioned previously. OGG1, a Zn-finger protein, possess a cysteine rich-
environment and critical thiol moieties that are necessary for catalytic activity [11]. NO and its 
intermediates, have a high affinity for cysteine-rich environments and are potent scavengers of 
cysteine, therefore suggests NO targets OGG1 directly [146]. A study by Jaiswal and 
colleagues, demonstrated that NO directly S-nitrosylates OGG1 which results in the loss of 
bound Zn and the irreversible loss of enzyme activity [12]. This was predated by Wink and 
Laval ‘s study on Zn-finger motif (Fpg) proteins; which showed that NO dramatically inhibited 
the Fpg proteins [146]. It was also found that the Cys326 variant of OGG1 SNP was more 
susceptible to oxidation by NO compared to the Ser326 wt [208]. Other enzymes containing Zn-
finger motifs are possible targets of NO, with studies confirming this that showed cytochrome 
P450 [210] and SOD activity [211] were suppressed by NO action [146]. 
 
1.7.4. Human immunodeficiency virus’s induction of Nitric oxide 
NO plays a pivotal role in the generation of the innate immune response against IC pathogens, 
such as HIV. NO passes readily into viral-infected cells and causes non-specific damage, which 
leads to various pathological events. NO acts as a host response modulator rather than an 
antiviral agent [198, 212]. 
 
HIV is a lentivirus that infects and kills vital immune cells within the body, which leads to 
acquired immune deficiency syndrome (AIDS) when the immune system is completely 
compromised and opportunistic infections are present [213]. HIV, is a ss-positive sense 
enveloped RNA virus, that consists of 9 genes within its genome. These genes encode 19 
proteins essential for its function. The pol gene encodes reverse transcriptase, integrase and 
protease enzymes, the env gene generates glycoprotein (gp) 160 that is cleaved into gp120 and 
gp41 and the gag gene ensures the production of the capsid, matrix and nucleocapsid proteins. 
The 6 remaining genes regulate proteins that control the virus’s ability to infect cells and 
replicate new copies [214]. 
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Upon entry into the target cell, HIV reverse transcribes its RNA genome to dsDNA, by reverse 
transcriptase, and is transported into the nucleus and integrated into the host genome by 
integrase. Once HIV is integrated into the host genome, it either becomes latent to avoid 
detection or it undergoes viral replication. During viral replication, the genome transcribes and 
translates new copies of the viral proteins that are packaged and released from the host cell as 
new viral particles that are able to infect other target cells [214, 215]. 
 
Several studies have found an increase in NO production within HIV infected individuals: 
adults with AIDS showed increased NO production [216], Zangerle and colleagues found HIV 
infected patients had greater nitrites and nitrates compared to blood controls, with even greater 
levels being observed in low CD4 count individuals [217]. The same effect was observed in 
HIV infected children, with an increase in circulating cytokines IL-1β, TNF-α and INF-ƴ, also 
observed [218]. Groeneveld’s study showed serum nitrate was positively associated with cell-
associated and plasma viral loads of HIV [219]. NO was reported to inhibit HIV replication and 
induce HIV reactivation within infected cells. It is speculated that the overproduction of NO is 
able to activate viral replication, especially within the primary infection and late stages of 
disease. However, the low production of NO may inhibit viral replication, most notably 
observed within the symptomless stage of disease or during treatment with antiretroviral drugs 
[198, 220–223]. HIV infected patients have been reported to be under chronic OS, other than the 
increased NO already noted, the tat gene has been shown to enhance Nrf2 expression, therefore, 
leading to the activation of the ARE and decreased GSH levels which induces RO. In addition, 
HIV infection has been reported to compromise SOD activity, increase LP and decrease the 
antioxidant response [212, 224–226]. 
 
HIV has been implicated in NO-mediated RNS, the degradation of the antioxidant system and 
increased risk for adverse birth outcomes such as LBW and PTB (reviewed by Xiao et al. [227]. 
This chronic OS environment could be detrimental to foetal growth and development within 
pregnant woman. However, no studies linking these effects of HIV and the effects of AAP on 
HIV toxicity have been reported. Understanding the combined effect of HIV and AAP exposure 
may identify potential biomarkers or targets of intervention; especially within SA.  
 
1.8. Oxidative stress and Endoplasmic reticulum stress 
The imbalance of ROS, as a result of endogenous or exogenous toxicants, leads to the disruption 
of cellular calcium homeostasis [105].  
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The ER acts as a major reservoir of IC calcium and therefore plays a critical role in calcium 
homeostasis [17, 18]. This homeostasis is necessary for the proper functioning of the protein 
folding machinery; disruption results in the activation of the UPR pathway that endeavours to 
restore balance within the ER (Figure 1.17). This is achieved through co-ordinated steps that 
reduce the misfolded/unfolded protein (UP) concentration through the suppression of protein 
synthesis, facilitation of protein degradation and increasing the protein folding capacity of the 
ER (reviewed elsewhere [18, 19, 228]). Failure to mitigate ER stress can lead to cellular death 
[105]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.17 The unfolded protein response pathway. In stress free conditions, luminal protein chaperone 
binding immunoglobulin protein (BiP) also known as  78 kDa glucose-regulated protein (GRP78) binds 
to the intraluminal domain of the three UPR sensors: PERK, inositol-requiring enzyme 1α (IRE1α) and 
ATF6, rendering them inactive. Upon ER stress and the accumulation of UP and increased protein cargo 
within the ER, BiP dissociates from the UPR sensors and sequesters UP within the ER lumen, due to its 
higher affinity for UP. The dissociation of BiP from IRE1α and PERK causes the oligomerisation, auto-
phosphorylation and activation of these sensors and downstream signalling pathways. The activation of 
the PERK arm leads to the phosphorylation of eukaryotic initiation factor 2 (eIF2) α which subsequently 
induces ATF4 mRNA translation and the inhibition of global protein translation. Pro-apoptotic genes 
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such as CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP) are induced by ATF4 
resulting in cellular death. Global translational inhibition results in decreased translation of antioxidant 
proteins leading to increased ROS and apoptosis. Whilst the dissociation of BiP from ATF6, allows the 
translocation of ATF6 to the Golgi apparatus where it is processed by serine protease 1 (S1P) and 
metalloprotease site-2 protease (S2P) to yield an active transcription factor which enters the nucleus. The 
UP sequestered on BiP are translocated to the cytosol for proteasomal degradation by ER-associated 
degradation (ERAD) machinery. These three arms of UPR pathway endeavour to mitigate ER stress by 
facilitating protein degradation, increasing the ER’s protein folding capacity by inducing protein 
chaperone production and by suppressing protein synthesis [18, 19, 228]. 
 
A reciprocal interplay between ROS production and increased ER stress due to calcium release 
has been suggested. Calcium release channels on the ER membrane, including the ryanodine 
receptor and the inositol-1,4,5-triphosphate receptor (IP3R), are activated by ROS. This induces 
calcium ions (Ca
2+
) to migrate into the cytosol from the ER lumen. Increased IC Ca
2+ 
results in 
the loss of ER chaperone proteins which impairs ER function. This leads to increased UP levels 
that can generate ROS in its attempt to repair UP. Increased IC Ca
2+ 
also adversely affects 
mitochondrial activity which further increases ROS production [105]. This will be discussed in 
detail in sections: 1.8.1. and 1.8.2. below. 
 
1.8.1. Mitochondrial ROS generation as a result of increased intracellular calcium occurs via 
the following mechanisms: 
The mitochondria experiences increased calcium loading; which generates increased ROS 
production. Calcium loading inhibits the ETC at complex III through the opening of the 
permeability transition pore (PTP). This releases cytochrome c from the inner mitochondrial 
membrane which blocks complex III. Calcium inhibition of complex III results in the increase 
of ubisemiquinone radical intermediate (QH·) (the quantity of QH· reflects the amount of 
mitochondrial ROS produced) which increases ROS production. There is also an increase in 
QH· generation observed when the ETC turnover occurs more rapidly [229, 230]. 
 
Additional increases in ROS occur via the following mechanisms: 
 Increased cytosolic Ca2+ stimulates the tricarboxylic acid cycle leading to increased O2 
consumption and ROS production. 
 The Ca2+ induced opening of the PTP may result in GSH leakage into the cytosol from the 
mitochondrial matrix. This indirectly causes increased ROS generation as a result of 
reduced antioxidant capability. 
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The amplified levels of mitochondrial ROS generation; further activates Ca
2+
 release from the 
ER due to their close proximity. Increased Ca
2+
 close to the mitochondria causes increased ROS 
production, as a result of Ca
2+ 
loading and the opening of the PTP. Generation of ROS then acts 
on Ca
2+
 release channels further increasing Ca
2+
. A feedback loop is then established where 
increased IC Ca
2+ 
induces ROS production which increases Ca
2+
 release into the cytosol, which 
loops back around. Therefore, suggesting a reciprocal interaction between ROS and ER stress 
that threatens cell survival [105, 229, 231]. 
 
1.8.2. Unfolded protein repair induces ROS generation by the following proposed 
mechanism: 
The ER is a vast membranous organelle [18] that is the site of synthesis, folding, maturation and 
modification and trafficking of secreted and transmembrane proteins [19, 232]. The addition of 
a disulphide bonds are required for the stability, function and maturation of secretory proteins.  
 
Misfolded proteins, formed as a result of incorrectly paired cysteine residues, may have an 
inappropriate disulfide bond that requires removal [229].  The formation of disulfide bonds 
generates about 25% of ROS in the cell, during ER oxidation protein folding [233].  Disulfide 
bond formation is driven by protein disulfide isomerase (PDI), where PDI becomes oxidized 
and subsequently reduced by ER oxidoreductin 1 that transfers electrons onto O2. This leads to 
the generation of ROS. Reduced GSH may assist this process in UP which results in the 
generation of oxidized GSSG. The depletion of GSH induces ROS formation [229, 234]. 
 
Reactive oxygen species can be generated independent of disulfide bond formation. The 
accumulation of UP, within the ER lumen, causes Ca
2+
 to leak into the cytosol which generates 
ROS production. Alternatively, due to the high energy dependent processes of folding and 
refolding proteins within the ER, ATP depletion could result from UP accumulation. This would 
induce the mitochondrial oxidative phosphorylation pathway to increase ATP turnover thereby 
increasing ROS production [229]. 
 
1.8.3. Ambient air pollution, Adverse birth outcomes and Endoplasmic reticulum stress 
There are a few studies that have investigated the effect of AAP on ER stress. Andersson et al. 
demonstrated that exposure to low levels of 1-nitropyrene (diesel exhaust) increased DNA 
damage which resulted in increased ROS and GRP78, a marker of ER stress [64]. Watterson et 
al. associated PM levels with the induction of ER stress [235]. Laing et al. demonstrated that 
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PM2.5 induced PERK-dependent CHOP expression in mouse lung, liver and macrophage models 
[236]. This induction was dependent on ROS production for PM2.5 induced apoptosis to occur. 
This gives evidence for AAP induced ER stress as a result of ROS production; demonstrating a 
reciprocal interaction between OS and ER stress. 
 
The effect of ER stress on LBW has only been briefly investigated. Kawakami et al. has 
demonstrated that ER stress markers are increased in LBW neonates [237]. This area of research 
is important due to the reciprocal interaction shown between OS and ER stress, as well as the 
strong relationship observed between OS and LBW. It could be a potential mechanism linking 
OS and adverse birth outcome pathology to AAP toxicity. 
 
1.9. Future considerations for ambient air pollution induction of adverse birth outcomes 
In developing and developed countries, low birthweight and preterm birth are important 
indicators of infant morbidity [79]. Ambient air pollution has also increased within countries 
due to large industrial services such as power plants, coal-mines and petroleum factories. The 
vulnerable and highly susceptible state of foetuses in utero, due to their fast differentiation, high 
sensitivity to signals and rapid developmental processes, makes exposure to AAP during 
pregnancy highly risky and harmful.  
 
As mentioned in this review, several studies have shown the negative effect of AAP and foetal 
development, with OS playing an important role in adverse birth outcomes. The mechanism by 
which OS causes these adverse birth outcomes needs further investigation, with ER stress and 
NO metabolism playing an important role in its pathology. The link between ER stress, RNS 
and OS is minimally understood and needs further analysis.  
 
However, in the context of SA, two crucial factors need to be taken into account when 
investigating AAP exposure effects on adverse birth outcomes. These include obesity and the 
HIV status of the pregnant women.  
 
Sub-Saharan Africa is heavily burdened with HIV where approximately 25.6 million people are 
living with HIV, of these about 27.4% are living within SA, with women accounting for more 
than half the total infected population [27]. In addition, SA has the highest obesity rate within 
sub-Saharan Africa, with more than 68% of women classified as overweight or obese [28]. The 
interaction between these conditions and AAP exposure may affect an individual’s 
susceptibility to oxidative injury and disease, as both these conditions are associated with 
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chronic stress and inflammation. In addition, these conditions individually have been associated 
with adverse birth outcomes and infant morbidity; in combination, their effect may be 
potentiated [227, 238, 239]. 
 
The discovery of novel biomarkers and targeted interventions for the prevention of adverse birth 
outcomes, especially within the context of SA, requires the consideration of obesity and HIV 
status of the pregnant women. Identifying risk factors would allow for the better stratification of 
mother’s disease susceptibility and risk, which could lead to better surveillance of AAP as well 
as guide potential targeted interventions. 
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Abstract 
The purpose of the study was to evaluate the effect nitric oxide (NOx) pollution had on maternal 
serum 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-OHdG) levels and neonatal outcomes in 
pregnant women living in Durban, South Africa (SA). Women, in their third trimester with 
singleton pregnancies, were recruited from the heavily industrialised south (n=225) and less 
industrialised north (n=152).  Biomarker levels of serum 8-OHdG concentrations were analysed 
and the women were genotyped for glutathione-S-transferases pi 1 (GSTP1) and glutathione-S-
transferases mu 1 (GSTM1) polymorphisms. The level of NOx pollution in the two regions was 
determined using land use regression modelling. The serum 8-OHdG was shown to significantly 
correlate with NOx levels; this relationship was strengthened in the south (p<0.05). This 
relationship was still observed after adjusting for maternal characteristics. GSTP1 was 
significantly associated with the south region, where the variant (AG+GG) genotype was 
associated with increased 8-OHdG levels as a result of NOx exposure (p<0.05). GSTM1 null 
genotype was associated with a positive correlation between NOx and 8-OHdG levels (p<0.05). 
NOx levels was found to marginally reduce gestational age (p<0.05), with mothers carrying 
male neonates, variant GSTP1 and living in the north being factors that contributed to 
gestational age reduction (p<0.05). Our study demonstrated that NOx exposure resulted in 
increased 8-OHdG levels in pregnant women living in Durban, SA which then led to gestational 
age reduction. The GSTP1 variant increased susceptibility of individuals to harmful effects of 
NOx. 
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1.  Introduction 
 
Durban, South Africa (SA), is a rapidly developing city with increased road traffic and 
industrial development in close proximity to residential areas. Durban is divided into a heavily 
industrial south region (also known as the South Durban Industrial Basin) and a less industrial 
north region; however both regions are undergoing increased urbanisation and development. 
This is of major health concern due to increased levels of ambient air pollution (AAP) in both 
these areas (Naidoo et al. 2013). Ambient air pollution and associated oxidative stress has been 
implicated in many pathological conditions, including cancer, asthma, acute respiratory 
infections and adverse birth outcomes (Šrám et al. 2005; Kampa and Castanas 2008; Wu et al. 
2009; Fleischer et al. 2014; Chen et al. 2015; Moorthy et al. 2015). Pregnant females are highly 
susceptible to oxidative stress due to increased basal oxygen and changes in energy 
consumption during placental and foetal development. Infants in utero are highly susceptible to 
the harmful effects of AAP; exposure has been associated with low birth weight (LBW), inter-
utero growth restrictions, preterm birth (PTB) and pre-eclampsia (Glinianaia et al. 2004; Negi et 
al. 2012a; Proietti et al. 2013). High levels of pollutants, including sulphur dioxide, carbon 
monoxide (CO), particulate matter (PM) and nitric oxides (NOx), have been reported 
(Kistnasamy et al. 2008). Oxides of nitrogen are of particular interest as they are by-products of 
vehicle combustion, smoking and cooking with gas, and have a nitrogen-centred free radical. 
They interact directly with macromolecules (DNA, lipids and proteins) and often result in a 
cascade of radical production and compromised cellular antioxidant function (Kelly 2003).  
 
The increase in reactive oxygen species (ROS) and decrease in antioxidants lead to oxidative 
stress. The premutagenic deoxyguanosine DNA lesion is highly susceptible to oxidative stress, 
resulting in the hydroxylation of the guanosine residue at position C8. This produces oxidative 
8-oxo-7,8-dihydro-2’-deoxyguanosine (8-OHdG) and acts as a biomarker for oxidative DNA 
damage (Kim et al. 2005). 
 
Glutathione-S-transferases (GST) are a family of phase II isoenzymes that protect against 
oxidative stress. This occurs through the conjugation of glutathione to electrophilic species that 
can react with and form protein or DNA adducts (Romieu et al. 2006). Two common and highly 
polymorphic antioxidants that have been implicated in health effects in response to chemical 
exposure are GST mu (M) and pi (P) 1(Wong et al. 2008). Common single-nucleotide 
polymorphisms (SNP) in the GSTM1 GSTP1 affect the enzymatic activity of GST, and have 
been associated with AAP associated health effects and increased oxidative stress (Romieu et al. 
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2006; Mustafa et al. 2010). A homozygous deletion in the GSTM1 gene results in the complete 
absence of enzyme activity (Seidegård et al. 1988; Xu et al. 1998), whilst a single nucleotide 
substitution of adenine (A) for guanine (G) results in the amino acid change of isoleucine for 
valine in GSTP1, at codon 105. This codon forms part of the active site of the enzyme, therefore 
this change results in the alteration of the substrate-specificity of the enzymes’ binding site 
(Johanssona et al. 1998; Moyer et al. 2008). These polymorphisms have been associated with 
adverse birth outcomes due to AAP, such as increased risk of PTB (Sram et al. 2006; Mustafa et 
al. 2010; Slama et al. 2010). 
 
To investigate a possible correlation between NOx and maternal oxidative stress, this study 
measured serum 8-OHdG in third trimester bloods of women, living in the south and north 
regions of Durban. To determine whether NOx and maternal oxidative stress impacted on 
neonatal birth weight (BW) and gestational age (GA), associations were investigated between 
NOx, 8-OHdG adduct concentration and neonatal BW and GA. Multivariate analyses were 
performed to assess whether the relationship held, when confounding factors were controlled. 
The study further investigated the prevalence of GST polymorphisms in South African women 
and their potential to affect the susceptibility of mothers, exposed to AAP, to oxidative stress. 
 
2.  Methodology 
 
2.1  Study Population 
 
The Mother and Child in the Environment (MACE) longitudinal cohort study recruited pregnant 
women from public sector anti-natal clinics in the heavily-polluted south Durban (n=225). A 
comparison sample of women with similar socio-economic statuses was recruited from the less-
industrialised north Durban (n=152). The women were residents of the geographical area for the 
full duration of the pregnancy. Women with hypertension, multiple pregnancies, diabetes, 
placenta previa, genital tract infections and other complications which result in adverse growth 
effects were excluded from the study. 
 
The study was approved by the Biomedical Research Ethics Committee of the University of 
Kwa-Zulu Natal (BF263/12) (Appendix 1) and informed consent from study participants was 
obtained. 
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2.2  Nitric Oxide levels 
 
Land use regression modelling was used to determine the exposure levels of NOx for individual 
study participants. The method was developed following the ESCAPE approach (Beelen and 
Hoek 2010). Model development entailed measurement of NOx at selected locations and 
regressing these measurements against site-specific a priori defined (i.e. direction of effect) 
geographic predictors such as road length, land use types, topography and population and 
housing density in a multivariate regression model. NOx measurements were conducted over 
two, two-week periods during mid-winter and mid-summer using Ogawa samplers which were 
deployed at 40 randomly selected sites in the north & south Durban areas.  The sampling 
periods selected are representative of the two distinct seasons to occur in Durban (Tyson and 
Preston-Whyte 2004; Tularam and Ramsay 2013), thus accounting for seasonal variation.  The 
adjusted NOx measurements were then used in model development of which the regression 
coefficients were applied to each participant. This determined individual NOx exposure levels 
for each study participant (Muttoo et al. 2017). 
 
2.3  Collection and Preparation of Samples 
 
Third trimester blood was collected from pregnant women during the period between 2013 and 
2015. The serum and whole blood was stored (-80°C) for analyses. Isolated serum was used for 
8-OHdG adduct quantification and whole blood for genotyping of polymorphisms. 
 
2.4  Polymorphisms of GSTM1 and GSTP1  
 
DNA was isolated from whole blood using the Qiagen FlexiGene
®
 DNA Kit (as per 
manufacturer’s instructions). Isolated DNA was quantified using the Nanodrop 2000 
spectrophotometer and standardised to 10ng/µl. 
 
Differentiation polymerase chain reaction (PCR) was performed to assess the GSTM1 
polymorphism (n=372), using β-globin as a reference gene. GSTM1 (215 base pair (bp)) and β-
globin (268bp) PCR products were amplified using 40pmol of GSTM1 and β-globin primers 
(Inqaba Biotech, SA - Table 1) in a 30µl reaction (1x Green GoTaq Flexi buffer, 1.25mM 
MgCl2, 0.5U GoTaq DNA polymerase (Promega), 200µM of each deoxyribonucleotide (dNTP), 
10ng DNA template). Initial denaturation was applied (96°C, 5min), followed by 30 cycles of 
denaturation (96°C, 30sec), annealing (57°C, 30sec) and extension (72°C, 30sec), concluding 
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with final extension occurring at 72°C for 5min. Amplification products were electrophoresed 
on agarose gel (4%, 2µl GelRed) and visualised on the Bio-Rad ChemiDoc
TM
 XRS+ System, 
using the Image Lab
TM
 software. The presence of a single 268bp is indicative of homozygous 
null genotype and the presence of 218bp indicates either a homozygous positive or 
heterozygous (wild-type (wt)) genotype (Appendix 2:Fig.A2.1). 
 
PCR- restriction fragment length polymorphism (RFLP) was used to investigate GSTP1 
genotypes (n=377). A 176bp PCR product was amplified using 10pmol of GSTP1 primers 
(Inqaba Biotech, SA - Table 1) in a 25µl reaction (1x Green GoTaq Flexi buffer, 1.5mM MgCl2, 
0.5U GoTaq DNA polymerase (Promega), 200µM of each dNTP, 10ng DNA template). Initial 
denaturation was applied (96°C, 5min), followed by 30 cycles of denaturation (96°C, 30sec), 
annealing (55°C, 30sec) and extension (72°C, 30sec), concluding with final extension (72°C, 
5min). Amplification products were electrophoresed on agarose gel (3%, 1µl GelRed) and 
visualised. The PCR amplicon underwent restriction endonuclease digestion to determine the 
presence of the polymorphic restriction site. An overnight digestion (37°C) was performed in 
28µl reactions:  10µl PCR product and 18µl (18µl nuclease free water, 2µl 10x Buffer Tango, 
1µl Alw261 (BsmA1) (Thermo Fisher Scientific)). Amplicons completely digested into 2 
restriction fragments (91bp and 85bp) were homozygous for G105 allele (Appendix 2: Fig.A2.2). 
The restriction fragments were electrophoresed on an agarose gel (3%, 2µl GelRed) and 
visualised on the Bio-Rad ChemiDoc
TM
 XRS+ System, using the Image Lab
TM
 software. 
 
Table 1: Primer sequences for PCR 
Primer Primer Sequence 
GSTM1 forward 5’-GAACTCCCTGAAAAGCTAAAGC-3’ 
GSTM1 reverse 5’-GTTGGGCTCAAATATACGGTGG-3’ 
β-globin forward 5’-CAACTTCATCCACGTTCACC-3’ 
β-globin reverse 5’-GAAGAGCCAAGGACAGGTAC-3’ 
GSTP1 forward 5’-ACCCCAGGGCTCTATGGGAA-3’ 
GSTP1 reverse 5’-TGAGGGCACAAGAAGCCCCT-3’ 
 
2.5  Determination of 8-Hydroxydeoxyguanosine 
 
The amount of serum 8-OHdG adduct was determined using a competitive OxiSelect
TM
 
Oxidative DNA Damage ELISA Kit (Cell Biolabs, Inc.), with a sensitivity range of 100pg/mL 
to 20ng/mL. Non-haemolysed serum samples (n=166) were chosen, at random by region, from 
the study population; diluted (1:5) in assay diluent and assayed as per manufacturer’s 
instructions. A 1:5 dilution was recommended as per manufacture protocol, an initial 
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experiment was performed using this dilution and the levels of 8-OHdG fell within the range of 
the 8-OHdG standards and therefore this dilution was used for all subsequent analysis. A 
standard curve was set up using known concentrations of 8-OHdG standards (0-20ng/mL); the 
logarithmic equation for the best fit line was used to extrapolate the concentrations of the 
unknown samples (Appendix 3: Fig.A3.1). Each 96-well plate that was used had its own set of 
standards, to ensure human-error and variation between experiments was accounted for. The 
final concentration of 8-OHdG adduct was the anti-log multiplied by the dilution factor of 5.  
 
2.6  Statistical Analysis 
 
Statistical analyses were preformed using GraphPad Prism V5 Software Package (GraphPad 
Software Inc., San Diego, California, USA). Comparisons between north and south groups for 
maternal and neonatal characteristics, atmospheric NOx levels and maternal serum 8-OHdG 
adduct concentrations were determined using the Student t test. Data was log transformed to 
ensure normalcy, and allow graphical representation of the data. Correlations among 
atmospheric NOx, maternal serum 8-OHdG and neonatal BW, neonatal GA and genotypes of 
GSTM1 and GSTP1 were done using the non-parametric Spearman correlation. The Chi square 
and Fischer’s exact tests were used to test the significant difference in the prevalence of GSTM1 
and GSTP1 genotypes between north and south groups. A one way ANOVA was performed to 
determine the level of difference for maternal serum 8-OHdG adduct concentrations among the 
genotypes of GSTM1 and GSTP1. All statistical tests were two-sided. Multivariate linear 
regression was used to determine whether the relationship between atmospheric NOx and 
maternal serum 8-OHdG was affected by potential confounders, namely: maternal age, maternal 
body mass index (BMI), HIV status, area, maternal systolic and diastolic blood pressure (BP) 
and haemoglobin (Hb) levels. The relationship between neonatal GA and atmospheric NOx and 
maternal serum 8-OHdG was also determined using linear regression, and potential confounders 
were controlled. The linear regression analyses were done using STATA version 13.1. 
 
3.  Results 
 
Maternal and neonatal characteristics of study participants are described in Table 2. The 
maternal age was slightly higher in the north compared to the south (p=0.0844). Mothers in the 
north were significantly shorter with higher BMI levels; compared to the south mothers who 
were taller and had lower BMI levels (p<0.0001). Maternal Hb levels were higher in the north 
compared to the south (p=0.0002). The systolic and diastolic BP measurements were 
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significantly lower in the north compared to the south (p<0.05). Mean GA and BW were lower 
in the north compared to the south (p=0.0540 and 0.0951 (Table 2), respectively) but did not 
reach significance. 
 
The level of atmospheric NOx in the south (37.04 ± 7.46) was significantly greater than in the 
north (33.26 ± 8.51, p<0.0001) (Fig.1A).   This corresponds to a significant increase in maternal 
serum 8-OhdG concentration observed in the south (20.26 ± 40.88ng/mL) compared to the north 
(11.51 ± 18.51ng/mL, p=0.0197) (Fig.1B).  
 
 
 
 
 
 
 
 
 
 
Figure 1: The concentrations of (A) atmospheric NOx (µg/cm3) and (B) maternal serum 8-OHdG 
(log(ng/mL)) for patients living in the North [(A) n=142; (B) n=59] and South [(A) n=185; (B) n=97]. 
Statistical significance: *** p<0.0001 and * p<0.05. 
Table 2: Maternal and neonate characteristics 
 North South 
 
 n Mean (SD) n Mean (SD) p-value 
Maternal Age (years) 152 26.38 (5.90) 225 25.32 (5.67) 0.0844 
Maternal height (cm) 152 142.3 (19.85) 224 159.0 (6.28) ***<0.0001 
Maternal BMI 152 34.12 (12.41) 224 25.99 (6.64) ***<0.0001 
Haemoglobin (g/dL) 152 10.96 (1.73) 224 7.79 (5.50) ***0.0002 
BP systolic (mmHg) 152 109.1 (13.20) 224 111.8 (11.97) *0.0143 
BP diastolic (mmHg) 152 67.75 (9.187) 224 70.34 (8.58) **0.002 
Gestational age (weeks) 137 38.55 (1.81) 202 38.85 (1.76) 0.0540 
Birthweight (g) 139 3003 (670.7) 202 3125 (610.1) 0.0951 
n= sample size, SD= standard deviation. Statistical significance: *p<0.05, **p<0.01, ***p<0.0001 
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A significant positive correlation (Spearman r=0.2173; p=0.0158) was found between the levels 
of maternal serum 8-OHdG and atmospheric NOx (Fig.2A). When the specific area was taken 
into consideration, the south (Spearman r= 0.2337; p=0.0466) atmospheric NOx was correlated 
significantly with maternal serum 8-OHdG concentration (Fig.2C) whilst the north (Spearman 
r=0.1270; p=0.3795) showed a positive trend, although not significant (Fig.2B). No relationship 
was observed between NOx and neonate BW (Spearman r=0.09865; 95%CI -0.016-0.210; 
p=0.0814) and NOx and neonatal GA (Spearman r= -0.0716; 95%CI -0.185 – 0.043; p=0.0814). 
When area was considered a negative trend is suggested for NOx and BW in both north 
(Spearman r= -0.1135; 95%CI -0.282-0.062; p=0.19) and south (Spearman r=-0.060; 95%CI -
0.211 – 0.093; p=0.43).  A similar negative trend is observed between NOx and GA in both the 
north (Spearman r= -0.1135; 95%CI -0.282 – 0.062; p=0.19) and south (Spearman r= -0.060; 
95%CI -0.211 – 0.093; p=0.43).  Maternal serum 8-OHdG was not shown to correlate with BW 
(Spearman r=0.058; 95%CI -0.1521 – 0.2635; p=0.58) and GA (Spearman r= 0.044; 95%CI -
0.121 – 0.207; p=0.59). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Relationship between the concentrations of atmospheric NOx (log(µg/cm3)) and maternal serum 
8-OHdG (log(ng/mL)) for all patients (A) [Spearman r=0.2173; 95%CI 0.03657 to 0.3843; *p=0.0158; 
A) 
B) C) 
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n=123], patients living in the North (B) [Spearman r=0.1270; 95%CI -0.1652 to 0.3987; p=0.3795; n=50] 
and South (C) [Spearman r= 0.2337; 95%CI -0.003195 to 0.4457; *p=0.0466; n=73]. Dotted lines 
represent 95%CI interval. Statistical significance: *p<0.05 
 
Maternal HIV status was thought to influence maternal serum 8-OHdG adduct concentration, 
however no difference between HIV positive (16.02±21.39ng/mL) and negative (18.48 
±40.23ng/mL) 8-OHdG concentration was observed (Fig.3).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Maternal serum 8-OHdG adduct (log(ng/mL)) concentration between HIV positive (n=52) and 
HIV negative (n=113) patients in the total sample group. 
 
The genotypic prevalence of GSTM1 and GSTP1 amongst study participants are shown in 
Table 3 and Table 4, respectively. For all subjects, the prevalence of the GSTM1 null (0/0) and 
wt (0/+ or +/+) type was 25.3% and 75.7%, respectively. The frequencies of the A105 and G105 
allele of GSTP1 were 44.2% and 55.8%, respectively. A significantly greater fold increase 
(p=0.0144) was observed in the south for the GSTP1 A105 allelotype compared to G105 allelotype 
(1.8 and 1.2, respectively). The prevalence of GSTP1 AA (wt) and AG+GG (variant) 
(p=0.0281) was significantly different between the north and south; whilst the prevalence of 
GSTM1 (p=0.9038) did not differ significantly. The GSTP1 AG and GG genotypes were 
combined for analysis, as it has been shown that subjects with a single GSTP1 G105 allele have 
reduced enzyme activity compared to those with the GSTP1 A105 allele (Zimniak et al. 1994). 
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No difference was observed in the levels of maternal serum 8-OHdG among the GSTM1 
genotypes between the north and south (Fig.4A). Maternal serum 8-OHdG concentration was 
higher in AA genotyped mothers (29.31±10.10ng/mL, n=38) compared to AG+GG genotyped 
mothers (13.16±1.772, n=127, p=0.1589), although not significant. When area was considered, 
the level of maternal serum 8-OHdG was higher in the north GSTP1 AA (21.11±8.9ng/mL) 
mothers compared to the GSTP1 AG+GG (8.70±2.0ng/mL) mothers but did not reach 
Table 3: Genotypic frequency of GSTM1 in patients living in the North and 
South (n=372). 
 Total North South 
p-value 
 n (%) n (%) n (%) 
Genotype frequency  
   
GSTM1 0/0 94 (25.3) 39 (41.5) 55 (59.5) 0.9038
#
 
GSTM1 0/+ or +/+ 278 (75.7) 113 (40.7) 165 (59.3) 
 
     
#
RR (1.021, 95%CI: 0.7722 - 1.349); OR (1.035, 95%CI: 0.6438 – 1.665) 
n= sample size, RR= relative risk, OR= Odds ratio, CI= confidence interval
 
Table 4: Genotype and allele frequencies of GSTP1 in patients living in the North 
and South (n=377). 
 Total North South 
p-value 
 n (%) n (%) n (%) 
Genotype frequency     
GSTP1 A105/A105 92 (24.4) 28 (30.4) 64 (69.6) *0.0281
#1
 
GSTP1 A105/G105 and G105/G105 285 (75.6) 124 (43.5) 161 (56.5) 
 
Allelotype frequency  
   
GSTP1 A105 361 (44.2) 129 (35.7) 232 (64.3) *0.0144
#2
 
GSTP1 G105 456 (55.8) 175 (44.5) 218 (55.5) 
 
     
#1
RR(0.6995; 95%CI: 0.4998 - 0.9790); OR(0.5680; 95%CI: 0.3438 - 0.9386) 
#2
RR(0.8025, 95%CI: 0.6723 - 0.9579); OR (0.6927, 95%CI: 0.5166 - 0.9286) 
n= sample size, RR= relative risk, OR= Odds ratio, CI= confidence interval. 
Statistical significance: *p<0.05 
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significance (p=0.1421).  The south GSTP1 AG+GG (13.50±2.0ng/mL) mothers had 
significantly greater levels of maternal serum 8-OHdG compared to the north (8.70±2.0ng/mL, 
p=0.0188) (Fig .4B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Maternal serum 8-OHdG adduct (log(ng/mL)) concentration between the GSTM1 (A) and 
GSTP1 (B) genotypes for patients living in the North and South. Statistical significance: *p<0.05. 
 
 
The relationship between the atmospheric NOx and maternal serum 8-OHdG concentration was 
investigated among the different genotypes in Table 5. A significant correlation was observed 
between the atmospheric NOx and the level of maternal serum 8-OHdG within the GSTM1 null 
genotype (Spearman r=0.4227, p=0.0199) and the GSTP1 AA+GG genotype (Spearman 
r=0.2105, p=0.0395).  No relationship was observed when north and south was taken into 
consideration. 
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Table 5: Relationship between the concentrations of atmospheric NOx (log(µg/cm
3
)) and maternal 
serum 8-OHdG (log(ng/mL)) among the different SNP genotypes (GSTM1 and GSTP1) for the total 
patient sample and those living in the North and South. 
 
 
GSTM1 SNP Genotypes 
 
 
0/0 0/+ or +/+ 
Total Spearman r (95%CI) 
p-value 
0.4227 (0.06250 to 0.6855) 
*0.0199 
0.1566 (-0.05478 to 0.3546) 
0.1338 
North Spearman r (95%CI) 
p-value 
0.5758 (0.0816) 
ns 
0.03247 (-0.2907 to 0.3490) 
0.8424 
South Spearman r (95%CI) 
p-value 
0.3046 (-0.1732 to 0.6663) 
0.1916 
0.2218 (-0.05980 to 0.4707) 
0.1104 
 
 
GSTP1 SNP Genotypes 
 
 
A105/A105 A105/G105 and G105/G105 
Total Spearman r (95%CI) 
p-value 
0.2525 (-0.1527 to 0.5851) 
0.2038 
0.2105 (0.004413 to 0.3995) 
*0.0395 
North Spearman r (95%CI) 
p-value 
-0.1459 (0.6876) 
ns 
0.07900 (-0.2474 to 0.3893) 
0.6280 
South Spearman r (95%CI) 
p-value 
0.3887 (-0.1284 to 0.7397) 
0.1231 
0.1864 (-0.08845 to 0.4348) 
0.1690 
CI= confidence interval, ns= not significant. Statistical significance: *p<0.05 
 
 
The relationship between atmospheric NOx and maternal serum 8-OHdG concentration, 
controlled for potential confounders, is described in Table 6. The β-coefficient and regression 
model for the total samples was strengthened when maternal characteristics were controlled 
(unadjusted =1.14, adjusted
2
=1.21, p<0.05). For every 1% increase in NOx it would lead to a 
1.21% increase in maternal serum 8-OHdG. This almost doubled when area was taken into 
consideration, where a 1% increase in atmospheric NOx would result in a 1.99% increase in 
maternal 8-OHdG, in the south (p=0.004). When polymorphisms were considered, a 1% 
increase in atmospheric NOx would lead to a 1.14% increase in maternal 8-OHdG for the 
variant GSTP1 genotype (p=0.026) whilst an almost equal change in percent was observed 
between NOx and 8-OHdG for the GSTM1 wt genotype (p=0.076). The neonate gender was 
shown to influence the concentration of maternal serum 8-OHdG, where a 1% increase in NOx 
would result in a 2.48% increase in maternal serum 8-OHdG for women carrying female 
neonates (p=0.002). 
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Table 6: Impact of atmospheric NOx (log) concentration on maternal serum 8-OHdG adduct (log) 
concentration – linear regression analysis for total mothers and  subdivided into area, GSTM1 and 
GSTP1 SNP with adjustments for maternal characteristics. 
  
Maternal serum 8-OHdG (log) concentration 
  
β-coefficient (95%CI) p-value R-squared (p-value) 
Atmospheric NOx (log)     
Total      
 
Unadjusted 
(n=123) 
1.14 (0.251 – 2.02) *0.012 0.0507 (*0.012) 
 
Adjusted
1
 
(n=123) 
1.14 (0.256 – 2.03) *0.012 0.0517 (*0.041) 
 
Adjusted
2
 
(n=123) 
1.21 (0.244 – 2.18) *0.015 0.1423 (*0.022) 
Area      
 
North 
(n=50) 
0.317 (-1.41 – 2.04) 0.713 0.1061 (0.662) 
 
South 
(n=73) 
1.99 (0.679 – 3.30) **0.004 0.1818 (0.060) 
GSTP1 
 
    
 
AA 
(n=27) 
1.29 (-1.70 – 4.28) 0.378 0.3063 (0.350) 
 
AG+GG 
(n=96) 
1.14 (0.137 – 2.14) *0.026 0.1195 (0.118) 
GSTM1 
 
    
 
0/+ or +/+ 
(n=93) 
1.01 (-0.108 – 2.13) 0.076 0.1171 (0.144) 
 
0/0 
(n=30) 
0.824 (-1.36 – 3.01) 0.442 0.3835 (0.101) 
Neonate Gender      
 
Male 
(n=70) 
0.75 (-0.588 – 2.08) 0.268 0.1445 (0.185) 
 
Female 
(n=48) 
2.48 (1.02 – 3.95) **0.001 0.2932 (*0.040) 
Adjusted
1
: HIV status; Adjusted2: HIV status, area, maternal age, body mass index, haemoglobin, blood pressure systolic and 
diastolic. 
Area, GSTP1 and GSTM1 results were all adjusted for HIV status, maternal age, body mass index, haemoglobin, blood pressure 
systolic and diastolic. 
CI= confidence interval, n= sample size. Statistical significance: *p<0.05, **p<0.01 
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The relationship between atmospheric NOx and GA, controlled for potential confounders, is 
described in Table 7. Controlling for potential maternal and neonate confounders, strengthened 
the β-coefficient and regression model for the total samples (unadjusted =-0.464, adjusted2=-
1.64, p<0.05). Therefore for every 1% increase in NOx there would be a 0.0164% reduction in 
GA. The maternal serum 8-OhdG did not significantly impact GA; however when it was not 
included in the regression model, NOx was also not found to influence GA. Controlling for 8-
OHdG, therefore was an important factor for NOx influencing GA. When area was considered, 
a 1% increase in NOx would result in a 0.0196% decrease in GA (p=0.023). The GSTP1 variant 
caused a 0.013% reduction in GA, whilst the GSTM1 wt genotype caused a 0.0126% decrease 
in GA if a 1% increase in NOx is observed (p<0.05, Table 7). Mothers carrying a male foetus, 
were significantly associated with a 0.0156% decrease in GA if NOx were to increase by 1% 
(p=0.027). This decrease was almost doubled (0.0203% change) with mothers carrying a female 
foetus, although not significant (p=0.097).  
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Table 7: Impact of atmospheric NOx (log) concentration on gestational age – linear regression 
analysis for total mothers and subdivided into area, GSTM1 and GSTP1 SNP with adjustments for 
maternal characteristics. 
  Gestational Age (weeks) 
  β-coefficient (95%CI) p-value R-squared (p-value) 
Atmospheric NOx (log)     
Total      
 
Unadjusted 
(n=311) 
-0.464 (-1.12 – 0.194) 0.166 0.2075 (***<0.0001) 
 
Adjusted
1 
(n=118) 
-1.49 (-2.60 – -0.377) **0.009 0.3384 (***0.003) 
 
Adjusted
2
 
(n=64) 
-1.64 (-3.21 – -0.066) *0.042 0.5597 (***0.0008) 
Area      
 
North 
(n=49) 
-1.96 (-3.63 – -0.287) *0.023 0.5254 (**0.0093) 
 
South 
(n=69) 
-0.688 (-2.59 – 1.21) 0.471 0.3030 (0.0884) 
GSTP1 
 
    
 
AA 
(n=27) 
-1.35 (-4.15 – 1.46) 0.316 0.7943 (*0.0222) 
 
AG+GG 
(n=91) 
-1.30 (-2.52 – -0.072) *0.038 0.2553 (*0.0445) 
GSTM1 
 
    
 
0/+ or +/+ 
(n=88) 
-1.26 (-2.66 – -0.109) *0.034 0.3115 (**0.0093) 
 
0/0 
(n=30) 
-1.38 (-4.39 – 1.88) 0.407 0.6875 (0.0554) 
Neonate Gender 
 
    
 
Male 
(n=70) 
-1.56 (-2.95 – -0.184) *0.027 0.3541 (*0.0135) 
 
Female 
(n=48) 
-2.03 (-4.44 – 0.385) 0.097 0.3550 (0.1922) 
Unadjusted: birthweight; Adjusted
1
: neonatal characteristics: birthweight , child gender, Apgar scores: 1m and 5m, body: brain 
ratio, ponderal index and maternal characteristics: HIV status, area, maternal age, body mass index, haemoglobin, blood pressure 
systolic and diastolic, GSTP1 and GSTM1; Adjusted2: same as Adjusted1 with parity included 
Area, GSTP1, GSTM1 and neonate gender results were all adjusted for neonatal characteristics: birthweight, child gender, Apgar 
scores: 1m and 5m, body: brain ratio, ponderal index and maternal characteristics: HIV status, maternal age, body mass index, 
haemoglobin, blood pressure systolic and diastolic. 
CI= confidence interval, n= sample size. Statistical significance: *p<0.05, **p<0.01, ***p<0.0001 
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4.  Discussion 
 
Exposure to NOx was shown to directly influence maternal serum 8-OHdG concentrations in 
pregnant women living in Durban, SA. Gestational age of these women was also shown to 
significantly decrease as a result of increased NOx exposure. This is the first study in Durban, 
SA to link the increase in oxidative stress in pregnant women to increased NOx pollution. 
 
Oxides of nitrogen, a by-product of combustion, have been linked to several adverse health 
conditions, including respiratory diseases, cardiovascular diseases, low birth weight and preterm 
birth (Seo et al. 2007; Wu et al. 2009; César et al. 2015). This nitrogen centred free radical, 
upon inhalation, is absorbed in lung fluids producing free radical products that enter the blood 
stream. These free radicals are then able to react directly with macromolecules (protein, lipids 
and DNA) present resulting in ROS production (Tabacova et al. 1998). Guanine, having the 
lowest redox potential among the nucleic bases, is highly susceptible to oxidation by ROS; 
which results in the production of 8-OHdG mutagenic lesions (Kershaw and Hodges 2012; Ba 
et al. 2015). Therefore this accounts for the significant increase in maternal serum 8-OHdG 
adduct concentration as a result of NOx exposure (Fig. 1 and 2).  
 
The Durban south region has been shown previously to have higher levels of air pollution 
(Naidoo et al. 2013) and in the present study with significantly increased NOx concentration 
(Fig.1A) compared to the north. Previously, pregnant women in the south region have been 
shown to exhibit increased markers of oxidative stress compared to the north (Nagiah et al. 
2015). This finding was corroborated in our study, where pregnant women in the south had 
increased levels of serum 8-OHdG compared to the north (Fig.1B). Our study went further and 
investigated the relationship between NOx and 8-OHdG, the influence of GST polymorphisms 
as well as linking NOx to GA.  
 
Several studies have found an association of pollution (polycyclic aromatic hydrocarbon (PAH), 
diesel-exhaust smoke and smoking) to increased 8-OHdG and oxidative stress (Risom et al. 
2005; Lewtas 2007; Leonardi-Bee et al. 2008; Ren et al. 2010). Studies have also observed that 
a dose-effect relationship occurs between PAH exposure and levels of urinary 8-OHdG (Kuang 
et al. 2013; Li et al. 2015). Our study found a significantly positive correlation between 
atmospheric NOx and maternal serum 8-OHdG (Fig.2A, p=0.158). As mentioned above, the 
south region is considered to have a higher pollution level than the north. When area was taken 
into consideration, the relationship between NOx and 8-OHdG was strengthened in the heavily 
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industrialised south (Fig.2C, p=0.0466) whilst the relationship was lost in the less industrialised 
north (Fig.2B). This relationship was further investigated by controlling for potential 
confounding factors, to determine whether this effect was indeed a response to NOx exposure. 
The results confirmed that NOx exposure caused a significant increase in 8-OHdG 
concentration when controlled for maternal characteristics (Table 7). It was found that a 1% 
increase in NOx results in a 1.21% (p=0.015) increase in 8-OHdG, with an even higher increase 
(1.99%, p=0.004) observed for south living mothers. The results provide evidence that exposure 
to atmospheric NOx increases serum 8-OHdG levels in pregnant women.  
 
An important controller of oxidative stress, are antioxidants that help reduce and eliminate 
oxidants to prevent oxidative stress-related damage. However, genetic susceptibility plays an 
important role in determining the effect and responses an individual has to oxidative damage. 
Therefore the risk for cancer, adverse reproductive outcomes and cardiovascular diseases are a 
consequence of air pollution exposure and genetic susceptibility (Lewtas 2007; Lagadu et al. 
2010). GSTs are antioxidant enzymes that protect against oxidative stress by conjugating 
electrophilic species and thereby neutralising their effect. These GSTs have two common 
polymorphisms that influence an individual’s genetic susceptibility to oxidants. A homozygous 
deletion in GSTM1 results in the enzyme inactivation (Mustafa et al. 2010), while the 
substitution of isoleucine for valine at codon 105 in GSTP1 reduces substrate specificity (Wong 
et al. 2008).  
 
Our results indicate that GSTP1 is associated with the heavily industrialised south (Table 4, 
p=0.0281), with increased serum 8-OHdG observed in the GSTP1 AG+GG genotypes compared 
to the AA genotype. This suggests that wt GSTP1 is able to scavenge oxidants more effectively 
than the variant which leads to reduced serum 8-OHdG concentrations observed. When 
subdivided into areas, no difference in 8-OHdG was observed in north and south wt GSTP1 
whilst the north variant mothers had significantly lower 8-OHdG levels compared to the south 
variant mothers (Fig.4B, p<0.05). This suggests that at low pollution levels (north) the variant 
GSTP1 enzymes, with its reduced specificity is still able to conjugate electrophiles and reduce 
their effect whilst at higher pollution levels (south) the variant genotype is overwhelmed and 
becomes inefficient at scavenging which leads to increased oxidants present that attack DNA 
leading to increased 8-OHdG levels.  
 
It has been shown that the variant GSTP1 allele has a 7 fold greater efficacy against PAH diol 
epoxides than wt allele, whilst 3 fold less effective against 1-chloro-2,4-diinitrobenzene 
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(Strange et al. 2000). However, this study showed that the variant genotype is less efficient 
compared to the wt, at detoxifying oxidant products. A significant positive correlation was 
observed between NOx and 8-OHdG levels in AG+GG GSTP1 genotyped mothers (Table 5, 
p=0.0395); further confirming that the variant GSTP1 mothers when exposed to NOx are unable 
to effectively scavenge oxidants leading to increased DNA damage. No association was 
observed between GSTM1 and the heavily industrialised south (Table 3), with no difference in 
serum 8-OHdG levels observed between the null and wt GSTM1 genotypes. A significant 
positive correlation was observed between NOx and serum 8-OHdG for null GSTM1 mothers 
(Table 5, p=0.0199), thus suggesting that the inactive enzyme GSTM1 was unable to neutralise 
oxidants leading to increased DNA damage. These results were further analysed in multivariate 
analyses to determine whether the results observed in bivariate correlations remained when 
controlling for maternal characteristics as potential confounders.  
 
The GSTP1 variant mothers where shown to have increased serum 8-OHdG (1.14%) with 
increasing NOx (1%, p=0.026, Table 6), whilst in GSTM1 null mothers this relationship was 
lost. This could be a result of small sample size, once all confounding factors were taken into 
account, only 30 GSTM1 null mothers remained, which could account for the lack of 
association between NOx and 8-OHdG. Other studies have shown no association between 
GSTM1 null individuals, DNA damage and pollution (PAH (Marczynski et al. 2002; Garte et al. 
2007) and particulate matter (Sørensen et al. 2003)). The multivariate analysis however, 
suggests a parallel increase in 8-OHdG (1.01%) as a result of NOx (1%) exposure for GSTM1 
wt mothers (Table 6, p=0.076). The results provide evidence that GSTP1 variant genotype 
increases the susceptibility of mothers to NOx exposure leading to increased oxidative stress. 
 
Pregnancy, a physiological state characterised by increased basal oxygen demand and high 
energy requirement, favours ROS production and has been shown to exhibit increased 
susceptibility to oxidative stress in normal pregnancies (Saker et al. 2008). This already highly 
susceptible condition in the presence of high AAP would exasperate antioxidant stores and lead 
to increased oxidative stress. Exposure to traffic-related air pollution (i.e. NOx, CO and primary 
exhaust particles) have been implicated in deceased foetal growth, LBW and PTB (Seo et al. 
2007; Darrow et al. 2011). Several studies have also reported oxidative stress as a potential 
mechanism for LBW and PTB, with reports showing increased 8-OHdG in LBW and PTB (Kim 
et al. 2005; Mustafa et al. 2010; Rossner et al. 2011).  
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Our study first set out to find an association between NOx and serum 8-OHdG with neonate 
BW and GA. Using simple correlations, no association was observed between serum 8-OHdG 
and BW, with a negative trend suggested between NOx and BW in north and south.. This 
negative trend was not significant; however this could be due to our small sample size as 
previous studies have shown a link between AAP and BW reduction (Lacasana et al. 2005; 
Darrow et al. 2011; Wilhelm et al. 2012). Next our study used bivariate linear regression to 
determine whether NOx was associated with reductions in GA. The results from the unadjusted 
bivariate analysis again suggested a negative trend but remained non- significant; also observed 
using simple correlation. We then controlled for maternal and neonatal characteristics, which 
revealed a small significant reduction in gestational age as a result of NOx exposure (Table 7, 
p=0.042). This relationship was only found to be significant when maternal serum 8-OHdG was 
controlled for, suggesting 8-OHdG may affect GA.  
 
Previous studies have found increased 8-OHdG in mothers who give birth prematurely 
(Matsubasa et al. 2002; Nassi et al. 2009; Darrow et al. 2011; Negi et al. 2012b). When area was 
considered, the north showed a significantly higher reduction in GA compared to the total 
mothers, with south mothers having no reduction observed. This study only measured the levels 
of NOx; however other pollutants or environmental factors may have been present in high 
concentrations within the north area. These pollutants or environmental factors may be potent 
enough to cause the reduction in GA observed within the north. This would be an ideal follow 
up study. The GTSP1 variant and GSTM1 wt mothers were susceptible to GA reduction as a 
consequence of NOx exposure (p=0.034 and p=0.038 (Table 7), respectively). Neonatal gender 
was also found to be associated with reduced gestational age due to NOx exposure, where 
mothers carrying male infants exposed to NOx had a significant reduction in GA. These 
reductions in GA observed, were small (<0.1 weeks per percent change in NOx), therefore 
would not impact on clinical significance for individual neonate. However, a negative shift in 
GA on the population level could result in increased PTB nationwide. 
 
The findings of our study must be interpreted in light of the following limitations. Firstly, upon 
subdivision, by area and genotype, our sample size becomes relatively small. Secondly, due to 
our relatively small sample size, ethnicity was not taken into account; this could be addressed in 
a future study with increased population numbers. Although significant results are obtained, 
increasing population numbers in future studies could give further insight into the conclusions 
observed. Thirdly, measuring other pollutants in study areas could give further insight into their 
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effects on 8-OHdG levels and GA. A combined effect of NOx and other pollutions such as 
particulate matter would also be interesting to investigate. 
 
In conclusion, this study demonstrated increased maternal serum 8-OHdG in pregnant women 
exposed to higher levels of NOx pollution in the south. This increase in DNA damage was 
found to be a direct consequence of increased NOx exposure, with increased susceptibility 
found in GSTP1 variant carriers and GSTM1 wt carriers. Gestational age was also found to be 
reduced as a consequence of NOx exposure, with male neonates making mothers more 
susceptible to GA reduction. This study highlights the need for better systems in place to reduce 
traffic-related air pollution close to residential areas, so that vulnerable individuals are better 
protected against oxidative stress related injury. 
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Abstract: 
The global HIV and obesity epidemics are major public health concerns; particularly as both are 
associated with increased risk of adverse birth outcomes. Despite extensive research, their 
combined effect, in terms of birth outcomes, has not been investigated. A single-nucleotide 
polymorphism (SNP) within 8-oxoguanine glycosylase 1 (OGG1) (Ser326Cys) has been 
suggested to affect body mass indices and therefore could predispose South African (SA) 
women to adverse effects of obesity. This study investigated the associations of OGG1 
Ser326Cys SNP in relation to HIV and obesity on the susceptibility of low-birthweight (LBW) 
and pre-term birth (PTB) in SA women exposed to ambient air-pollution living in Durban. In 
our study population, the OGG1 SNP was associated with HIV and obesity. Wild-type (CC)-
carrying patients had increased susceptibility for HIV-associated LBW and PTB. Co-morbid 
HIV and obese patients delivered neonates with decreased birthweights. Living within the 
heavily-polluted south-Durban and carrying the CC-genotype increased the risk for PTB within 
our study population. 
 
Keywords: 
Low birthweight, HIV, obesity, OGG1 Ser326Cys polymorphism, pre-term birth, air pollution 
 
Highlights 
 OGG1 Ser326Cys polymorphism associated with HIV 
 Comorbid HIV and obesity associated with decreased neonatal BW 
 Wild-type OGG1 Ser326Cys genotype increased risk of PTB and HIV associated LBW 
 Living in heavily polluted south Durban increased susceptibility of PTB 
 
Introduction 
The global human immunodeficiency virus (HIV) epidemic affects approximately 36.5 million 
people worldwide, with majority of these infected people living in low- and middle-income 
countries. Sub-Saharan Africa represents the highest number of people living with HIV (25.6 
million people) with approximately 27.4% living within South Africa (SA). Women account for 
more than half the infected population [1]. In addition to the HIV epidemic, SA has the highest 
obesity rate in sub-Sahara Africa, with more than 68% of women classified as overweight or 
obese [2]. Women being the most vulnerable to these diseases are cause for concern because not 
only does it affect the health of women but the health of future generations. With obesity and 
HIV both individually associated with increased susceptibility to adverse birth outcomes, 
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neonate morbidity and mortality, together they could potentially pose a significant threat to 
public health [3–6]. 
 
Various adverse birth outcomes linked to obesity include gestational diabetes and hypertension, 
neonatal macrosomia, intrauterine growth restriction and pre-term birth (PTB) [5,7,8]. HIV 
infection has been shown to increase the risk for low birthweight (LBW) and PTB [3,4,9]. As 
HIV infection was most commonly associated with reduced weight, which has been shown to 
increase the risk of LBW and PTB, a shift to increased obesity in HIV infected patients has been 
observed in developed countries [10]. Studies in developing countries however have shown 
decreased BMI in HIV positive (HIV+) patients, even with the increased use of antiretroviral 
therapy [11,12]. Therefore the combined effect of obesity and HIV could further potentiate risk 
for adverse birth outcomes. Studies have shown that both HIV and obesity affect the metabolic 
state of the infected person, with oxidative stress and inflammation implicated in LBW and PTB 
aetiology [13,14]. 
 
It has been reported that ambient air pollution (AAP) exposure is linked to increased risk of 
LBW and PTB [13,15,16]. In developing countries, e.g. SA, increased industrialisation and 
urbanisation leads to increased AAP which negatively impacts on the health of the population. 
This is most notable observed within the Durban South Industrial basin (DSIB) where high 
levels of AAP have been reported. Studies have associated these AAP to adverse health effects 
in children including moderate to severe asthma, wheezing and airway hyperactivity [17,18]. 
 
The combined effect of both external and internal exposures, either through infection, obesity or 
pollution exposure, on birth outcomes is important to fully understand the complex aetiology of 
these adverse outcomes. However, an important determinate of an individual’s response to toxic 
insult, either by HIV infection, obesity or AAP exposure, is their genetic susceptibility. Genes 
of the DNA repair pathway have been shown to be highly polymorphic which affects structure 
and function of its proteins. The human 8-oxoguanine glycosylase 1 (OGG1) gene, a key 
component of the DNA repair pathway, consists of eight cysteine residues within its active site 
and is susceptible to oxidative modification [19–21]. A functional single nucleotide 
polymorphism (SNP) exists within the OGG1 gene, as a result of an amino acid substitution of 
serine with cysteine at positon 326 (Ser326Cys) within exon 7 [22]. This polymorphism has 
been suggested to reduce the repair activity of OGG1, with carriers of the homozygous C326 
(G) allele (rs1052133 GG variant) and heterozygous (CG) genotypes having reduced activity 
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compared with the homozygous S326 (CC) wild-type (wt) genotype, and may affect an 
individual’s response to external insults [22,23]. 
 
Limited data is available within the indigenous African population for the OGG1 Ser326Cys 
SNP, and its effect on adverse birth outcomes. The high incidence of obesity and HIV within 
this population group together with their known metabolic abnormalities and well-established 
link between HIV and adverse birth outcomes, necessitates an investigation of OGG1 (an 
enzyme involved in metabolic activities) Ser326Cys SNP that may give further insight to the 
susceptibility of adverse birth outcomes within this population.  This longitudinal birth cohort 
study was therefore conducted to investigate the effects of the OGG1 Ser326Cys SNP, HIV and 
obesity on the susceptibility of LBW and PTB in woman exposed to AAP living in Durban, SA.  
Additionally, the effect of the exposed woman’s clinical parameters on LBW and PTB 
susceptibility was also explored. 
 
Methods 
Study Population 
The Mother and Child in the Environment (MACE) longitudinal cohort study recruited HIV 
negative (HIV-) (n=282) and HIV+ (n=155) pregnant women from public sector anti-natal 
clinics in the heavily-polluted DSIB and less-industrialised Durban north region. Ethical 
approval from the Biomedical Research Ethics Committee of the University of Kwa-Zulu Natal 
(BF263/12) (Appendix 1) and informed consent from study participants was obtained. The 
female participants were residents of the geographical area for the full duration of the 
pregnancy. Women with hypertension, multiple pregnancies, diabetes, placenta previa, genital 
tract infections and other complications which result in adverse growth effects were excluded 
from the study. 
 
Clinical Parameters of Study Population 
Upon enrolment, at trimester one (T1), study participants underwent clinical tests to determine 
the following parameters: weight, height, body mass index (BMI), iron and haemoglobin (Hb) 
levels, systolic and diastolic blood pressure (BP) and age. The study population was followed 
up at trimester three (T3), where the above parameters were measured once again. 
 
Collection and Preparation of Samples 
Third trimester blood was collected in BD Vacutainer® EDTA, aliquoted and stored at -80°C 
for genotyping of polymorphisms. 
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OGG1 rs1052133 Ser326Cys Polymorphism 
DNA was extracted from whole blood using the Qiagen FlexiGene® DNA Kit (Qiagen, 
ID:51206), as per manufacturer’s instructions. Extracted DNA was quantified using the 
Nanodrop 2000 spectrophotometer and standardised to 10ngµl
-1
. 
 
Polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP) was used to 
investigate OGG1 SNP genotypes (n=309). A 234bp PCR product was amplified using 6pmol 
of primers (Inqaba Biotech, SA; OGG1 forward: 5’-CCCAACCCCAGTGGATTCTCATTGC-
3’, OGG1 reverse: 5’-GTGCCCCATCTAGCCTTGCGGCCCTT-3’). The 30µl reaction 
consisted of 1x Green GoTaq Flexi buffer, 1.25mM MgCl2, 0.5U GoTaq DNA polymerase 
(Promega), 200µM of each dNTP, and 10ng DNA template. Initial denaturation was applied 
(94°C, 4min), followed by 35 cycles of denaturation (94°C, 30sec), annealing (60°C, 1min) and 
extension (72°C, 30sec), concluding with final extension (72°C, 5min). Amplification products 
were electrophoresed on agarose gel (1.8%, 1µl Gel Red (catalogue no.41003, Biotium Inc., 
Hayward, CA)) and visualised on the Bio-Rad ChemiDocTM XRS+ System, using the Image 
Lab
TM
 software. The PCR amplicon underwent restriction endonuclease digestion to determine 
the presence of the polymorphic restriction site. An overnight digestion (37°C) was performed 
in 28µl reactions; each reaction consisting of 10µl PCR product, nuclease-free water, 2µl 10x 
Buffer G, and 1µl Sat1 (Fnu4HI) (Thermo Fisher Scientific). A 21bp fragment was present in 
all samples due to a Sat1 invariant site induced by the mismatch. Amplicons digested 
completely with 164bp, 49bp and 21bp restriction fragments were homozygous for the G-allele 
(Appendix 2: Fig.A2.3). The restriction fragments were electrophoresed on an agarose gel 
(1.8%, 2µl GelRed) and visualised as mentioned above. 
 
Statistical Analysis 
Statistical Analyses were performed using GraphPad Prism V5 Software Package (GraphPad 
Software Inc., San Diego, California, USA) and STATA version 13.1. Measurements taken 
during the mothers’ T1 and T3 were used for BMI, iron, Hb and systolic and diastolic BP data. 
The Student t test with Welch’s correction was used to determine statistical significance 
between the HIV-/+ and obesity groups for maternal and neonatal characteristics. The Chi 
square and Fischer’s exact tests were used to test the significant difference in the prevalence of 
OGG1 genotypes between HIV-/+ and obesity groups, including PTB and LBW and maternal 
characteristics: BMI, Hb, iron and diastolic and systolic BP. All statistical tests were two-sided. 
The relationship between PTB, HIV and location of birth was determined using logistic 
regression, and potential confounders were controlled. 
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Results 
Maternal Clinical Characteristics 
The study participants were divided into two categories: normal birthweight (NBW)/LBW and 
term birth (TB)/PTB, these were then further subdivided by HIV status. The mean gestational 
age (GA) for women giving birth to NBW and LBW infants were 39.1 weeks and 36.9 weeks, 
respectively (p<0.0001). The mean birthweight (BW) for term and pre-term infants were 
3135.95g and 2393.02g, respectively (p<0.0001). The distribution of age, height and BMI was 
significantly different among all groups in LBW/NBW and TB/PTB categories (p<0.0001) 
(Table.1). 
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Table 1 Maternal clinical characteristics 
 
NBW HIV- 
(n=260) 
NBW HIV+ 
(n=125) 
LBW HIV- 
(n=34) 
LBW HIV+ 
(n=27) 
ap-value 
TB HIV- 
(n=270) 
TB HIV+ 
(n=132) 
PTB HIV- 
(n=23) 
PTB HIV+ 
(n=18) 
ap-value 
Age (years) 24.35 ± 0.319 28.37 ± 0.476 23 ± 0.931 29.07 ± 1.41 ***<0.0001 24.17 ± 0.312 28.82 ± 0.479 24.65 ± 1.25 26.67 ± 1.62 ***<0.0001 
Age Range (years) 15 – 43 17 – 42 15 – 37 16 – 44  15-43 19-44 15-37 16 - 38  
Height (m) 1.55 ± 0.009 1.47 ± 0.017 1.54 ± 0.021 1.45 ± 0.040 **0.0053 1.55 ± 0.008 1.47 ± 0.017 1.54 ± 0.029 1.48 ± 0.052 **0.0076 
Height Range (m) 1 – 1.76 1 – 1.82 1.06 – 1.68 1.02 – 1.66  1 – 1.76 1 – 1.82 1.06 – 1.68 1 – 1.67  
BMI T1 (kg/m2) 28.77 ± 0.641 34.21 ± 1.20 24.67 ± 1.69 35.64 ± 2.71 ***<0.0001 28.28 ± 0.624 34.93 ± 1.19 27 ± 2.25 29.78 ± 2.78 ***<0.0001 
BMI T3 (kg/m2) 31.92 ±0.694 37.95 ± 1.31 28.19 ± 2.09 37.35 ± 2.53 ***<0.0001 31.50 ± 0.687 38.23 ± 1.28 30.35 ± 2.44 33.14 ± 2.32 ***<0.0001 
Results described: mean ± standard error 
NBW = normal birth weight, LBW = low birth weight, TB = term birth, PTB = pre-term birth, n=sample size, T1= trimester one, T3= trimester three, BMI= body mass index 
a
Comparison between all four groups 
Statistical significance: ** *p<0.0001, ** p<0.01 
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Association between OGG1 polymorphism, HIV and obesity 
A significant association between HIV and obesity for both T1 and T3 are shown in Table 2. 
The frequency of obese patients in T1 increased 1.4 fold in HIV+ patients compared to the 0.4 
fold decrease observed in non-obese HIV+ patients (p<0.0001).  In T3, a 0.9 decrease in 
frequency was observed in HIV+ obese compared to a 0.4 fold decrease in HIV+ non-obese 
patients (p<0.0001). 
 
Table 2 Association of HIV and Obesity for trimester one (n=496) and three 
(n=472) 
 Total 
n (%) 
HIV- 
n (%) 
HIV+ 
n (%) 
p-value 
Obesity     
Trimester 1     
         Non-obese 306 (66.9) 222 (72.6) 84 (27.4) ***<0.0001
a
 
        Obese 190 (33.1) 104 (54.7) 86 (45.3) 
 
Trimester 3     
         Non-obese 240 (50.8) 186 (77.5) 54 (22.5) ***<0.0001
b
 
         Obese 232 (49.2) 126 (54.3) 106 (45.7) 
 
n=sample size, RR= risk ratio, OR= odds ratio, CI= confidence interval, BMI= body mass index,  non-
obese (BMI<30), obese (BMI>30) 
Statistical significance: ***p<0.0001; **p<0.01 
aRR(1.325; 95%CI 1.145, 1.535); OR(2.185; 95%CI 1.494, 3.197) 
bRR(1.427, 95%CI 1.245, 1.635); OR (2.898, 95%CI 1.946, 4.315) 
 
 
The genotypic and allelotypic prevalence of OGG1 amongst HIV and obese study participants 
are shown in Table 3. For all subjects, the prevalence of the OGG1 CC and CG+GG genotypes 
was 66.9% and 33.1%, respectively. The C and G allele frequencies were 81.1% and 18.9%, 
respectively.  The frequency and prevalence of the allelotypes and genotypes were significantly 
different among HIV+ and HIV- individuals. The frequency of the G-allelotype decreased 0.7 
fold whilst the C-allelotype increased 1.1 fold (Table.3: p=0.0089) in HIV+ patients.  
 
The prevalence of OGG1 allelotypes and genotypes were significantly different between obese 
and non-obese individuals in T1 (Table.3). In T1, both CC and CG+GG genotype frequencies 
were decreased in obese patients by 0.7 and 0.4, respectively (Table.3: p=0.0324). However, the 
C-allelotype increased by 1.1 fold versus the 0.6 decrease in G-allele frequency observed in 
obese patients (Table.3: p=0.0410). In T3, the CC-genotype frequency increased 1.1 fold whilst 
the CG+GG-genotype decreased 0.7 fold in obese patients (Table.3: p=0.08). Both allele 
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frequencies decreased in obese patients by 0.99 fold and 0.7 fold, respectively (Table.3: 
p=0.0863). The genotypic frequency distributions were consistent with the Hardy-Weinberg 
equilibrium for this study (Chi
2
 test: p>0.05). 
 
Table 3 Genotypic and allelotypic frequencies of OGG1 patients that are HIV+ or 
HIV- (n=302) and non-obese (BMI<30) or obese (BMI>30) in trimester one (n=301) 
and three (n=288) 
  HIV   
 Total 
n (%) 
HIV- 
n (%) 
HIV+ 
n (%) 
p-value 
Genotype frequency     
        OGG1 CC 202 (66.9) 82 (40.6) 120 (59.4) **0.0048
a
 
        OGG1 CG and GG 100 (33.1) 24 (24) 76 (76)  
Allelotype frequency     
        OGG1 C 490 (81.1) 306 (78.1) 184 (86.8) **0.0089
b
 
        OGG1 G 114 (18.9) 86 (21.9) 28 (13.2)  
  Obesity   
 
Total 
n (%) 
Non-obese 
n (%) 
Obese 
n (%) 
p-value 
Genotype frequency     
Trimester 1     
        OGG1 CC 201 (66.8) 117 (58.2) 84 (41.8) *0.0324
c
 
        OGG1 CG and GG 100 (33.1) 71 (71) 29 (29)  
Trimester 3     
        OGG1 CC 194 (67.4) 94 (48.5) 100 (51.6) 0.08
d
 
        OGG1 CG and GG 94 (32.6) 56 (59.6)  38 (40.4)  
Allelotype frequency     
Trimester 1     
        OGG1 C 488 (81.1) 295 (78.1) 193 (86.8) *0.0410
e
 
        OGG1 G 114 (18.9) 81 (21.9) 33 (13.2)  
Trimester 3     
        OGG1 C 469 (81.4) 236 (50.3) 233 (49.7) 0.0863
f
 
        OGG1 G 107 (18.6) 64 (59.8) 43 (40.2)  
n=sample size, RR= risk ratio, OR= odds ratio, CI= confidence interval, BMI= body mass index 
Statistical significance: *p<0.05 
aRR(0.7817; 95%CI 0.6671, 0.9160); OR(0.4621; 95%CI 0.2698, 0.7916) 
bRR(0.8278, 95%CI 0.7303, 0.9383); OR (0.5415, 95%CI 0.3404, 0.8612) 
cRR(0.8198; 95%CI 0.6906, 0.9733); OR(0.5689; 95%CI 0.3399, 0.9522) 
dRR(0.8133, 95%CI 0.6521, 1.014); OR (0.6379, 95%CI 0.3872, 1.051) 
eRR(0.8508, 95%CI 0.7415, 0.9761); OR (0.6227, 95%CI 0.3996, 0.9705) 
fRR(0.8413, 95%CI 0.7030, 1.007); OR (0.6805, 95%CI 0.4441, 1.043) 
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Effect of OGG1 polymorphism and HIV on the risk of LBW and PTB 
Obesity and the genotypic influence of OGG1 Ser326Cys genotypes on the association between 
HIV, obesity and LBW or PTB are described in Table 4. HIV infection was suggested to be 
associated with LBW in the total population (p=0.071), this was found to be significant for CC-
carrying patients (p=0.034). Where being HIV+ increased the susceptibility of having LBW by 
a 1.45 fold change and PTB by a 2.26 fold increase (Table.4, p=0.034 and p=0.036, 
respectively). 
 
Being obese in both T1 and T3 increased the susceptibility of delivering a LBW infant for HIV+ 
patients by 5.4 fold and 2.4 fold, respectively (Table.4: p=0.006 and p=0.017, respectively). 
Additionally, being obese in T3 and carrying CC-genotype increased the susceptibility of 
delivering a LBW infant by 3.4 fold in HIV+ patients (Appendix 4: Table A4.1: p=0.029) and 
being obese in T1 and living in the south increased the risk of HIV associated LBW by 8.01 fold 
(Appendix 4: Table A4.1: p=0.022). Whilst, carrying the CC-genotype and being non-obese in 
T3 increased the susceptibility of PTB in HIV+ patients by 3 fold (Appendix 4: Table A4.1: 
p=0.024). 
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The distribution of BW for obesity and HIV are shown in Figure 1. In T1, obese patients gave 
birth to higher BW infants compared to non-obese (Fig.1A, p=0.0331) whilst HIV+ patients 
gave birth to smaller BW infants compared to HIV- (Fig.1A, p=0.0547). In HIV- patients this 
trend was also observed where obese patients gave birth to higher BW infants than non-obese, 
Table 4 OGG1 Genotypic and obesity frequency distributions among patients delivering 
LBW or NBW neonates, at term (TB) or pre-term (PTB) that are HIV+ and HIV- 
(n=302) 
 Birth Weight (g) Gestational Age (weeks) 
 
NBW 
n(%) 
LBW 
n(%) 
p-value TB n(%) PTB n(%) p-value 
Total       
HIV- 
260 
(88.44) 
34 (11.56) 
0.071 
270 
(92.15) 
23 (7.85) 
0.154 
HIV+ 
125 
(82.24) 
27 (17.76) 132 (88) 18 (12) 
CC       
HIV- 98 (89.91) 11 (10.09) 
*0.034 
100 
(91.74) 
9 (8.26) 
*0.036 
HIV+ 59 (78.67) 16 (14.67) 61 (81.33) 14 (18.67) 
CG+GG       
HIV- 62 (86.11) 10 (13.89) 
0.621 
66 (91.67) 6 (8.33) 
0.864 
HIV+ 18 (81.82) 4 (18.18) 19 (90.48) 2 (9.52) 
Non-obese       
T1       
HIV- 
172 
(85.57) 
29 (14.43) 
0.680 
183 
(91.04) 
18 (8.96) 
0.146 
HIV+ 61 (83.56) 12 (16.44) 62 (84.93) 11 (15.07) 
T3       
HIV- 
146 
(85.38) 
25 (14.62) 
0.851 
155 
(90.64) 
16 (9.36) 
0.100 
HIV+ 43 (84.31) 8 (15.69) 42 (82.35) 9 (17.65) 
Obese       
T1       
HIV- 88 (94.62) 5 (5.38) 
**0.006 
87 (94.57) 5 (5.43) 
0.357 
HIV+ 64 (81.01) 15 (28.99) 70 (90.91) 7 (9.09) 
T3       
HIV- 111 (92.5) 9 (7.5) 
*0.017 
112 
(94.12) 
7 (5.88) 
0.496 
HIV+ 81 (81.82) 18 (18.18) 89 (91.75) 8 (8.25) 
n=sample size, NBW= normal birth weight, LBW= low birth weight, TB=term birth, PTB= pre-term birth, 
T1= trimester one, T3= trimester three, BMI= body mass index 
NBW (>2500g), LBW (<2500g), TB (>37 weeks), PTB (<37 weeks), non-obese (BMI<30), obese (BMI>30) 
Statistical significance: **p<0.01, *p<0.05 
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however HIV+ obese patients gave birth to significantly smaller BW infants than HIV- obese 
patients (Fig.1A p=0.0039). A similar trend was also observed in T3 (Fig.1B, p=0.0177), where 
HIV+ obese patients gave birth to smaller BW infants compared to HIV- obese patients. The 
OGG1 SNP genotypes showed no significant change in BW among HIV-/+ and obesity, 
however CC-carrying HIV+ patients (2952.23±84.05) had lower BW than CC HIV- patients 
(3115.85±46.51, p=0.0911). This same trend was observed in obese HIV+ CC patients (T1: 
2990.15±116.77; T3: 2967.08±112.11) compared to obese HIV- CC patients (T1: 3167±67.07, 
p=0.1939; T3: 3143.60±58.09, p=0.1663).  The effect of OGG1 SNP, obesity and HIV on GA 
was also determined. No change was observed between obese patients, however in non-obese 
patients those that were HIV- CC-carrying (T1: 38.96±0.207; T3: 38.90±0.225) gave birth later 
than compared to HIV+ CC-carrying patients (T1:37.92±0.329, p=0.0095; T3: 37.75±0.357, 
p=0.0091). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Birthweight disruption within obese (BMI>30) and non-obese (BMI<30) patients that are HIV+ 
and HIV- for trimester one (a) and three (b) Statistical significance: **p<0.01, *p<0.05 
 
OGG1 polymorphism association with maternal clinical parameters 
The association between the OGG1 CC and CG+GG genotypes and LBW/PTB among the 
maternal clinical characteristics are described in Table 5. No significant difference between the 
genotypes for clinical characteristics was observed in PTB. However, a significant increase in 
BMI for both T1 and T3 was observed in LBW for CC-carrying patients compared to CG+GG 
(T1:p=0.0104 and T3:p=0.0076, Table.5). This was also observed for iron, where the CC-
carrying patients had significantly higher iron levels compared to CG+GG for both trimesters 
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for LBW (T1:p=0.0314,  T3:p=0.0454, Table.5). A similar trend was observed for PTB, where 
iron in T3 was higher in CC-carrying patients compared to CG+GG (p=0.0992). 
 
Table 5 Association of OGG1 Ser326Cys genotypes with maternal clinical parameters in LBW and PTB 
neonates 
 (a) LBW (n=41)  (b) PTB (n=31)  
Variable CC vs CG+GG p-value CC vs CG+GG p-value 
BMI T1 33.55 ± 2.71 vs 23.06 ± 1.33 *0.0104 30.04 ± 2.10 vs 26.56 ± 2.25 0.3701 
BMI T3 36.50 ± 2.66 vs 25.19 ± 2.34 **0.0076 32.00 ± 1.82 vs 29.17 ± 2.57 0.4139 
Hb T1 11.20 ± 0.246 vs 9.29 ± 1.41 0.0776 9.23 ± 0.992 vs 9.53 ± 1.47 0.8759 
Hb T3 10.48 ± 0.469 vs 9.46 ± 1.14 0.3318 9.70 ± 0.796 vs 8.19 ± 1.88 0.3898 
Iron T1 10.16 ± 0.599 vs 6.88 ± 1.70 *0.0314 7.89 ± 1.13 vs 4.11 ± 2.08 0.1073 
Iron T3 10.01 ± 0.536 vs 7.24 ± 1.54 *0.0454 9.07 ± 0.918 vs 5.65 ± 2.21 0.0992 
BP systolic T1 110.07 ± 2.44 vs 106 ± 3.40 0.3356 111.17 ± 2.51 vs 115.5 ± 3.91 0.3795 
BP systolic T3 110.12 ± 2.13 vs 108 ± 2.99 0.5643 105.05 ± 2.37 vs 103 ± 5.68 0.6958 
BP diastolic T1 66.63 ± 1.44 vs 67 ± 2.11 0.8836 67.57 ± 1.95 vs 70.38 ± 2.63 0.4490 
BP diastolic T3 65.46 ± 1.86 vs 66.64 ± 1.68 0.6789 64.27 ± 1.69 vs 63.88 ± 2.73 0.9034 
Results described: mean ± standard error of mean (n=sample size) 
n=sample size, LBW= low birth weight, PTB= pre-term birth, BMI= body mass index, Hb= haemoglobin, BP= blood pressure, T1= 
trimester one, T3= trimester three 
Statistical significance: **p<0.01, *p<0.05 
 
A sub-analysis of BMI and iron for T1 and T3 are represented in Table 6. The data showed that 
the BMI for T1 and T3 was significantly greater in CC-carrying patients compared to CG+GG 
for all LBW and NBW (T1: p=0.0104 and p=0.0269, T3: p=0.0076 and p=0.0453, respectively). 
HIV infection was associated with a higher BMI (T1) in LBW compared to NBW (p=0.621: 
35.64±2.71 and 34.21±1.20, respectively) whilst HIV- was significantly associated with lower 
BMI (T1) in LBW compared to NBW (p=0.030: 24.67±1.67 and 28.77±0.641, respectively) for 
all patients. This pattern was also observed between BMI T1/T3 and LBW for CC- and 
CG+GG-carrying patients, although not significant. 
 
Iron is significantly greater in CC-carrying patients compared to CG+GG patients giving birth 
to LBW infants (Table.6: T1:p=0.0314 and T3:p=0.0454). HIV infection greatly influences this 
relationship where HIV+ CC-carrying patients have greater iron levels compared to HIV- CC 
patients whilst the opposite is observed within CG+GG-carrying patients. No association 
between iron for T1/T3 was observed for NBW and OGG1 genotypes, however it was observed 
that HIV infection increased iron levels significantly for both CC and CG+GG-carrying patients 
(p=0.0022 and p=0.0424, respectively). 
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Table 6 Sub-analysis of  body mass index, iron and OGG1 Ser326Cys for 
all groups 
Groups CC vs CG+GG p-value 
BMI T1   
All LBW 33.55 ± 2.71 (27) vs 23.06 ± 1.33 (14) *0.0104 
LBW HIV- 24.96 ± 2.18 (11) vs 22.30 ± 1.54 (10) 0.3401 
LBW HIV+ 39.46 ± 3.68 (16) vs 24.94 ± 2.70 (4) 0.0728 
All NBW 30.67 ± 0.875 (157) vs 27.62 ± 0.855 (80) *0.0269 
NBW HIV- 29.58 ± 0.917 (98) vs 26.27 ± 0.818 (62) 0.0824 
NBW HIV+ 34.13 ± 1.68 (59) vs 32.27 ± 2.27 (18) 0.5732 
BMI T3   
All LBW 36.50 ± 2.66 (26) vs 25.19 ± 2.34 (14) **0.0076 
LBW HIV- 30.07 ± 2.95 (11) vs 24.51 ± 3.14 (10) 0.2121 
LBW HIV+ 41.22 ± 3.67 (15) vs 26.89 ± 2.78 (4) 0.0691 
All NBW 34.09 ± 0.972 (157) vs 31.01 ± 0.926 (78) *0.0453 
NBW HIV- 31.82 ± 1.04 (98) vs 29.79 ± 0.929 (60) 0.1822 
NBW HIV+ 37.85 ± 1.83 (59) vs 35.10 ± 2.36 (18) 0.4443 
Iron T1   
All LBW 10.16 ± 0.599 (27) vs 6.88 ± 1.70 (14) *0.0314 
LBW HIV- 9.3 ± 1.24 (11) vs 8.13 ± 1.82 (10) 0.5957 
LBW HIV+ 10.74 ± 0.539 (16) vs 3.75 ± 3.75 (4) **0.0029 
All NBW 7.61 ± 0.411 (157) vs 7.56 ± 0.600 (80) 0.9498 
NBW HIV- 6.75 ± 0.540 (98) vs 6.71 ± 0.729 (62) 0.9621 
NBW HIV+ 9.04 ± 0.584 (59) vs 10.53 ± 0.445 (18) 0.1774 
Iron T3   
All LBW 10.02 ± 0.536 (26) vs 7.24 ± 1.54 (14) *0.0454 
LBW HIV- 9.4 ± 1.08 (11) vs 8.74 ± 1.52 (10) 0.7243 
LBW HIV+ 10.47 ± 0.489 (15) vs 3.5 ± 3.5 (4) **0.0021 
All NBW 8.50 ± 0.378 (157) vs 8.33 ± 0.564 (78) 0.7963 
NBW HIV- 7.62 ± 0.520 (98) vs 7.71 ± 0.700 (60) 0.9172 
NBW HIV+ 9.97 ± 0.458 (59) vs 10.41 ± 0.496 (18) 0.6195 
Results described: mean ± standard error of mean (n=sample size) 
NBW= normal birth weight, LBW= low birth weight, T=trimester 
Statistical significance: **p<0.01, *p<0.05 
 
 
Multiple-variables logistic regression analysis 
We further analysed the impact of maternal characteristics on PTB as shown in Table 7. The 
logistic regression was used to control for any potential confounding factors that may have 
influenced the relationships observed thus far. The results show that HIV increased the odds of 
104 
 
PTB although not significantly (p=0.244).  Patients living in the heavily polluted DSIB or 
carrying the CC-genotype have significantly greater odds (13.06 and 15.66, respectively) for 
PTB. Maternal clinical characteristics had no impact on the risk of PTB. The impact of maternal 
characteristics on LBW showed no significant results (Appendix 4: Table A4.2). 
 
Table 7 Impact of maternal clinical characteristics on the risk of pre-term birth – a 
multi-variate logistic regression analysis (n=128) 
Variable OR
a
 (95%CI) p-value 
 Pre-term Birth 
HIV 2.73 (0.505, 14.74) 0.244 
Maternal age 0.922 (0.771, 1.10) 0.372 
BMI 1.00 (0.998, 1.00) 0.482 
Hb 0.984 (0.953, 1.02) 0.324 
Iron 1.00 (0.973, 1.03) 0.886 
BP systolic 1.00 (0.999, 1.00) 0.170 
BP diastolic 1.00 (0.998, 1.00) 0.491 
OGG1 (CC genotype) 15.66 (1.10, 222.32) *0.042 
Area (South) 13.06 (1.10, 155.17) *0.042 
NOx levels 0.912 (0.809, 1.03) 0.132 
 R
2
 = 0.4248 (**p=0.0040) 
Results described: OR, (95%CI), p-value with regression model R2-value and p-value 
n= sample size, OR= odds ratio, CI= confidence interval, HIV= HIV positive, BMI= body mass index, 
Hb= haemoglobin, BP= blood pressure, OGG1 represents CC genotype, Area represents heavily polluted 
south 
aAdjusted for maternal characteristics: HIV status, BMI, area, NOx levels, maternal age, haemoglobin, 
iron, blood pressure systolic and diastolic, OGG1 CC SNP and neonatal characteristics: low birth weight, 
neonate gender, neonate length, head circumference,  parity, body: brain index, ponderal index, Apgar 
scores 1min and 5min 
Statistical significance: **p<0.01, *p<0.05 
 
 
Discussion 
To the best of our knowledge, this is the first study to show the association between Ser326Cys 
OGG1 SNP with HIV infection and its influence on LBW and PTB, in a South African 
population. It was observed that co-morbid HIV infection and obesity resulted in decreased 
neonatal BW; with the wild-type OGG1 genotype increasing the risk for PTB and HIV 
associated LBW. Patients exposed to higher levels of AAP within the DSIB were also shown to 
have an increased risk for PTB. 
 
In developed countries, a shift from HIV associated wasting to obesity has been observed. This 
shift is in response to HIV being a chronic condition with infected people living longer and 
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gaining weight, similar to the general population [10,14]. This study is in agreement to those 
done in developed countries, where being HIV+ significantly increases the odds for being obese 
(Table.2, T1:OR 2.185, T3: OR:2.898) [14,24,25]. Other studies done in SA have shown the 
opposite where HIV+ patients have been reported to have reduced BMI, even with ART 
treatment [11,12]. The discrepancy between this study and those previously done in SA, could 
be due to the increased use of ART therapy within HIV+ patients from 31.2% in 2012 to 47% in 
2014 [26]. In addition to the socio-behavioural attitudes, where ethnic black obese women are 
perceived as attractive and is associated with affluence, wealth, respect and dignity. Excessive 
loss of weight is also associated with HIV; therefore being overtly overweight masks the disease 
from relatives and acquaintances [12,14]. 
 
Individual genetic susceptibility is highly important when considering interactions between the 
environment and health outcomes. These genetic differences influence the response individuals 
have to external and internal stresses. Both obesity and HIV infection have been associated with 
metabolic abnormalities and increased oxidative stress [14]. Increased BMI has been associated 
with the OGG1 Ser326Cys SNP within a Japanese population; however this association was 
removed when the population area was controlled [27]. Our study investigated and showed that 
obesity in T1 and HIV infection was associated with OGG1 Ser326Cys SNP (Table.3: p=0.0048 
and p=0.0324, respectively). To our best knowledge, this is the first study to show an 
association between HIV infection and OGG1 Ser326Cys SNP. 
 
Our study then investigated the effect HIV and obesity had on adverse birth outcomes. It was 
observed that HIV was suggested to increase the frequency of LBW (Table.4, p=0.071). In CC-
carrying patients, this association strengthened and became significant. Carrying the CC-
genotype therefore increased the susceptibility of HIV+ associated PTB and LBW (Table.4). It 
is well known that male neonates generally have larger BW for GA than female neonates [28] 
therefore it was interesting to note that carrying a female neonate and the CC genotype 
increased the susceptibility of HIV associated LBW (Appendix 4: Table A4.3, p=0.024); whilst 
carrying a male neonate increased the susceptibility of HIV associated PTB (Appendix 4: Table 
A4.3, p=0.024). 
 
There was increased BMI observed in CC-carrying versus variant mothers, for both LBW and 
NBW neonates. However an increased BMI was observed for LBW delivering HIV+ CC-
carrying mothers compared to NBW mothers, whilst the opposite is true for HIV- CC-carrying 
mothers. Therefore, HIV infection has been shown to increase the BMI of LBW delivering 
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mothers (Table 6, p=0.621) whilst being HIV- significantly reduced BMI in LBW delivering 
mothers (Table.6, p=0.03). This may suggest a differential effect of HIV and the OGG1 SNP on 
BMI levels within mother’s delivering LBW neonates. This correlates well with the observed 
increased risk of HIV associated LBW, in patients that are obese (Table.4, T1:p=0.006 and 
T3:p=0.017). Although obesity has been shown previously to be associated with macrosomia 
(large BW) and reduced BMI associated with LBW [5,8], HIV infection has never been taken 
into consideration. It was observed that neonates born to obese versus non-obese mothers had 
significantly greater BW; this is in line with what is observed within literature [5,29]. However, 
obese mothers with HIV co-infection gave birth to neonates with significantly smaller BW than 
HIV- obese mothers (Fig.1, p=0.0039). It has been suggested that restriction of foetal growth is 
related to increased oxidative stress, coagulation and alterations in endothelial and vascular 
functions which compromises blood flow and oxygen transfer between the foetus and mother 
[4,13]. HIV and obesity both result in increased inflammation and oxidative stress, with obesity 
linked to endothelial dysfunction and atherosclerosis which could result in reduced blood flow 
to the foetus resulting in foetal growth restriction [5,30]. 
 
Although the OGG1 SNP had no direct impact on neonatal BW, it was observed that carrying 
the CC-genotype increased the susceptibility of PTB by 15.66 (Table.7, p=0.042). Previously, 
the variant was shown to have reduced BW compared to the wt, although not significant and the 
study sample size was small [31]. Studies have also reported conflicting reports that the variant 
has reduced repair capacity [22,32], whilst others show no difference in repair capacity 
[22,33,34]. The combined effect of HIV, obesity and pollution on the OGG1 SNP has not be 
considered, therefore in light of these interactions this study suggests that that co-morbid 
infection with HIV and OGG1 CC-genotype increases the risk for LBW and PTB. 
 
The DSIB has been shown previously to have high levels of AAP that affect children’s health 
[17,18,35]. This study shows that those living with the DSIB have a 13.06 fold increased risk of 
PTB (Table.7, p=0.042). The DSIB has been shown to have increased levels of nitrogen oxides 
(NOx), compared to the less polluted north Durban [36]. Nitrogen oxides are common by-
products of vehicle combustion, cooking with gas and smoking [37]. These pollutants are free-
radicals and as such upon inhalation result in increased oxidative stress, with high levels of NO 
being reported in PTB [38]. Several studies have reported AAP increases the risk of PTB [39–
41]. Therefore patients exposed to higher levels of AAP within the DSIB, compared to the north 
Durban are at greater risk for delivering prematurely, which puts them at a greater risk for PTB-
107 
 
associated morbidities, such as asthma, respiratory complications and neurodevelopmental 
impairments [42]. 
 
Limitations of our study include the relatively small sample size; a larger study population 
would increase the power of our results. Additionally, the effect antiretroviral drug use and 
ethnicity was not controlled for; this could be further investigated in future larger studies. 
 
In conclusion this study identifies patient’s carrying the OGG1 Ser326Cys CC genotype are at 
greater risk for HIV associated LBW, and delivering prematurely. Living within the DSIB and 
being exposed to higher levels of AAP increased the susceptibility of PTB. Co-morbid HIV 
infection and obesity are additional risk factors for BW reduction within this South African 
population. To better improve the prevalence of adverse birth outcomes, education on the effect 
of HIV and obesity on pregnancy should be improved to reduce pre-pregnancy HIV and obesity 
rates. This is of particular importance in SA, due to the high incidence of obesity and HIV. 
Education and identifying risk factors are important preventive measures which are essential for 
reducing adverse birth outcomes in all populations. 
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Abstract  
HIV has been implicated in adverse birth outcomes, due to increased oxidative stress and 
inflammation. In addition, HIV has been reported to increase nitric oxide levels. Therefore the 
combined exposures to HIV and traffic-related air pollution, within south Durban, South Africa 
(SA), may lead to adverse birth outcomes. However, the exact mechanism of action is still 
unknown, therefore this study aimed to identify a potential mechanism. HIV’s influence on 
oxidative and nitrosative stress markers within pregnant women was first assessed. Second, the 
effect of these stress makers and oxides of nitrogen (NOx) exposure have on neonatal 
birthweight (BW) was evaluated. Finally, the effect HIV and traffic-related pollution exposure 
has on the oxidative and endoplasmic profile and epigenetic regulation of Nrf2-Keap1 pathway 
by miR-144 and miR-28 in pregnant women was determined. Women, in their third trimester 
with singleton pregnancies, who were HIV+ and HIV-, were recruited from Durban, SA. 
Biomarker levels of serum nitrites/nitrates (NO) and malondialdehyde (MDA) were analysed 
and mRNA expression levels of oxidative and endoplasmic stress response genes were assessed. 
Land regression modelling was performed to determine NOx exposure levels. HIV exposure 
during pregnancy was associated with increased NO levels. NO was shown to reduce neonatal 
BW. NO and MDA was found to reciprocally increase each other, with HIV differentially 
influencing MDA effect on BW. HIV downregulated miR-144 which was negatively associated 
with Nrf2, suggesting a potential mechanism for HIV associated chronic oxidative stress.  This 
study proposes that NO plays a key role in neonatal BW reduction in response to HIV and 
traffic-related air pollution. 
 
Keywords 
HIV, oxidative stress, NO, MDA, adverse birth outcomes, traffic-pollution, Nrf2-Keap1 
pathway, ER stress, epigenetics 
 
Highlights 
 HIV exposure increased serum NO, with reciprocal action on MDA levels 
 HIV induced miR-144 suggested as a mechanism for increased oxidative stress 
 Exposure to heavily polluted south Durban activated the ER stress 
 Maternal serum NO reduced neonatal birthweight, in heavily polluted Durban south 
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Introduction 
An estimated 36.7 million people in the world are living with the human immunodeficiency 
virus (HIV). Of these, 7 million are living in South Africa (SA) and women account for more 
than half of the total HIV infected population in SA [1]. This is of major concern, not only due 
to the associated morbidity and mortality, but due to increased risk of adverse birth outcomes 
associated with HIV infection [2]. 
 
HIV infection in pregnant women has been reported to increase the susceptibility of neonates to 
shunting, wasting and reduced weight with increased risk of low birth weight (LBW) and 
preterm births (PTB) [2]. Factors that affect LBW and PTB pathology include oxidative stress, 
inflammation, endothelial dysfunction, reduced oxygen transport across the placenta and 
abnormalities of the placenta [3]. HIV is a lentivirus that infects and kills vital cells of the 
immune system [4]. Upon HIV infection, it triggers the innate immune response activating 
macrophages to produce nitric oxide (NO), which is a major mediator of inflammation and 
apoptosis [5]. Studies have shown increased levels of NO and inflammatory markers in HIV 
infected patients [5,6]. HIV has also been associated with increased oxidative stress, where 
decreased antioxidant capacity and increased oxidative damage have been reported [4,7]. 
Therefore HIV could illicit LBW and PTB as a result of increased inflammation and oxidative 
stress, with NO potentially playing a key role. 
 
Nitric oxide is an inorganic free radical that is produced endogenously by a family of 
isoenzymes as a reaction by-product, during the catalytic conversion of L-arginine to L-
citrulline [8]. Three isoenzymes of NO synthases (NOS) have been identified; neural (nNOS), 
endothelial (eNOS) and inducible (iNOS). NO readily diffuses across cell membranes; at low 
concentrations it binds to haemoglobin (Hb) and becomes inactive, whilst in excess NO reacts 
with superoxide and oxygen to form peroxynitrite and dinitrogen trioxide, respectively. NO and 
its intermediates are highly reactive and result in macromolecular damage; including modifying 
cysteine amino acids of target proteins, triggering lipid peroxidation (LP), inhibiting the 
electron transport chain and oxidising biological thiol-containing compounds. Both NO and 
peroxynitrite are highly unstable and degrade to nitrates and nitrites, which act as markers of 
NO concentration [9,10]. Increased levels of NO have been associated with PTB [11].  
 
Lipid peroxidation is the oxidative conversion of polyunsaturated fatty acids (PUFA) to 
products known as malondialdehyde (MDA) or lipid peroxides, which act as biomarkers. The 
decomposition of NO and peroxynitrite to form hydroxyl radicals and nitrite radicals initiate LP 
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chain reactions, where hydroxyl radicals and nitrite abstract hydrogen ions from the methylene 
group of PUFA resulting in an unpaired electron on carbon that reacts with oxygen present to 
form peroxyl radicals. This sets up the chain reaction of LP, which can continue to cause 
macromolecular damage or is terminated by antioxidants [12]. Several studies have associated 
increased LP with adverse birth outcomes, especially PTB [13,14]. 
 
Alternatively, exogenous sources of NO include vehicle exhaust fumes and cigarette smoke 
[15,16]. Durban, in SA, is a rapidly developing city with increased urbanisation and road traffic, 
all factors associated with an increase in oxides of nitrogen (NOx) pollution within the 
atmosphere. This in combination with residential areas in close proximity to busy highways and 
roads makes individuals highly susceptible to adverse effects of NOx exposure, with infants’ in 
utero being highly vulnerable to the negative effects. It has been reported previously that 
exposure to NOx and other air pollution (AP) have been associated with increased risk of LBW 
and PTB [13,17–20]. Durban, consisting of a highly industrialised south region (SD) and a less 
industrialised north region (ND), is an ideal location to investigate the effects of traffic-related 
AP on birth outcomes. 
 
Endogenous and exogenous toxic insult, viz. exposure to HIV or traffic-related AP, results in 
macromolecular and cellular damage leading to increased stress responses. Cytoprotection 
against these insults is provided by antioxidant enzymes such as catalase (CAT), superoxide 
dismutase 2 (SOD2) and glutathione peroxidase (GPx) [21] and repair enzymes including the 
human 8-oxoguanine glycosylase 1 (OGG1) gene which is a key component within the DNA 
repair pathway. OGG1 is highly susceptible to oxidative modification and has been shown to be 
inhibited by NO [22,23]. These responses are regulated via the antioxidant response element 
(ARE) where nuclear factor (erythroid-derived 2)-like 2 (Nrf2) acts as the key transcription 
factor. Upon increased oxidative damage and subsequent dissociation from kelch-like ECH-
associated protein 1 (Keap1), Nrf2 translocates to the nucleus where it binds to the ARE 
resulting in transcriptional activation of specific target genes, including antioxidants [24]. 
Epigenetic regulation of  Nrf2-Keap1 pathway by microRNA (miR)-144 and miR-28 has been 
found to be an important determinate of an individual’s response to certain adverse conditions 
[25,26]. The endoplasmic reticulum (ER) stress response is also activated when there is 
increased oxidative insult resulting in increased unfolded proteins (UP). Increased UP and ER 
stress is sensed by ER chaperones, including BiP, which activates the UP response pathway 
(UPR) to mitigate ER stress [27]. 
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A pilot study conducted by Nagiah and colleagues reported increased markers of oxidative 
stress within pregnant women living in the heavily industrialised south [28]. However this study 
did not investigate the effects HIV may have on these stress profiles, due to their small sample 
size, nor the subsequent effect on adverse birth outcomes. As a follow on study we aimed to 
determine whether HIV infection influenced oxidative and nitrosative stress markers within 
pregnant women, with consideration taken for the NOx exposure and living area of each 
women. The effect of the stress markers and NOx exposure on neonatal birth weight (BW) was 
then investigated. To further understand the oxidative profile of HIV and locational effect on 
these mothers, gene expression for oxidative and ER stress markers, including epigenetic 
regulation of the Nrf2-Keap1 pathway by miR-144 and miR-28 were also investigated.  
 
Methodology 
Study population 
The Mother and Child in the Environment (MACE) longitudinal cohort study recruited HIV 
negative (HIV-) (n=230) and positive (HIV+) (n=126) pregnant women from public sector anti-
natal clinics in the heavily-polluted Durban south region and less-industrialised Durban north 
region KwaZulu-Natal, SA). Ethical approval from the Biomedical Research Ethics Committee 
of the University of KwaZulu-Natal (BF263/12) (Appendix 1) and informed consent from study 
participants was obtained. The women participants were residents of the geographical area for 
the full duration of the pregnancy. Women with hypertension, multiple pregnancies, diabetes, 
placenta previa, genital tract infections and other complications which result in adverse growth 
effects were excluded from the study.  
 
NOx pollution  
The exposure levels of atmospheric NOx for individual study participants was determined using 
land use regression modelling, developed following the ESCAPE approach [29]. NOx 
measurements were collected using Ogawa samplers over two-week periods during mid-
summer and mid-winter. Measurements were taken at 40 randomly selected sites in the north 
and south Durban areas.  The regression-derived parameter estimates were used to determine 
pollutant levels at un-monitored locations such as participant homes [30]. 
 
Sample collection and preparation  
Third trimester blood was collected in BD Vacutainer® EDTA and SST tubes. The SST tubes 
were centrifuged at 1000xg for 10min to isolate serum and stored at -80°C until NO and MDA 
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quantification. Equal parts whole blood and RNALater® (ThermoFischer Scientific; AM7021) 
was stored at -80°C for the assessment of various gene expressions. 
 
Nitrates and Nitrites Assay 
NO has a short half-life, approximately 6-10s, and thus degrades rapidly to nitrites and nitrates 
[11]. The detection of these NO metabolites was used to determine the NO concentration within 
each individual. This was performed using vanadium (III) chloride as the reducing agent and an 
acidic Griess reaction for detection. Non-haemolysed serum samples (n=301) were chosen, at 
random, from the study population recruited above and diluted (1:4) in deionised water (dH2O). 
Sodium nitrate (200µM) was serial diluted to make up standards (0-200µM). 50µl of samples 
and standards (in duplicate) were pipetted into a 96-well microtitre plate. Into each well, 50µl 
VCl3 was added. Rapidly 25µl SULF followed by 50µl NEDD was added into each well. The 
plate was incubated for 45min at 37°C. The absorbance was measured at 540nm using the 
BioTek
®
 µQuant
TM
 Microplate Spectrophotometer (BioTek
®
 Instruments, Inc.). A standard 
curve was constructed and the linear equation used to extrapolate the concentration of the 
unknown samples (Appendix 5: Fig.A5.1). The final concentration (µM) of NO was multiplied 
by the dilution factor (4). 
 
Lipid peroxidation 
The amount of serum lipid peroxidation was determined using the thiobarbituric acid reactive 
substances (TBARS) assay, which quantified MDA as described by Halliwell and Gutteridge 
[31]. Non-haemolysed serum samples (n=299) were diluted (1:2) in phosphate-buffered saline 
(PBS). Then, 100µl 2% H3PO4, 100µl 7% H3PO4 and 200µl thiobarbituric acid (1%,w/v)/0.1 
mM butylated hydroxytoluene solution (TBA/BHT) was added to the 1.5ml tube containing 
100µl diluted serum. A positive and negative control were prepared, 0.5µl 1% MDA (200µl 
TBA/BHT) and 200µl 3mM HCl, respectively. Samples were vortexed, 100µl 1M HCl was 
added to ensure optimal pH. The samples were boiled for 45min (100°C) and allowed to cool to 
room temperature (RT). Butanol (750µl) was added to each tube, vortexed and allowed to 
separate for 20min at RT into two phases. The butanol phase was transferred to a 96-well plate 
(100µl), following aspiration and centrifugation at 18,506xg for 6min (RT). The absorbance was 
measured at wavelength 532nm, with a reference wavelength of 600nm, using the BioTek
®
 
µQuant
TM
 Microplate Spectrophotometer (BioTek
®
 Instruments, Inc.).  The MDA concentration 
was calculated by dividing the mean absorbance of the samples by the absorption coefficient 
156mM
-1
. 
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RNA isolation 
Complementary DNA (cDNA) was synthesised from total RNA and used in Real-Time (RT) 
PCR for analysis of gene expression. Total RNA was isolated from whole blood stored in equal 
parts RNALater® using an in house protocol. Briefly, 500µl of whole blood was mixed with red 
blood cell lysis buffer (2,500µl), incubated on ice for 15min  and centrifuged (400xg, 10min, 
4°C). The supernatant was discarded, 1000µl lysis buffer was added, vortexed and centrifuged 
(400xg, 10min, 4°C). Thereafter, the supernatant was removed and discarded. QIAzol lysis 
reagent (Qiagen #79306) (500µl) was added and incubated overnight at -80°C. Following 
incubation, chloroform (100µl) was added, and centrifuged (12,000xg, 15min, 4°C). The 
aqueous phase was transferred to a fresh 1.5ml tube, cold isopropanol (250µl) added and stored 
overnight at -80°C. Following incubation, samples were centrifuged (12,000xg, 20min, 4°C) 
and the supernatant was removed. The pellet was washed with cold 75% ethanol and finally 
centrifuged (7,400xg, 15min, 4°C). The ethanol was aspirated and the pellet was allowed to air-
dry. The pellet was resuspended in 15µl nuclease free water and quantified using the Nanodrop 
2000 spectrophotometer. The RNA were subsequently standardised to a concentration of 
300ng/µl. 
 
cDNA synthesis and mRNA expression  
Isolated RNA was pooled into groups (25 participants per group) according to their 
geographical area (ND and SD) and HIV status. The pooled RNA was converted to cDNA using 
the iScript
TM
 cDNA synthesis kit (Bio-Rad #170-8891). A total reaction volume of 20µl (4µl 5x 
iScript reaction mix, 1µl iScript Reverse transcriptase, 1000ng of RNA template and nuclease 
free water) was incubated under the following conditions: 25°C for 5min, 42°C for 30min, 85°C 
for 5min and a final hold at 4°C. 
 
Antioxidant gene expression, ER and oxidative stress markers were investigated using RT-PCR. 
The mRNA expression levels of the relevant genes (Table 1) were measured using the 
commercially available iQ
TM
 SYBR
®
 Green Supermix kit (Bio-Rad #170-8882). Briefly, a 10µl 
reaction volume consisting of 25µM of each sense and antisense primer (Inqaba Biotech, SA - 
Table 1), 1µl cDNA template, 5µl IQ
TM
 SYBR
®
 Green supermix and nuclease free water) was 
used. Following initial denaturation (95°C, 8min), amplification was carried out over 37cycles 
of denaturation (95°C, 15sec), annealing (Table 1, 40sec) and extension (72°C, 30sec). A 
housekeeping gene (ribosomal 18S, Table 1) was amplified under the same conditions. The RT-
PCR was carried out using the CFX96 Touch
TM
 Real-Time PCR Detection System (Bio-Rad). 
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The fold change (2
-ΔΔCt
) was calculated using the method described by Livak and Schmittgen 
[32]. 
 
Table 1 RT-PCR Primer sequences and annealing temperatures 
Gene  Sequence 
Annealing Temperature 
(°C) 
Antioxidant Genes 
  
SOD2 
Sense 5’ GAGATGTTACACGCCCAGATAGC 3’ 
57 
Antisense 5’ AATCCCCAGCAGTGGAATAAGG 3’ 
CAT 
Sense 5’ TAAGACTGACCAGGGCATC 3’ 
58 
Antisense 5’ CAACCTTGGTGAGATCGAA 3’ 
GPx 
Sense 5’ GACTACACCCAGATGAACGAGC 3’ 
58 
Antisense 5’ CCCACCAGGAACTTCTCAAAG 3’ 
Oxidative stress markers 
  
Nrf2 
Sense 5’ AGTGGATCTGCCAACTACTC 3’ 
58 
Antisense 5’ CATCTACAAACGGGAATGTCTG 3’ 
Keap1 
Sense 5’ CCTTCAGCTACACCCTGGAG 3’ 
57 
Antisense 5’ AACATGGCCTTGAAGACAGG 3’ 
OGG1 
Sense 5’ GCATCGTACTCTAGCCTCCAC 3’ 
60 
Antisense 5’ AGGACTTTGCTCCCTCCAC 3’ 
ER Stress Markers 
  
BiP 
Sense 5’ CGGGCAAAGATGTCAGGAAAG 3’ 
55 
Antisense 5’ TTCTGGACGGGCTTCATAGTAGAC 3’ 
eIF2 
Sense 5’ CCTCACCATTTGCCTAAGGA 3’ 
57 
Antisense 5’ GGGGGACTTTCCTTCTTCTG 3’ 
ATF4 
Sense 5’ GTTCTCCAGCGACAAGGCTA 3’ 
65 
Antisense 5’ ATCCTCCTTGCTGTTGTTGG 3’ 
CHOP 
Sense 5’ ACCAAGGGAGAACCAGGAAACG 3’ 
55 
Antisense 5’ TCACCATTCGGTCAATCAGAGC 3’ 
Housekeeping   
18S 
Sense 5’ CAAATCGCTCCACCAACTAA 3’  
Antisense 5’ ACACGGACAGGATTGACAGA 3’  
 
miScript cDNA synthesis and microRNA expression 
RNA grouped according to their geographical area (ND and SD) and HIV status, was converted 
to miScript cDNA using the miScript II RT kit as per manufacturer instructions (Qiagen 
#218160). Briefly, a 20µl total reaction volume (4µl 5x miScript HiFlex, 2µl 10x miScript 
nucleics mix, 2µl miScript reverse transcriptase mix, 1000ng of RNA template and nuclease 
free water) was incubated for 60min at 37°C followed by 5min at 95°C. The miScript cDNA 
was then diluted (1:3).  
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The expression of miR-144 and miR-28 were investigated using RT-PCR. The miRNA 
expression of miR-144 (Qiagen #218300, MS00020328) and miR-28 (Qiagen #218300, 
MS00003255) were determined using commercially available primer assays and the miScript 
SYBR Green PCR Kit (Qiagen #218073). The RT-PCR control RNU6-2 (Qiagen #218300, 
MS00033740) was used alongside the miRNA of interest to ensure normalcy. The reaction was 
carried out according to the manufacturer’s instructions. Briefly a total reaction volume of 
12.5µl (6.25µl 2x Quantitect SYBR green master mix, 1.25µl Universal primer, 10x primer 
assay (miR-144/miR-28/RNU6-2), 1µl cDNA and nuclease free water) underwent initial 
denaturation  at 95°C for 15min, followed by 40 cycles of denaturation (94°C, 15s), annealing 
(55°C, 30s) and extension (70°C, 30s). The RT-PCR was carried out using the CFX96 Touch
TM
 
Real-Time PCR Detection System (BioRad). The fold change (2
-ΔΔCt
) was calculated using the 
method described by Livak and Schmittgen [32]. 
 
Statistical Analysis 
Statistical Analyses were preformed using GraphPad Prism V5 Software Package (GraphPad 
Software Inc., San Diego, California, USA). NO, NOx and MDA data was log transformed to 
ensure normalcy, and allow graphical representation of the data. Measurements taken during the 
mothers’ third trimester was used for body mass index (BMI), iron, Hb, systolic and diastolic 
blood pressure (BP) data. The Student t test was used to determine statistical significance 
between the HIV- and HIV+ groups for maternal and neonatal characteristics, atmospheric NOx 
levels and maternal NO and MDA concentrations. Correlations among atmospheric NOx, 
maternal serum NO and MDA and neonatal BW were done using the non-parametric Spearman 
correlation. A one way ANOVA was performed to determine the level of difference for the 
oxidative and ER stress markers and miRNA analysed in RT-PCR. Multivariate linear 
regression was used to determine whether the relationship between maternal serum NO and 
MDA and atmospheric NOx was affected by potential confounders, namely: maternal age, 
maternal BMI, HIV status, area, maternal systolic and diastolic blood pressure and Hb and iron 
levels. The relationship between neonatal BW and atmospheric NOx and maternal serum NO 
and MDA was also determined using linear regression, and potential confounders were 
controlled. The linear regression analyses were performed using STATA version 13.1. 
Statistical significance was set at p < 0.05. 
 
Results 
Maternal and Neonatal Characteristics 
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Maternal and neonatal characteristics of study participants are described in Table 2. The 
maternal age is greater in HIV+ compared to HIV- (p<0.0001) patients. HIV+ mothers are 
shorter (p<0.0001) and have larger BMIs (p<0.0001) compared to HIV- mothers (Table 2). The 
level of Hb and iron in HIV+ are greater than HIV- mothers (p=0.0186 and p<0.0001, 
respectively). BP measurements showed no difference (Table 2). The mean gestational age 
(GA) is shorter (p=0.0344), and BBR greater (0.0175) for HIV+ mothers compared to HIV- 
mothers. No difference was observed for PI, 1min and 5min Apgar scores (Table 2). 
 
Table 2 Maternal and neonatal characteristics 
  
HIV-  
 
HIV+  
 
 
n Mean (SD) n Mean (SD) p-value 
Maternal Characteristics      
Maternal Age (years) 230 24.48 (5.39) 126 28.21 (5.67) ***<0.0001 
Maternal height (cm) 230 156.0 (11.65) 125 148.5 (18.56) ***<0.0001 
Maternal BMI 219 30.53 (9.58) 120 37.23 (13.94) ***<0.0001 
Haemoglobin (g/dL) 219 9.40 (4.49) 120 10.36 (3.01) *0.0186 
Iron 219 7.51 (5.25) 120 9.69 (3.82) ***<0.0001 
BP systolic (mmHg) 219 108.8 (12.42) 120 109.0 (13.68) 0.9002 
BP diastolic (mmHg) 219 67.34 (9.29) 120 67.28 (7.83) 0.9543 
Neonatal Characteristics      
Gestational age (weeks) 207 38.86 (1.84) 113 38.44 (2.03) *0.0448 
Birthweight (g) 208 3107 (625.9) 114 2974 (668.7) 0.0874 
Body: brain ratio (BBR) 208 12.49 (10.94) 114 13.41 (12.43) *0.0175 
Ponderal Index (PI) 208 2.59 (0.845) 114 2.54 (0.999) 0.0965 
Apgar score (1min) 208 8.26 (0.901) 114 8.184 (1.28) 0.6703 
Apgar score (5min) 208 9.29 (0.685) 114 9.254 (1.189) 0.3466 
n= sample size, SD= standard deviation, g= grams, BMI= body mass index  
Statistical significance: ***p<0.0001, *p<0.05. 
 
 
HIV and location effects on maternal serum NO and MDA levels 
The level of atmospheric NOx is significantly greater in the south (37.35±0.66µM) compared to 
the north (33.54 ± 0.80µM, p=0.0007) (Fig.1A). Maternal serum NO concentration is 
significantly higher in the north (67.75 ± 4.45µM) compared to the south (56.18 ± 2.69µM, 
p=0.0111) (Fig.1B).  However, no correlation was observed between total atmospheric NOx and 
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maternal serum NO levels (Spearman r=-0.06334, 95%CI -0.2076 to 0.08358, p=0.3840, 
including correlations between patients living in the north (Spearman r=0.02235, 95%CI -
0.1979 to 0.2404, p=0.8391) and south (Spearman r=-0.08259, 95%CI -0.2744 to 0.1156, 
p=0.4000). The maternal serum MDA concentrations did not differ between the north and south. 
A significant positive correlation was observed between maternal serum NO and MDA 
concentration as well as for patients living in the north and south (Total: Spearman r=0.2339, 
95%CI 0.1202 to 0.3415, p<0.0001; North: Spearman r=0.2502, 95%CI 0.06309 to 0.4203, 
p=0.0075; South: Spearman r=0.2113, 95%CI 0.063136 to 0.3503, p=0.0043). 
 
 
 
 
 
 
 
 
Figure 1 The concentrations of atmospheric NOx (µg/cm3) (A), maternal serum NO (µM) (B) and 
maternal serum MDA (µM) (C) for patients living in the North ([A] n=109, [B] n=114, [C] n=113) and 
South ([A] n=135, [B] n=183, [C] n=181). Statistical significance: ***p<0.0001, *p<0.05. 
 
Atmospheric NOx showed no difference between HIV+ (36.64 ± 0.80µg/cm
3
) and HIV- (35.07 
± 0.69µg/cm
3
, p=0.1911) patients (Fig.2A), whilst maternal serum NO levels were significantly 
greater in HIV+ (75.29 ± 4.31µM) compared to HIV- (52.84 ± 2.72µM, p<0.0001) patients 
(Fig.2B). The atmospheric NOx levels in HIV+ patients living in the north (36.47 ± 
1.09µg/cm
3
) were significantly higher compared to HIV- patients (31.31 ± 1.07µg/cm
3
, 
p=0.0021), with north HIV- patients having significantly lower atmospheric NOx levels 
compared to south HIV- patients (37.60 ± 0.79µg/cm
3
, p<0.0001) (Fig.2D). The maternal serum 
NO concentration was significantly higher in HIV+ patients in the north (76.35 ± 5.89µM, 
p=0.0022) and south (74.03 ± 6.38µM, p<0.0001) compared to their respective HIV- patients 
(North= 59.45 ± 6.50µM, South= 50.02 ± 2.69µM) (Fig.2E). No relationship between 
atmospheric NOx and maternal serum NO was observed among HIV+ and HIV- patients living 
in the north and south. Maternal serum MDA concentrations showed no difference among 
patients irrespective of HIV status and living location (Fig.2C and 2F). A significant negative 
correlation was observed in HIV- patients between atmospheric NOx and maternal serum MDA 
(Spearman r=-0.1926, 95%CI -0.3635 to -0.009263, p=0.0343), this correlation was 
strengthened in south living HIV- patients (Spearman r=-0.2368, 95%CI -0.4470 to -0.001832, 
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p=0.0422).  However, no correlation is observed in north living patients (Spearman r=-0.09837, 
95%CI -0.3825 to 0.2027, p=0.5106). A significant positive correlation was observed between 
NO and MDA across all subdivisions of HIV status and living location, except HIV+ north 
patients (Table 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Atmospheric NOx (A and D), maternal serum NO (B and E) and maternal serum MDA (C and 
F) concentrations in HIV+ and HIV- patients, including patients subdivided by their living location (D, E 
and F). Statistical significance: ***p<0.0001, **p<0.001.  
 
Table 3 Relationship between the maternal serum NO (log(µM)) concentration and maternal serum 
MDA (log(µM)) for all patients living in the North and South, as well as HIV status 
  
Total HIV+ HIV- 
Total 
Spearman r 
(95%CI) 
p-value 
0.2339 
(0.1202 to 0.3415) 
***<0.0001 
0.2301 
(0.03045 to 0.4122) 
*0.0206 
0.2525 
(0.1112 to 0.3838) 
***0.0004 
          
North 
Spearman r 
(95%CI) 
p-value 
0.2502 
(0.06309 to 0.4203) 
**0.0075 
0.09260 
(-0.1849 to 0.3564) 
0.5013 
0.3378 
(0.07932 to 0.5538) 
**0.0095 
          
South 
Spearman r 
(95%CI) 
p-value 
0.2113 
(0.06316 to 0.3503) 
**0.0043 
0.4450 
(0.1690 to 0.6563) 
**0.0019 
0.2099 
(0.03738 to 0.3703) 
*0.0145 
Statistical significance: ***p<0.0001, **p<0.01 *p<0.05 
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Multivariate analysis for inducers of NO and MDA 
The relationship among maternal serum NO and MDA, atmospheric NOx and HIV status, 
controlled for maternal characteristics, is described in Table 4. An increase in maternal serum 
MDA was associated with a significant increase in maternal serum NO, when controlled for 
potential confounders (Table 4).  For every 1% increase in MDA there would be a 0.6% 
increase in NO for the total population (p<0.0001), 0.76% increase for HIV- mothers 
(p<0.0001), 0.71% for HIV+ mothers (p=0.037), 0.56% for the north (p=0.026) and 0.84% for 
the south (p<0.0001).  A reciprocal increase in MDA resulted from an increase in NO was 
observed in Table 4. Where every 1% increase in NO would lead to a 0.12% increase in MDA 
for the total population (p<0.0001), 0.14% for HIV- mothers (p<0.0001), 0.1% for HIV+ 
mothers (p=0.037), 0.11% for the north (p=0.026) and 0.14% for the south (p<0.0001). In 
HIV+ south living mothers a 1% increase in serum NO would result in a 1.56% increase in 
MDA (β-coefficient: 1.562, 95%CI 0.571 to 2.55, p=0.0003; R2=0.4301, p=0.0699). Mothers 
living in the north was associated with a 0.5% reduction in maternal serum NO if atmospheric 
NOx increased by 1% (p=0.051). The negative correlation between atmospheric NOx and 
serum MDA observed in HIV- patients previously, was further investigated controlling for 
potential confounders. This result was confirmed, were every 1% increase in atmospheric NOx 
would cause a 0.16% reduction in MDA (p=0.045) in HIV- mothers. In HIV- south living 
mothers a reduction of 0.24% in MDA (β-coefficient: -2.375, 95%CI -0.457 to -0.018, p=0.034; 
R
2
=0.1890, p=0.0814) would result from a 1% increase in atmospheric NOx. Being HIV+ 
significantly increased maternal serum NO for the total population, those living in the north and 
south (Table 4). 
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The effects of HIV, location and maternal serum NO and MDA levels on neonatal BW 
Maternal serum NO was significantly greater in patients who delivered babies with a LBW 
(70.00 ± 6.761µM) compared to normal BW (NBW) (57.59 ± 2.340µM, p=0.0292) (Fig.3A). 
No difference was observed for maternal serum MDA (Fig.3B). No difference was observed 
between NO and MDA levels when the patients for LBW and NBW were divided into HIV+ 
and HIV- (Appendix 6: Fig.A6.1). 
 
 
 
Table 4 Impact of atmospheric NOx (log) and HIV on maternal serum NO and MDA (log) 
concentrations – linear regression analysis for total mothers and subdivided into HIV status and 
area with adjustments for maternal characteristics 
 Maternal serum NO (log) concentration 
 
Total HIV Status Area 
 
 (n=189) 
HIV-  
(n=120) 
HIV+ 
(n=69) 
North 
(n=84) 
South 
(n=105) 
Serum MDA (log) 
0.672 
(0.342 - 1.00) 
***<0.0001 
0.759 
(0.344 - 1.17) 
***<0.0001 
0.707 
(0.043 - 1.37) 
*0.037 
0.564 
(0.068 - 1.06) 
*0.026 
0.837 
(0.379 - 1.30) 
***<0.0001 
Atmospheric NOx 
(log) 
-0.153 
(-0.441 - 0.134) 
0.282 
-0.037 
(-0.411 - 0.337) 
0.845 
-0.325 
(-0.854 - 0.203) 
0.369 
-0.444 
(-0.89 - 0.002) 
0.051 
0.113 
(-0.294 - 0.521) 
0.582 
HIV+ 
0.373 
(0.222-0.524) 
***<0.0001 
  
0.493 
(0.236 - 0.750) 
***<0.0001 
0.332 
(0.132 - 0.531) 
**0.001 
 
R2 = 0.2576 
(***p<0.0001) 
R2 = 0.1667 
(*p=0.0142) 
R2 = 0.1585 
(p=0.2920) 
R2 = 0.2720 
(**p=0.0035) 
R2 = 0.3032 
(***p<0.0001) 
 Maternal serum MDA (log) concentration 
 
Total HIV Status Area 
 
(n=189) 
HIV- 
(n=120) 
HIV+ 
(n=69) 
North 
(n=84) 
South 
(n=105) 
Serum NO (log) 
0.124 
(0.063 - 0.184) 
***<0.0001 
0.141 
(0.064 - 0.218) 
***<0.0001 
0.101 
(0.006 - 0.196) 
*0.037 
0.115 
(0.014 - 0.216) 
*0.026 
0.145 
(0.066 - 0.225) 
***<0.0001 
Atmospheric NOx 
(log) 
-0.081 
(-0.205 - 0.042) 
0.193 
-0.161 
(-0.320 - -0.003) 
*0.045 
0.0001 
(-0.202 - 0.203) 
0.999 
-0.031 
(-0.237 - 0.176) 
0.768 
-0.136 
(-0.304 - 0.031) 
0.110 
HIV+ 
-0.047 
(-0.116 - 0.021) 
0.174 
  
-0.034 
(-0.160 - 0.093) 
0.599 
-0.056 
(-0.143 - 0.031) 
0.204 
 
R2 = 0.1213 
(**p=0.009) 
R2 = 0.1800 
(**p=0.0074) 
R2 = 0.32752 
(*p=0.0175) 
R2 = 0.0999 
(p=0.5191) 
R2 = 0.1713 
(*p=0.0299) 
Results described: β-coefficient, (95%CI), p-value with regression model R2-value and p-value. 
Adjusted for maternal characteristics: HIV status, BMI, area, maternal age, Hb, iron and blood pressure systolic and 
diastolic 
Statistical significance: ***p<0.0001, **p<0.01, *p<0.05 
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Figure 3 Maternal serum NO (µM) (A) and MDA (µM) (B) concentrations in patients who delivered 
infants with low BW (LBW) (<2500g) ([A] n=36 and [B] n=36) and normal BW (NBW) (>2500g) ([A] 
n=230 and [B] n=228). Statistical significance: *p<0.05. 
 
A negative trend is suggested between neonatal BW and maternal serum NO (Table 5, 
p=0.0843) concentration. When the HIV status of the patient is taken into consideration the BW 
is significantly correlated with NO, with an increase in NO resulting in a decrease in BW (Table 
5, p=0.0249). This is also observed in patients living in the south (Table 5, p=0.0224). This 
relationship between BW and NO strengthens and is most strongly correlated in HIV+ patients 
living in the south (Spearman r= -0.5167, p=0.0005; Table 5). 
 
In HIV+ patients, a significantly negative correlation was observed between maternal serum 
MDA and neonatal BW (Table 6, p=0.02). This correlation was strengthened in south living 
Table 5  Relationship between the maternal serum NO (log(µM)) concentration and neonatal 
birthweight (log(g)) for all patients living in the North and South, as well as HIV status 
  
Total HIV+ HIV- 
Total 
Spearman r 
(95%CI) 
p-value 
-0.1060 
(-0.2269 to 0.01802) 
0.0843 
-0.2325 
(-0.4215 to -0.02405) 
*0.0249 
0.009826 
(-0.1440 to 0.1632) 
0.8979 
     
North 
Spearman r 
(95%CI) 
p-value 
0.04468 
(-0.1578 to 0.2436) 
0.6573 
-0.04905 
(-0.3279 to 0.2376) 
0.7325 
0.2173 
(-0.07349 to 0.4740) 
0.1296 
     
South 
Spearman r 
(95%CI) 
p-value 
-0.1777 
(-0.3259 to -0.02107) 
*0.0224 
-0.5167 
(-0.7139 to -0.2437) 
***0.0005 
-0.05843 
(-0.2381 to 0.1251) 
0.5209 
Statistical significance: ***p<0.0001, *p<0.05 
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patients (Table 6, p=0.0129), but lost in north living patients (Table 6, p=0.3213). No 
correlation was observed in HIV- patients (Table 6).  
 
Table 6 Relationship between the maternal serum MDA (log(µM)) and neonatal birthweight 
(log(g)) for all patients  living in the North and South, as well as HIV status 
  
Total HIV+ HIV- 
Total 
Spearman r 
(95%CI) 
p-value 
-0.01026 
(-0.1344 to 0.1142) 
0.8682 
-0.2423 
(-0.4310 to -0.03326) 
*0.0200 
0.09462 
(-0.06028 to 0.2451) 
0.2169 
          
North 
Spearman r 
(95%CI) 
p-value 
-0.01905 
(-0.2203 to 0.1838) 
0.8508 
-0.1431 
(-0.4124 to 0.1492) 
0.3213 
0.1039 
(-0.1879 to 0.3789) 
0.4726 
          
South 
Spearman r 
(95%CI) 
p-value 
-0.007495 
(-0.1650 to 0.1504) 
0.9241 
-0.3807 
(-0.6195 to -0.07756) 
*0.0129 
0.08815 
(-0.09635 to 0.2668) 
0.3343 
Statistical significance:*p<0.05 
 
Multivariate analysis determined factors associated with BW reduction 
Factors affecting neonatal BW, controlled for maternal and neonatal characteristics, are 
described in Table 7. Gestational age increased BW significantly across all divisions (Table 7). 
For every 1 unit increase in parity there would be a 9.271g increase in BW for the total 
population (p=0.049) and a 18.1g increase in BW for HIV- mothers (p=0.017). Maternal serum 
NO was negatively correlated with BW in Table 5, this was further investigated and controlled 
for potential confounders in Table 7, which was shown to cause a significant decrease in BW. 
Every 1% increase in maternal serum NO would cause a 18.93g decrease in BW for the total 
population (p=0.022). This strengthened in the HIV- population, where a 1% increase in NO 
resulted in a 23.85g decrease in BW (p=0.02). For south living mothers, a 36.5g decrease in 
BW (p=0.01) resulted from every 1% increase in NO. Mothers carrying male neonates were 
associated with a 37.5g decrease in BW for every 1% increase in NO (p=0.006). Maternal 
serum MDA showed both an increase and decrease in neonatal BW (Table 7). Every 1% 
increase in MDA for HIV- mothers would cause a 61.9g increase in BW (p=0.011) while for 
HIV+ mothers a 107.6g decrease (p=0.052) in BW was observed.  Mothers carrying female 
neonates were associated with a 66.8g increase in BW when a 1% increase is observed in 
atmospheric NOx. Controlling for HIV+ patients showed no significant change in BW (Table 
7).
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Table 7 Impact of atmospheric NOx (log), maternal serum NO and MDA (log) concentrations on neonate birthweight (g) – linear regression 
analysis for total mothers and subdivided into HIV status, area and neonate gender with adjustments for maternal and neonate characteristics 
 Neonate Birthweight (g) 
 
Total HIV Status Area Neonatal Gender 
 
(n=103) 
HIV- 
(n=56) 
HIV+ 
(n=47) 
North 
(n=50) 
South 
(n=53) 
Male 
(n=60) 
Female 
(n=43) 
Gestational 
Age 
101.13 
(50.23 - 152.02) 
***<0.0001 
100.62 
(30.68 - 170.62) 
**0.006 
167.41 
(48.43 - 286.39) 
**0.007 
74.5 
(-13.15 - 162.14) 
*0.093 
109.7 
(33.45 - 185.95) 
**0.006 
123.74 
(33.62 - 213.86) 
**0.008 
68.14 
(0.610 - 135.68) 
*0.048 
Parity 
92.71 
(0.244 - 185.17) 
*0.049 
180.91 
(34.20 - 327.61) 
*0.017 
22.52 
(-118.49 - 163.52) 
0.746 
65.25 
(-59.60 - 190.1) 
0.295 
129.85 
(-47.59 - 307.29) 
0.146 
96.85 
(-57.75 - 251.45) 
0.213 
124.28 
(-3.64 - 252.20) 
0.056 
Serum NO 
(log) 
-189.29 
(-350.57 - -28.01) 
*0.022 
-238.54 
(-437.09 - -39.99) 
*0.02 
-55.82 
(-358.88 - 247.23) 
0.709 
-48.57 
(-289.09 - 191.95) 
0.683 
-364.99 
(-636.81 - -93.17) 
*0.010 
-375.17 
(-636.66 - -113.69) 
**0.006 
-19.38 
(-312.78 - 274.02) 
0.893 
Serum MDA 
(log) 
372.55 
(-30.87 - 775.967) 
0.070 
619.03 
(150.50 - 1087.55) 
*0.011 
-1075.65 
(-2160.52 - 9.23) 
0.052 
309.54 
(-314.97 - 934.04) 
0.320 
414.07 
(-239.56 - 1067.71) 
0.207 
581.63 
(-19.49 - 1182.76) 
0.058 
47.26 
(-635.80 - 730.32) 
0.888 
HIV+ 
-33.01 
(-202.53 - 136.50) 
0.699 
  
-155.57 
(-476.21 - 165.08) 
0.330 
34.4 
(-233.45 - 302.25) 
0.796 
-0.645 
(-240.02 - 238.73) 
0.996 
-96.60 
(-411.67 - 218.46) 
0.533 
Atmospheric 
NOx (log) 
146.32 
(-191.32 - 483.97) 
0.391 
221.93 
(-211.34 - 655.20) 
0.306 
491.71 
(-226.36 - 1209.79) 
0.172 
275.72 
(-287.48 - 838.91) 
0.326 
121.05 
(-424.8 - 666.91) 
0.655 
296.43 
(-270.84 - 863.71) 
0.297 
668.07 
(9.12 - 1327.02) 
*0.047 
 
R2 = 0.6600 
(***p<0.0001) 
R2 = 0.7778 
(***p<0.0001) 
R2 = 0.7057 
(**p=0.0009) 
R2 = 0.7562 
(***p<0.0001) 
R2 = 0.6881 
(**p=0.0002) 
R2 = 0.6990 
(***p<0.0001) 
R2 = 0.7918 
(**p=0.0002) 
Results described: β-coefficient, (95%CI), p-value with regression model R2-value and p-value 
Adjusted for maternal characteristics: HIV status, BMI, area, maternal age, Hb, iron, blood pressure systolic and diastolic, OGG1 Ser326Cys SNP (this polymorphism was taken 
into consideration due to it previously (unpublished data) being associated with HIV and influences birthweight) and neonatal characteristics: gestational age, parity, body: brain 
index, ponderal index, neonate gender, Apgar scores 1min and 5min. 
Statistical significance: ***p<0.0001, **p<0.01, *p<0.05 
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Effects of HIV and location on oxidative and ER stress markers 
Oxidative stress markers’ gene expressions are shown in Figure 4. HIV- mothers living in the 
south were shown to have decreased expression levels of Keap1, OGG1 and CAT with increased 
Nrf2, SOD2 and GPx expression levels compared to the north. In HIV+ south living mothers the 
gene expression of Keap1, OGG1 and GPx decreased, whilst Nrf2, SOD2 and CAT increased 
compared to the north. The OGG1 gene expression (Fig.4C) was increased in HIV+ compared 
to HIV- mothers, however when area was considered, HIV+ south living patients had 
significantly reduced OGG1 gene expression compared to the total HIV+ mothers. Nrf2 was 
positively correlated with CAT and GPx, where an increase in Nrf2 gene expression would lead 
to an increase in CAT and GPx gene expression (Table 9, p<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 The mRNA fold change of oxidative stress markers: A) Keap1, B) Nrf2, C) OGG1, D) SOD2, 
E) CAT, F) GPx found within the third trimester for HIV- and HIV+ patients living in the north and south. 
Statistical significance: ***p<0.0001, **p<0.01, *p<0.05. 
 
Table 9 Relationship among miR-28, miR-144 and Nrf2 RT-PCR fold changes and the 
antioxidant and oxidative stress markers for all patients (n=76) 
 Nrf2 Keap1 OGG1 SOD2 CAT GPx 
miR-144 -0.6290* -0.0033 0.4995* -0.0453 -0.1719 -0.0015 
miR-28 -0.5965* 0.7977* 0.8158* 0.3228* 0.2440 0.1889 
Nrf2 1.00 -0.0002 -0.1640 -0.7455 0.6167* 0.6020* 
Results described: Spearman r. 
Statistical significance:*p<0.05 
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The expression of miR-144 and miR-28 were significantly reduced in both HIV- and HIV+ 
south living patients compared to the north living patients (Fig.5, p<0.0001). The expression of 
miR-144 and miR-28 both were negatively correlated with Nrf2 (Table 9, p<0.05) and miR-28 
was positively associated with Keap1, OGG1 and SOD2 (Table 9, p<0.05). Living in the 
heavily polluted south reduced the expression of both miR-144 and miR-28 by -95.73 and -
11.73 fold respectively (Table 10, p<0.0001). Being HIV positive decreased miR-28 expression 
by -4.5 fold whilst it increased the expression of miR-144 by 51.07 fold (Table 10, p<0.0001). 
 
 
 
 
 
 
 
 
 
Figure 5 The expression of (A) miR-144 and (B) miR-28 within third trimester for HIV- and HIV+ 
patients living in the North and South. Statistical significance: **p<0.0001, ***p<0.01. 
 
Table 10 Impact of atmospheric NOx, HIV status and living in the south on the expressions of 
miR-144 and miR-28 (n=68) 
 miR-144 miR-28 
Atmospheric NOx (log) 
17.08 
(-7.8 to 41.97) 
0.174 
-2.29 
(-5.62 to 1.04) 
0.174 
HIV+ 
51.07 
(37.58 to 64.55) 
***<0.0001 
-4.50 
(-6.29 to -2.68) 
***<0.0001 
Area (South) 
-95.73 
(-108.26 to -83.20) 
***<0.0001 
-11.73 
(-13.41 to -10.05) 
***<0.0001 
 
R
2
=0.8908 
(***<0.0001) 
R
2
= 0.8538 
(***<0.0001) 
Results described: β-coefficient, (95%CI), p-value with regression model R2-value and p-value. 
Adjusted for maternal characteristics: BMI, maternal age, Hb, iron and blood pressure systolic and diastolic, NO and 
MDA 
Statistical significance: ***p<0.0001 
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It was interesting to note that SOD2 gene expression was shown to be influenced by maternal 
serum NO concentrations (Table 8). For the total population a positive correlation was observed 
between serum NO and SOD2 fold change. When area is taken into account, the south living 
mothers had a stronger positive correlation (Table 8, p<0.05) whilst north living mothers had a 
stronger negative correlation (Table 8, p<0.05) between serum NO and SOD2 gene expression. 
The gene expression for ER stress markers are shown in Figure 6. In HIV- mothers the gene 
expression for eIF2, ATF4 and CHOP were significantly increased within the south living 
(eIF2: 1.019±0.046; ATF4: 1.161±0.042; CHOP: 1.655±0.075) mothers compared to the north 
(eIF2: 0.763±0.021, p<0.05; ATF4:0.765±0.079, p<0.01; CHOP: 1.215±0.105, p<0.01). The 
expression of BiP increased (SHIV-:1.087±0.015; NHIV-: 1.057±0.029, p=0.536), although not 
significant. The gene expression of all ER stress markers were greater in HIV- south living 
patients compared to HIV+ south living patients (eIF2: 0.8593±0.080; ATF4: 1.141±0.061; 
CHOP: 0.5436±0.015; BiP: 0.7380±0.036), with CHOP (p<0.0001) and BiP (p<0.0001) fold 
changes significantly different. In HIV+ mothers the eIF2 and ATF4 gene expressions are 
greater in the south compared to north (eIF2: 0.8264±0.069, p>0.05; ATF4: 0.7967±0.019, 
p<0.05) living mothers, whilst both CHOP and BiP are significantly greater in the north 
(CHOP: 0.946±0.013, p<0.05; BiP: 0.9549±0.010, p<0.0001) compared to south living 
mothers. The gene expression of ER stress markers’ eIF2 and ATF4 were found to have a 
negative correlation with maternal serum NO for the total population (Table 8). This negative 
correlation was strengthened in south living mothers (Table 8, p<0.05) whilst it was reversed to 
a positive correlation in north living mothers (Table 8, p<0.05). 
 
 
 
 
 
 
Table 8 Relationship between maternal serum NO (log(uM)) and the fold change of antioxidant and ER stress markers for all 
patients (n=76), and those living in the North (n=39) and South (n=37) 
 RT-PCR Fold Change (2-ΔΔCt) 
 
OGG1 SOD2 CAT GPx Keap1 Nrf2 BiP eIF2 ATF4 CHOP 
Maternal serum NO 
Total -0.0653 0.2040 -0.3917* -0.3917* -0.3386* -0.3290* -0.3386* -0.1412 -0.1412 -0.3917* 
North -0.4540* -0.4540* -0.4540* -0.4540* -0.4540* -0.4540* -0.4540* 0.4540* 0.4540* -0.4540* 
South -0.4346* 0.4346* -0.4346* -0.4346* -0.4346* -0.4346* -0.4346* -0.4346* -0.4346* -0.4346* 
Results described: Spearman r. 
Statistical significance: *p<0.05. 
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Figure 6 The mRNA fold change of ER stress markers found within third trimester for HIV- and HIV+ 
patients living in the North and South. Statistical significance: ***p<0.0001, **p<0.01, *p<0.05. 
 
 
Discussion 
Macrophages, play a pivotal role in the innate immune response, are among the first cells in 
contact with HIV and have been implicated as a major reservoir of HIV during its subclinical 
infection [33]. HIV has shown to stimulate macrophages to produce NO, with HIV env gp120 
[34] and regulatory Tat protein considered inducers of NO through the activation of iNOS and 
eNOS genes [5,33]. Several studies have also shown increased sera NO production in 
asymptomatic HIV-infected patients [35], children and adults with acquired immune deficiency 
syndrome (AIDS) and especially those with opportunistic diseases [36–38]. Pro-inflammatory 
cytokines, such as TNFα and INFγ, increase NO production from HIV-infected macrophages 
[36,39]. Increased levels of NO have been reported in blood plasma of women during gestation 
[40]. Our study showed increased levels of serum NO concentrations in HIV+ mothers 
compared to HIV- mothers (Fig.2B and 2E), with being HIV+ shown to induce NO production 
(Table 4). 
 
NO’s highly reactive intermediate peroxynitrite, inhibits the electron transport chain, causes 
oxidation of biological thiol compounds and induces LP [10]. Therefore an increase in NO, 
within a highly aerobic environment would lead to increased peroxynitrite formation and 
subsequent LP. Our study supports this observation where increased serum NO was shown to 
increase serum MDA concentrations (Table 3 and 4). Interestingly, a reciprocal activity was 
observed between NO and MDA concentrations, where one increased the other and vice versa 
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(Table 3 and 4). Although an increase in MDA concentrations in HIV patients has been reported 
previously [41,42], HIV was shown to have no direct effect on MDA concentrations within our 
study population (Table 4), suggesting MDA increased as a result of the indirect activity of HIV 
through increased NO production. 
 
Additionally, exposure to pollutants in the heavily industrialised SD and less industrialised ND, 
especially traffic-related NOx AP, was hypothesised to have an effect on NO and MDA levels 
[28].  Atmospheric NOx was shown to have no effect on serum NO levels, however it was 
suggested to cause a decrease in NO levels in ND (Table 4, p=0.051). The north was shown to 
have a lower concentration of atmospheric NOx compared to the south (Fig.1A), thus proposing 
that low exogenous sources of NOx had a minimal effect on the endogenous production of NO. 
Inhalation of NOx from the environment enters the blood stream and is taken up by Hb, through 
this low levels of NOx become inactive [43]. Nagiah et al. reported increased MDA levels 
within SD [28], however this was not significant and increasing the sample size within this 
study showed no change was observed between ND and SD (Fig.1C). Taking into consideration 
HIV and a specific pollutant altered the initial finding. Atmospheric NOx was shown to 
decrease levels of MDA in HIV- patients (Table 4), with only a slight decrease in NOx levels 
observed in these patients (Fig.2A) and lower levels of NO (Fig.2B). This inhibition of LP as a 
result of NOx could be due to NO’s ability to terminate LP propagation, as the unpaired NO 
radical reacts with an unpaired peroxyl radical, thereby neutralising the reaction [44]. 
 
Our study further investigated the effects of maternal serum NO and MDA, HIV-infection and 
atmospheric NOx had on neonatal BW. Previous studies have shown that NOx pollution was 
associated with LBW [17], increased levels of NO and MDA in PTB [11,13] and HIV 
associated with risk of LBW and PTB [2].  
 
Our study shows NO may play a role in the aetiology of LBW, with HIV having no direct 
influence on the reduction of BW. The levels of NO increased within mothers delivering LBW 
neonates (Fig.3A), with the HIV status of the mother having no affect (Appendix 6: Fig.A6.1). 
In addition BW was reduced by increasing NO (Table 5 and 7). It has been proposed that the 
inhibition or restriction of foetal growth could be a consequence of pulmonary and placental 
inflammation, increased blood viscosity and coagulation. These alterations in endothelial and 
vascular functions thereby compromise placental blood flow and transfer of oxygen (O2) and 
nutrients between mother and foetus [45]. As mentioned previously, NO is readily absorbed into 
the blood stream and binds to Hb which forms methemoglobin (MethHb) [16]. MethHb is 
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known to have reduced O2 carrying capacity, which could in turn lead to reduced O2 transfer at 
the utero-placental interface thereby negatively impacting on foetal growth [13]. Although SD 
NOx concentrations did not directly increase NO (Table 4), other pollutants in the area (not 
measured) [46] could be responsible for the increasing NO which may lead to BW reduction. It 
was interesting to note that carrying a male neonate significantly impacted on NO concentration 
leading to reduced BW, while carrying a female neonate and being exposed to high levels of 
NOx increased BW (Table 7). Since, it is well known that male infants compared to female 
infants have a larger BW for GA [47]. 
 
Our results indicate that HIV may play a differential role in MDA induced effect on BW (Table 
7). It was observed that HIV- mothers were associated with an increase in BW (p=0.011) and 
HIV+ mothers were associated with a reduction in BW (p=0.052), as a consequence of 
increasing MDA (Table 6 and 7). Pregnancy is characterised by a high energy requirement and 
increased basal O2 demand that favours reactive oxygen species (ROS) production [43], and as 
such increased levels of ROS would be expected in HIV- mothers leading to increased MDA 
levels. However, this may not impact negatively on the foetus as scavengers of oxidants are 
present to help reduce ROS. This is observed in Figure 4, where SOD2 (Fig.4, p<0.05) and CAT 
(Fig.4, p>0.05) gene expression levels were greater in HIV- mothers compared to HIV+ 
mothers. The chronic oxidative stress observed in HIV+ patients [4] and increased NO 
production would lead to increased MDA concentrations, and potentially further increase NO 
levels (reciprocal interaction observed, Table 3 and 4), above antioxidants capacity. This could 
lead to vascular tissue damage, increased inflammation and alterations in placental O2 transfer 
which could impact negatively on foetal growth [45]. 
 
The Nrf2-Keap1 pathway is responsible for the regulation of antioxidants in response to 
oxidative damage to maintain homeostasis. Upon oxidative damage, Nrf2 dissociates from the 
Keap1 complex, allowing it to translocate to the nucleus where it binds to the ARE and induces 
the transcriptional activation of specific target genes, including SOD2, CAT and GPx [48]. This 
study showed that Nrf2 was positively associated with CAT and GPx (Table 9, p<0.05), with a 
significant increase observed in Nrf2, CAT and GPx expressions in HIV- south living patients 
compared to the total HIV- patients (Fig.4). A reduced Nrf2 expression was observed by Nagiah 
et al. [28], however HIV infection was not considered in their study and may explain the 
difference observed as HIV+ SD living patients had significantly reduced Nrf2 mRNA 
expression levels as compared to HIV- SD patients in this study (Fig.4B). It was interesting to 
note that the mRNA expression of SOD2 was significantly reduced in HIV+ patients compared 
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to HIV- patients; whilst HIV+ patients living in SD had greater SOD2 expressions than ND 
(Fig.4). The reduction of SOD2 in HIV+ patients could be due to the inhibition of SOD2 by the 
HIV Tat protein. It has been shown to inhibit the binding of Sp1 and Sp3 transcriptional factors 
to SOD2 gene promoter and binds to its mRNA [4]. The increase in SOD2 in south living HIV+ 
patients, also reported within Nagiah et al. SD patients [28], could be a result of increased 
maternal serum NO as it was observed within this study that serum NO was positively 
associated with SOD2 gene expression for SD patients whilst ND patients had a negative 
correlation between serum NO and SOD2 gene expression (Table 8). Reduced expression of 
OGG1 was observed for both HIV- and HIV+ SD patients compared to ND, which was also 
reported by Nagiah et al. [28]. However, this study identified a negative association that exists 
between maternal serum NO and OGG1 gene expression for both ND and SD patients (Table 
8). This is in agreement with literature where studies have reported that NO inhibits OGG1 gene 
expression [23,49]. 
 
Genetic susceptibility is highly important when considering interactions between the 
environment and health outcomes [50]. The study of epigenetics, defined as the study of 
heritable differences in gene expression that does not alter the DNA sequence, has been most 
notably highlighted as an important potential mechanism for regulation of the Nrf2-Keap1 
pathway [51]. Studies have shown that miR-144 and miR-28 are negatively associated with 
Nrf2 [25,26]. This study observed a similar effect, where an increase in miR-144 and miR-28 
expression levels led to a decrease in Nrf2 expression (Table 9), whilst miR-28 was positively 
associated with Keap1 (Table 9). The expression of miR-144 was reduced as a consequence of 
living in the industrialised SD but increased in HIV+ patients and exposure to atmospheric NOx 
(Table 10). MiR-144 has been shown previously to be upregulated in high viral load HIV+ 
patients [52]. The expression of miR-28 was decreased in HIV+ patients living in the 
industrialised SD (Table 10). MiR-28 has been reported to target the 3’-UTR of the HIV 
genome, thereby inhibiting HIV replication and contributing to viral latency [53]. These results 
suggest that HIV and atmospheric NOx induced miR-144 expression leading to reduced Nrf2 
expression levels and thus reducing antioxidant capacity with increased oxidative stress. 
 
The increase in oxidative stress, as a result of high pollution levels within the south could lead 
to the disruption of cellular calcium homeostasis. This homeostasis is necessary for the proper 
function of the ER’s protein folding machinery and disruption would lead to the activation of 
the UPR pathway [54,55]. The UPR endeavours to restore balance to the ER, failure to mitigate 
ER stress can lead to cellular death [56]. Upon increase in ER stress, the ER chaperone BiP 
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dissociates from UP sensors and activates the UPR. The UPR comprises of three separate arms 
initiated by PERK, IRE1α or ATF6. The PERK arm phosphorylates eIF2α which in turn induces 
translation of ATF4 mRNA. The PERK-eIF2α-ATF4 regulatory arm induces antioxidant stress-
response genes and pro-apoptotic genes including CHOP [57]. HIV- south living patients had 
increased eIF2, ATF4 and CHOP (Fig.6) gene expression levels compared to ND patients. 
Therefore the high levels of pollution found within the south, including atmospheric NOx would 
lead to increased ER stress via the PERK-eIF2-ATF4 pathway, thus increasing expression levels 
of CHOP which could lead to increased apoptosis. 
 
In conclusion, this study demonstrated increased maternal serum NO as a consequence of HIV 
infection, with reciprocal action on MDA levels. The induction of the miR-144 was implicated 
as a mechanism for increased oxidative stress due to HIV exposure. The PERK-eIF2α-ATF4 
pathway is proposed as a mechanism for increased ER stress due to exposure to the heavily 
polluted south Durban. Increased NO levels was observed to reduce BW, especially mothers 
exposed to higher levels of pollution. HIV was shown to differentially influence MDA effect on 
neonatal BW. The results of this study indicate that NO may play a key role in neonatal BW 
reduction as a consequence of traffic-related AP and HIV infection. This is of particular 
importance for SA, due to the high number of individuals with HIV infection and increased 
urbanisation. By identifying risks for LBW and PTB, it allows for the proper management and 
prevention of these adverse birth outcomes in developing countries. 
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CHAPTER 5 
Discussion, Conclusion and Recommendations 
 
In the African region, approximately 2.2 million deaths per annum are linked to living or 
working within an unhealthy environment. Of these 270,000 deaths are associated with neonatal 
conditions including PTB and LBW [1]. South Africa, a rapidly developing country that is 
heavily burdened by HIV/AIDS [2] and obesity [3], faces rapid deterioration of the environment 
and air quality as a consequence of a growing urban population. This is most notably observed 
within SD, where residents that largely comprise low-income households or informal 
settlements are living within close proximity to heavily industrialised areas. In addition to these 
dense communities living near busy roads, they rely mostly on domestic fuels for cooking and 
heating [4]. Therefore, these dense human settlements are continuously exposed to large 
amounts of AAP and are greatly at risk for adverse AAP effects including respiratory conditions 
and adverse birth outcomes [5].  
 
In SA, individuals living within low-income households or informal settlements rely largely on 
healthcare within government hospitals. These hospitals are often overcrowded and have limited 
provisions to care for premature babies or those born with adverse birth outcomes [6, 7]. 
Therefore, it is essential to identify novel biomarkers or interventional therapies to help reduce 
the burden of adverse birth outcomes. To do this understanding the aetiology of adverse birth 
outcomes is crucial and to determine risk factors associated with individual susceptibility to 
these conditions. Ambient air pollution and OS have been implicated in adverse birth outcome 
aetiology, including genetic susceptibility.  Pregnant women living within the SD have been 
reported to have increased OS markers [8], in addition to high pollution levels detected within 
SD [9, 10] makes for an ideal follow up study to determine their effects on adverse birth 
outcome susceptibility within this population. Therefore this study was conducted to investigate 
oxidative and endoplasmic stress responses within pregnant women exposed to AAP living 
within Durban (SA) and determined their effect on PTB and LBW susceptibility. In addition, 
HIV infection, obesity and gene-environment interactions were determined; this is paramount 
within SA context due to the heavy burden of these conditions. 
 
First, it was shown that an increase in atmospheric NOx exposure induced OS via the formation 
of 8-OHdG adducts within pregnant women, this was most noticeably observed within SD and 
for women carrying female neonates. This direct association was identified after the initial 
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finding that SD had higher levels of atmospheric NOx and pregnant women living in SD had 
greater concentrations of serum 8-OHdG. Inhalation of atmospheric NOx and subsequent 
absorption into the lung leads to the formation of free radicals that are able to directly interact 
with macromolecules present including DNA. This induces the production of mutagenic 8-
OHdG lesions leading to increased OS [11, 12]. Antioxidants such as GST are important 
controllers of OS; however, polymorphisms exist within GSTM1 and GSTP1 which have been 
shown to influence an individual’s response to toxic insult viz. exposure to AAP [13–15]. 
Pregnant women carrying the variant GSTP1 genotypes had increased susceptibility to OS 
following NOx exposure.  Although an increase in 8-OHdG did not directly influence the 
susceptibility to adverse birth outcomes, it may play a role in the reduction of GA. This 
reduction of GA as a consequence of increased atmospheric NOx levels was found to be 
significant only after maternal serum 8-OHdG levels were controlled within the multi-
regression analysis. In addition, carrying the variant GSTP1 genotypes and a male neonate 
increased the risk of reduced GA. It should be noted that although the individual reduction of 
GA was minimal, on a global scale this negative shift may lead to increased incidence of 
nationwide PTB. 
 
A polymorphism exists within OOG1; the key component within the DNA repair pathway that 
removes 8-OHdG adducts and reduces OS. This polymorphism (OGG1 Ser326Cys) has been 
suggested to affect BMI and therefore may predispose SA women to adverse effects of obesity 
[16]. In addition to obesity, SA is also heavily burdened with HIV infections where more than 
half the infected population are women [2, 3], which makes them susceptible to oxidative-
related injury including adverse birth outcomes [17–19].   The OGG1 Ser326Cys polymorphism 
was associated with HIV and obesity.  Pregnant women carrying the wt OGG1 Ser326Cys 
genotype were at greater risk for HIV associated LBW and PTB, this risk was found to increase 
in comorbid obese and HIV infected CC-carrying patients with those living in SD even more 
susceptible to HIV associated LBW. Women who were HIV+ and obese delivered larger BW 
neonates compared to HIV- obese women, therefore suggesting that comorbid HIV and obesity 
increases the risk for reduced BW and delivering LBW neonates. Women living within the 
heavily polluted SD and carrying the wt OGG1 Ser326Cys genotype had increased risk of 
delivering PTB neonates. Further investigation into the possible mechanism by which HIV, 
obesity and carrying the wt Ser326Cys OGG1 genotype increases the susceptibility of LBW and 
PTB may identify potential intervention strategies to help reduce the incidence of PTB with SA. 
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It has been reported that NO inhibits zinc-finger proteins, such as OGG1 [20, 21]. In addition, 
HIV patients present with increased levels of NO [22–24]. The levels of maternal serum NO 
were next investigated, as it may identify a potential pathway for adverse birth outcome 
susceptibility as a result of HIV or NOx exposure. As NO metabolites are known to initiate LP 
[25], maternal serum MDA levels were investigated in conjunction with NO levels.  HIV 
infection within pregnant women induced maternal serum NO production with reciprocal action 
on MDA levels. Atmospheric NOx was not shown to directly affect the concentration of NO, 
however living within SD strengthened the reciprocal activity of NO and MDA. 
 
This increase in NO, as a result of HIV induction, was shown to play a role in LBW aetiology 
through its ability to reduce neonatal BW and increased levels of NO present within mothers 
giving birth to LBW neonates.  The reduction or inhibition of foetal growth may be due to 
placental and pulmonary inflammation, with changes in endothelial and vascular functions 
leading to reduced placental blood flow and transfer of oxygen and nutrients between mother 
and foetus. Upon entry into the blood stream, NO binds to Hb and forms methHb that has 
reduced oxygen carrying capacity. This may prevent sufficient oxygenation of the foetus 
leading to reduced foetal growth [11, 26]. It was interesting to note that women carrying male 
neonates where highly susceptible to reduced BW as a consequence of increased NO 
concentrations, similarly observed above with reduced GA due to increased NOx exposure.  
 
In addition, HIV was shown to differentially affect MDAs effect on BW. In the presence of HIV 
infection, increased levels of MDA reduced neonatal BW. Whilst in the absence of HIV, 
increased levels of MDA increased neonatal BW. In the absence of HIV, antioxidants are able 
to scavenge free radicals which reduce the harmful effect of ROS and therefore would not 
impact negatively on foetal growth. However in the presence of HIV, the body is under chronic 
OS which induces high levels of NO and MDA above antioxidant capacity (decreased 
expression of SOD2 and CAT were observed). Furthermore, NO inhibited OGG1 gene 
expression, evidence by a negative association between serum NO and OGG1 expression, 
which may compromise the efficiency of the DNA repair pathway leading to increased DNA 
adducts and OS. This may cause vascular tissue damage, increased inflammation and alterations 
of placental oxygen exchange which may reduce foetal growth [27, 28].  
 
The key regulator of the antioxidant response, that endeavours to control oxidant homeostasis, is 
the transcription factor Nrf2 [29]. The expression of Nrf2 is under epigenetic control, where 
non-coding miRs including miR-144 and miR-28 have been described to suppress its expression 
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thereby preventing it from preforming its function [30–32]. This study provides further evidence 
for the inhibition of Nrf2 expression as a result of miR-144 and miR-28 induction, as observed 
by the negative association between miR-144/miR-28 and Nrf2. The exposure to HIV infection 
and increased levels of atmospheric NOx induced miR-144 expression within pregnant women. 
This has been proposed as a possible mechanism for OS induction and subsequent reduction in 
GA and BW as a consequence of HIV/NOx exposure. Targeting this pathway, through the 
suppression of Nrf2 inhibitors or the induction of Nrf2, may be a potential therapeutic invention 
strategy for the reduction of adverse birth outcome incidences. Where upon the activation of 
Nrf2, stimulates antioxidant gene transcription leading to reduced OS which may mitigate 
oxidative related injuries. However, further investigation into this pathway using a larger study 
size, is required to confirm these findings.  
 
Excessive ROS production, as observed within OS in response to high levels of pollution within 
SD, may lead to cellular calcium homeostasis. This disruption impairs the efficacy of the ER 
protein folding machinery resulting in the accumulation of UP and subsequent activation of the 
UPR [33]. It was observed that HIV- south living pregnant women were at greatest risk for ER 
stress, via the activation of the PERK-eIF2-ATF4 pathway, evidence by increased expression of 
eIF2, ATF4 and CHOP. This may further increase ROS production, due to the reciprocal 
activity of ER stress on OS and vice versa, potentiating oxidant-related injury [34]. This may 
predispose pregnant women living within SD to adverse birth outcomes. Investigating the other 
two arms of UPR, i.e. IRE1α and ATF6, in future studies would give further insight into the 
mechanism of ER stress induced OS and possible negative impacts on foetal growth. 
 
In conclusion, pregnant women living within SD and exposed to increased levels of atmospheric 
NOx and HIV infection have elevated OS which predisposes them to adverse birth outcomes. 
Implicated in the elevation of OS: induction of miR-144 leading to reduced Nrf2 control and 
antioxidant response, activation of the PERK-eIF2-ATF4 UPR pathway and the induction of 
NO, which plays a key role in HIV associated LBW/PTB. Pregnant women carrying the variant 
GSTP1 and wt OGG1 Ser326Cys genotypes were found to be susceptible to reduced GA and 
PTB, respectively. However, as disease aetiologies involve complex interactions between 
different genes and the environment, future studies focusing on multiple gene and environment 
interactions may give further insight into adverse birth outcome susceptibility as a result of 
AAP exposure. 
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The limitations for this study include a relatively small sample size; the power of the results 
would increase with a larger study population. In addition, this study focused on only one 
specific pollutant (NOx). As individuals are exposed to several pollutants within the air at once 
(e.g. PM. SO2, CO and NOx), studying pollutant interactions, gene-pollutant and multiple gene-
pollutant interactions may give further insight into the mechanistic link between elevated OS 
and adverse birth outcomes. Furthermore, the ethnicity of study participants should be 
considered (even though the majority of our study participants were black South Africans), as 
polymorphic susceptibilities vary among different racial groups. 
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APPENDIX 2 
 
Determination of Single Nucleotide Polymorphism Genotypes 
As described within the methodology sections of chapter 2 and 3, the genotypes of SNPs were 
determined using the differential PCR or PCR-RFLP. The visualisation of the amplification 
products after electrophoresis was done using the Bio-Rad ChemiDoc
TM
 XRS+ System and 
Image Lab
TM
 Software. The following band images were obtained to represent the genotypes of 
the SNPs investigated: 
 
Chapter 2 – The effect of NOx pollution on oxidative stress in pregnant women living in Duran, 
South Africa 
 
GSTM1 SNP genotypes 
 
 
 
 
Figure A2.1 Visualisation of GSTM1differential PCR amplicons after electrophoresis, representing the 
genotypes of the GSTM1 SNP. The 0/+ genotype is represented by two bands, a 268bp and 218bp 
amplicon. The 0/0 genotype is represented by one band, the 268bp amplicon. 
 
GSTP1 SNP Genotypes 
 
 
 
 
 
 
 
Figure A2.2 Visualisation of GSTP1 PCR-RFLP amplicons after electrophoresis, representing the 
genotypes of the GSTP1 SNP. The homozygous AA genotype is represented by a single band (176bp), 
the heterozygous AG genotype is represented by three bands (176bp, 91bp and 85bp), whilst the 
homozygous GG genotype is represented by two bands (91bp and 85bp). 
 
Genotypes       0/0        0/+          0/+        0/+         0/+        0/+         0/+        0/+        0/0 
268bp 
218bp 
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176bp 
91bp 
85bp 
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OGG1 SNP genotypes 
 
 
 
 
 
 
 
 
 
Figure A2.3 Visualisation of the OGG1 PCR-RFLP amplicons after electrophoresis, representing the 
genotypes of the OGG1 SNP. All genotypes have a 21bp amplicon due to a Sat1 invariant site induced by 
the mismatch. The homozygous CC genotype is represented by a one band (213bp), the heterozygous CG 
genotype is represented by three bands (213bp, 164bp and 49bp), whilst the homozygous GG genotype is 
represented by two bands (164bp and 49bp). 
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APPENDIX 3 
 
Quantification of 8-oxoguanosine – Standard curve for Chapter 2 
The OxiSelect™ Oxidative DNA Damage ELISA Kit (Cell Biolabs. Inc.) was used to quantify 
the concentration of 8-OHdG within maternal serum samples.  Ten 8-OHdG standards were 
prepared through serial dilution, where 10µL of the 8-OHdG was diluted in 990µL of assay 
diluent, followed by 8 dilutions of 500µL assay diluent. The last standard would contain only 
assay diluent which would set up 10 standards of 8-OHdG with concentrations ranging from 0-
20ng/mL. A standard curve was set up following the completed assay as per manufacturer’s 
instructions (Figure A3.1). This was used to generate a logarithmic equation for the best fit line 
which was used to extrapolate the concentrations of the unknown samples. 
 
 
Figure A3.1 Standard curve using known 8-OHdG concentrations (in duplicate) to extrapolate the 8-
OHdG concentration within unknown serum samples using the OxiSelect™ Oxidative DNA Damage 
ELISA. 
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APPENDIX 4 
 
Chapter 3 – OGG1 Ser326Cys polymorphism, HIV, obesity and air pollution exposure 
influences adverse birth outcome susceptibility, within South African Women – 
Supplementary Material 
 
Table A4.1 OGG1 Genotypic and obesity frequency distributions among patients delivering 
LBW or NBW neonates, at term (TB) or pre-term (PTB) that are HIV+ and HIV- (n=302) 
 Birth Weight (g) Gestational Age (weeks) 
 NBW n(%) LBW n(%) p-value TB n(%) PTB n(%) p-value 
Non-obese, CC genotype      
T3       
    56 (90.32) 6 (9.68) 
*0.024 
    17 (70.83) 7 (29.17) 
Obese, CC genotype      
T3       
HIV- 44 (93.62) 3 (6.38) 
*0.029 
   
HIV+ 39 (78) 11 (22)    
Obese, South living      
T1       
HIV- 45 (97.83) 1 (2.17) 
*0.022 
   
HIV+ 19 (82.61) 4 (17.39)    
n=sample size, NBW= normal birth weight, LBW= low birth weight, TB=term birth, PTB= pre-term birth 
NBW (>2500g), LBW (<2500g), TB (>37 weeks), PTB (<37 weeks) 
Statistical significance: *p<0.05 
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Table A4.2 Impact of maternal clinical characteristics on the risk of low birth weight – 
a multi-variate logistic regression analysis (n=128) 
Variable OR
a
 (95%CI) p-value 
 Low Birth Weight 
HIV 0.844 (0.045, 15.74) 0.910 
Maternal age 1.10 (0.783, 1.55) 0.578 
BMI 1.00 (0.999, 1.00) 0.482 
Hb 1.01 (0.960, 1.06) 0.746 
Iron 0.995 (0.956, 1.04) 0.836 
BP systolic 1.00 (0.999, 1.00) 0.770 
BP diastolic 0.999 (0.996, 1.00) 0.135 
OGG1 (CC genotype) 0.407 (0.013, 12.99) 0.611 
Area (South) 0.959 (0.028, 33.34) 0.982 
NOx levels 1.23 (0.990, 1.54) 0.061 
 R2 = 0.7930 (**p<0.0001) 
Results described: OR, (95%CI), p-value with regression model R
2
-value and p-value 
n= sample size, OR= odds ratio, CI= confidence interval, HIV= HIV positive, BMI= body mass index, Hb= 
haemoglobin, BP= blood pressure, OGG1 represents CC genotype, Area represents heavily polluted south 
a
Adjusted for maternal characteristics: HIV status, BMI, area, NOx levels, maternal age, haemoglobin, iron, 
blood pressure systolic and diastolic, OGG1 CC SNP and neonatal characteristics: low birth weight, neonate 
gender, parity, body: brain index, ponderal index, Apgar scores 1min and 5min (head circumference and 
neonatal length weren’t adjusted for because of collinearity) 
Statistical significance: **p<0.01, *p<0.05 
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Table A4.3 OGG1 Genotypic frequency distributions among patients delivering male and female 
neonates that are NBW/LBW, at TB/PTB that are HIV+ and HIV- (n=302) 
 Birth Weight (g) Gestational Age (weeks) 
 NBW n(%) LBW n(%) p-value TB n(%) PTB n(%) p-value 
Male       
HIV- 128 (88.28) 17 (11.72) 0.417 137 (94.48) 8 (5.52) *0.024 
HIV+ 71 (84.52) 13 (15.48)  72 (85.71) 12 (14.29)  
Female       
HIV- 132 (88.59) 17 (11.41) 0.073 133 (89.86) 15 (10.14) 0.813 
HIV+ 54 (79.41) 14 (14.29)  60 (90.91) 6 (9.09)  
Male CC       
HIV- 53 (88.33) 7 (11.67) 0.440 56 (93.33) 4 (6.67) *0.05 
HIV+ 34 (82.93) 7 (17.07)  33 (80.49) 8 (19.51)  
Male CG+GG       
HIV- 29 (82.86) 6 (17.14) 0.726 33 (94.29) 2 (5.71) 0.322 
HIV+ 11 (78.57) 3 (21.43)  12 (85.71) 2 (14.29)  
Female CC       
HIV- 45 (91.84) 4 (8.16) *0.024 44 (89.80) 5 (10.20) 0.325 
HIV+ 25 (73.53) 9 (26.47)  28 (82.35) 6 (17.65)  
Female CG+GG       
HIV- 33 (89.19) 4 (10.81) 0.890 33 (89.19) 4 (10.81) 0.362 
HIV+ 7 (87.50) 1 (12.50)  7 (100) 0 (0)  
n=sample size, NBW= normal birth weight, LBW= low birth weight, TB=term birth, PTB= pre-term birth 
NBW (>2500g), LBW (<2500g), TB (>37 weeks), PTB (<37 weeks) 
Statistical significance: *p<0.05 
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APPENDIX 5 
 
Quantification of nitrites and nitrates – Standard curve for Chapter 4 
An in-house method for the quantification of NO metabolites (nitrites/nitrates) was used to 
determine the concentration of NO within maternal serum samples.  Nine sodium nitrate 
standards were prepared through serial dilution. The last standard would contain only dH2O 
which would set up 9 standards of known nitrate concentration ranging from 0-200µM. After 
the assay was performed, as described in chapter 4 methodology section, a standard curve was 
set up (Figure A5.1). This was used to generate a linear equation for the best fit line which was 
used to extrapolate the concentrations of the unknown serum samples. 
 
 
Figure A5.1 Standard curve set up with known sodium nitrate concentrations (in duplicate) to extrapolate 
the NO concentration within unknown serum samples. 
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APPENDIX 6 
 
Chapter 4 – HIV induces nitric oxide and lipid peroxidation, which influences neonatal 
birthweight in a South African population – Supplementary Material 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A6.1 Maternal serum NO (µM) (A) and MDA (µM) (B) levels between HIV+ and HIV- mothers 
who deliver low birthweight (LBW) (<2500g) and normal birthweight (NBW) (>2500g) neonates. 
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